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ABSTRACT
Typhoid fever is a systemic infection caused by the bacterium Salmonella enterica 
serovar Typhi. It remains a major public health problem throughout the developing world 
with over 22 million people infected each year. The emergence o f resistance to 
chloramphenicol and other antimicrobials has been a major setback and we now face the 
very real prospect that untreatable typhoid fever will emerge. Understanding host genetics 
may yield answers that lead to the development of new therapeutics for infectious disease 
such as typhoid fever. Using a genetic approach we aim to investigate a number of 
immune response genes that may be important in the defense against typhoid fever. Here 
we describe studies investigating the genetic variation within some human innate 
immunity genes which may play an important role in susceptibility to typhoid fever.
The TLR4 gene encoding the principal receptor for bacterial endotoxin recognition, an 
element of innate immunity that contributes to the first line of defense against infectious 
disease was investigated. We determined the extent of genetic variation within TLR4 in a 
Vietnamese kinh population and identified a number of novel missense mutations. It 
appears that this gene may be involved in defense against typhoid fever, as evidenced by 
weak associations with two SNPs and the presence of low frequency non-synonymous 
SNPs in only typhoid fever cases which may have the potential to alter protein function. 
The haplotypic structure of a 150Kb genomic region encompassing TNFA was determined 
in a Vietnamese population. This allowed the identification of 15 haplotype tagging SNPs 
which were genotyped in a case/control genetic association study. Seven polymorphisms 
across three key genes in the TNF region were associated with typhoid fever. A haplotype 
spanning this region (* 12122* 1111) was strongly associated with protection from typhoid 
fever.
xviii
Polymorphisms in the chemokine and other immune response gene cluster on 
chromosome 17qll.22-q22 were also investigated. Our results show that the NOS2A 
gene within this region, which encodes iNOS, plays an important role in typhoid fever as 
polymorphisms within NOS2A were shown to be associated with protection from typhoid 
fever.
A number of genes or genomic regions encoding components of the innate and acquired 
immune responses contribute to an individual’s ability to mount an appropriate immune 
response to S. typhi infection during typhoid fever. Genetic variation in any of these genes 
may lead to the alteration of the host immune response with deleterious effects. Together 
with environmental factors and pathogen virulence, host genetic factors contribute to 
typhoid fever susceptibility, and studies of candidate genes and genomic regions add to 
our overall understanding of protective disease mechanisms.
xix
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Chapter one
1. Introduction
1.1. Typhoid Fever
Typhoid fever is a human systemic disease caused by Salmonella enterica serovar Typhi 
(S. typhi), a member of the family Enterobacteriaciae. It is a Gram-negative bacillus and 
Vi polysaccharide capsular antigen positive. Serologically it has lipopolysaccharide 
(LPS) antigens 09  and 12 and protein flagella antigen Hd. Humans are the natural host 
and the main source of S. typhi infection (reviewed by Forsyth, 1998).
1.1.1. Pathogenesis
S. typhi is transmitted directly from person to person via the fecal-oral route or by 
ingestion of infected food or water. The development of the disease is related to the 
number of bacteria ingested (Hornick 1970). Normally, a small amount of S. typhi is 
inactivated by the acidic environment in the stomach. Thus, low gastric pH is an 
important first line of defense against S. typhi. However, some bacteria may reach the 
small intestine and invade the gut mucosa leading to the development of disease if a large 
number of bacteria are ingested. Ingestion of contaminated water increases the risk of 
infection because the acidic environment in the stomach is diluted, enabling the bacteria 
to survive, multiply and then invade intestinal tissue. A challenge study in volunteers 
showed that ingestion of 105- 109 organisms may lead to typhoid fever, and the 
inoculation period is usually between 1 0 - 1 4  days (Hornick 1970). Vi polysaccharide 
capsular antigen positive or negative S. typhi strains can both cause typhoid fever. 
However it is believed that Vi-negative strains are less infectious and virulent than Vi- 
positive strains (Parry et al. 2002).
Observations of the disease in humans and animal models have given a general view of 
the S. typhi infection process (figure 1.1). After successfully passing the acidic 
environment in the stomach, the bacteria reach the small intestine. In the small intestine 
ingested S. typhi adheres to and invades intestinal epithelial cells, and via the macrophage
cells of the Peyer’s patches (PP), bacteria continue to migrate into the mesenteric lymph 
nodes and therein multiply. S. typhi are released from the lymph nodes via the 
bloodstream and migrate to the spleen, liver and bone marrow (Huang et al. 1998; Mills 
and Finlay 1994). In these organs, the bacteria are destroyed mainly after macrophage 
phagocytosis by the development of neutrophil and mononuclear cell rich microbascesses. 
These microabscesses restrict bacterial replication and limit further spreading of the 
pathogen (Kaufmann et al. 2001). However, a number of bacteria are also able to survive 
and multiply within the mononuclear phagocytic cells (House et al. 2001a), they re-enter 
the bloodstream and cause a secondary bacteraemia, leading to the onset o f clinical 
disease. S. typhi move from the spleen, liver and bone marrow to the gall bladder, and 
then re-infect the intestinal tract. They are localized in the PP of the distal ileum (the 
second exposure of PP to S. typhi) causing inflammation, ulceration and necrosis (Everest 
et al. 2001). Haemorrhage from ulcers can occur during the third week of illness, or 
perforation of the PP can cause generalized peritonitis and septicaemia, which is the most 
common cause of death in typhoid fever (Bitar and Tarpley 1985; Butler et al. 1991; 
Butler et al. 1985).
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Figure 1.1: Salmonella typhi infection process. S. typhi infects the small intestinal. Bacteria 
migrate to mesenteric lymph nodes and arrive at the liver and spleen via blood stream. After 
multiplication in these sites, a second bactereamia episode occurs and bacteria re-enter the 
intestinal tract via the gall bladder, exposing the PP to bacteria a second time. PP tissue damage 
occurs, resulting in ulceration, bleeding, necrosis, and in extreme cases, full-thickness 
perforation. Figure reproduced from Everest et al (Everest et al. 2001).
The essential step in development of Salmonella pathogenesis is the entry of bacteria into 
the host cells especially non-phagocytic cells, including the intestinal epithelial cells. The 
ability of S. typhi to invade epithelial cells was shown to be dependent on the growth 
phase of the bacteria and the environmental conditions. The adherence of Salmonella to 
epithelial cells was optimal when S. typhi were grown to mid-log phase with aeration 
(Tartera and Metcalf 1993). In the condition of low oxygen optimal epithelial cell
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invasion was achieved (Mills and Finlay 1994). The expression of the Vi antigen is 
down-regulated in conditions of high osmolarity (Pickard et al. 1994).
The genetic factors for S. typhimurium invasion are clearly characterized however little is 
known of the genetic factors responsible for S. typhi invasion. The ability of bacteria to 
invade into a host cell is dependent on the type III secretion system (Hersh et al. 1999). 
Type III secretion systems are highly specialised protein secretion systems found in gram- 
negative pathogens. These systems transfer proteins from the bacterial cytoplasm into the 
host cell cytoplasm, with the purpose to interfere with host cellular function. There are 
many invasion-associated factors identified in S. typhimurium however fewer specific 
factors been identified in S. typhi. Elsinghorst et al (Elsinghorst et al. 1989) identified a 
33 kb region of the S. typhi chromosome involved in the invasion of intestinal epithelial 
cells. However, the invasion-associated genes encoded by this region have not been 
identified and their role in invasion is still unclear. Recently, a number of invasion- 
defective mutants of S. typhi were identified. Some of them were identified in genes 
homologous to the S. typhimurium invG and prgH  genes, which are known to be involved 
in the type III secretion pathway of virulence proteins. Two insertions in genes sharing 
homology with the cpxA and damX genes from Escherichia coli K-12 were also identified 
having function in the early steps of host cell interaction (Leclerc et al. 1998). In 
addition, the expression of S. typhi invasion genes is dependent on specific environmental 
conditions (Leclerc et al. 1998).
1.1.2. Epidemiology
The annual incidence of typhoid fever worldwide is approximately 22 million cases, with 
an estimated 200,000 deaths (Crump et al. 2004). In some developing countries in Asia 
and Africa the annual incidence may reach 1,000-2,000 cases per 100,000 population 
with case fatality rates as high as 10%. The incidence of typhoid fever in developing
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countries peaks between the ages of 5 and 12 years (WHO 2000). According to a 2002 
World Wide Vaccine report, incidence rates in Africa and Asia are approximately 
500/100,000/year with the number deaths being 130,000 in Africa and 440,000 in Asia. 
In Latin America and Oceania incidence rates are approximately 150/100,000/year with 
10,000 deaths in Latin America and 124 deaths in Oceania. In Europe and North America 
incidence rates are much lower at 2/100,000/year with an estimated 74 deaths. However, 
the estimation in 2004 (Crump et al. 2004) shows that the high incidence regions of 
typhoid fever include south-central Asia and south-east Asia with more than 100/100,000 
cases/year. Regions of medium incidence include the rest of Asia, Africa, Latin America, 
and the Caribbean, and Oceania (except for Australia and New Zealand) with an incidence 
of 10-100/100,000 cases/year. Europe, North America, and the rest of the developed 
world have low incidence of typhoid fever with less than 10/100,000 cases/year (Crump et 
al. 2004). In Bangladesh, the highest incidence rate has been reported as 
2,000/100,000/year (WHO 2003). In Delhi, India the incidence rate of typhoid fever is 
980/100,000/year and it is a common and significant cause of morbidity between 1 and 5 
years of age with mortality rates around 12 -  30% (Sinha et al. 1999). In Indonesia there 
are estimated to be 900,000 cases per year with 20,000 deaths (WHO 2003).
Typhoid fever is endemic in Vietnam, however, the trend of incidence has been 
decreasing since 2001. In the year 2000 the number of cases was 10,705 with 10 deaths. 
In the year 2002 the number of cases was 7,090 with 3 deaths. In the year 2003 the 
number of cases was 5,946 with 2 deaths. In the year 2004 the number of cases decreased 
to 4,257 with only one death (Health Statistics YearBook (2000, 2003, 2004): HSID. 
Planning and Finance Department, Ministry of Health, Vietnam -  Country health 
information profile -  WHO) (WHO 2004; WHO 2005; WHO 2006). The disease 
prevalence is significantly high among pre-school and school-age children with 46% of all 
typhoid cases occurring in children aged between 5 and 14 (Lin et al. 2000).
In southern Vietnam, community based surveillance of disease prevalence in 1996 
reported that the incidence rate of typhoid fever was 198 per 100,000 population in Dong 
Thap Province in the Mekong Delta. The attack rate among 5 - 9  years olds was the 
highest at 531/100,000/ year (Lin et al. 2000). The incidence rate in Dong Thap Province 
appears to have declined over recent years based on the number of hospital admissions of 
typhoid patients. However, other provinces in the Mekong Delta, such as An Giang 
Province continue to see a significant number of typhoid cases, 358 confirmed 
hospitalized cases were identified between April 2004 to August 2005 (Christiane 
Dolecek, personal communication), although incidence rates are unavailable, as 
community based epidemiological surveillance has not been performed.
1.1.3. Clinical features
Clinical features of typhoid fever vary depending on the severity of the disease. A
common incubation period of typhoid fever is typically 8 to 14 days, however it can vary
from 3 days to 2 months depending on the number of bacteria ingested (Parry et al. 2002).
In the first week of infection, light fever and malaise signify the onset of bacteraemia,
however these symptoms are often not clear. The patients present to hospital during the
second period of the disease with high chills and fever (39-40°C) and headache. They
may have more symptoms at this time including further malaise, anorexia, abdominal
discomfort, dry cough and myalgia. Some physical signs may be observed such as a
coated tongue, tender abdomen and hepatomegaly/splenomegaly (Parry, PhD thesis, The
treatment of multidrug resistant typhoid fever in Vietnam, 2005) (Parry 2005). In severe
cases, signs of appendicitis or ileus such as abdominal distension and nausea may be
found. The fever persists for approximately two weeks and defervescence occurs slowly
over the following two to three (Stuart BM 1946). However, if  the patient is successfully
treated with an appropriate antibiotic the fever should clear after three to four days
(Woodward et al. 1948). Patients who are ill for more than two weeks present with
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accelerated weight loss, weakness, alteration of mental state and the development of 
complications. Complications occur in 10% to 15% of hospitalized patients and 
occasionally dominate the clinical picture deflecting attention from the underlying 
diagnosis of typhoid (Parry, PhD thesis, The treatment of multidrug resistant typhoid 
fever in Vietnam, 2005) (Parry 2005). Some observed significant complications are 
gastrointestinal bleeding, intestinal perforation and typhoid encephalopathy. 
Gastrointestinal bleeding is the most common complication, which occurs in up to 10% of 
patients. Intestinal perforation is the most serious complication, which occurs in 1% to 
3% of hospitalized patients (Bitar and Tarpley 1985; Butler et al. 1985; Parry et al. 2002). 
Typhoid encephalopathy, often accompanied by shock, is associated with high mortality 
(Hoffman et al. 1984; Rogerson et al. 1991).
1.1.4. Diagnosis
Non-specific clinical features of typhoid fever make diagnosis of the disease difficult. 
There are a number of laboratory diagnosis methods have been developed and used. 
Blood culture is considered the “gold standard” diagnostic method with 60 -  80 % 
sensitivity, although culturing bone marrow is more sensitive (80 - 95%) (Parry et al.
2002). The Widal test is considered to be sensitive and specific when it is used with 
locally determined cutoff points (Clegg et al. 1994; Parry et al. 1999). This test measures 
agglutinating antibodies to the O and H antigens of S. typhi. A Vi agglutination reaction 
has also been used for detection of S. typhi carriers with a report of 70 -  80% sensitivity 
and 80 -  95% specificity (Lanata et al. 1983). Recently, other quick tests have been 
developed, which are alternatives to the Widal test. They include IDL Tubex test, 
Typhidot, Typhidot-M, and IgM dipstick. The IDL Tubex test can detect IgM 0 9  
antibodies within a few minutes. Although Tubex has not been formally evaluated, it was 
reported to be better than the Widal test in both sensitivity and specificity (Lim et al.
1998). Typhidot was developed in Malaysia for detection of specific IgM and IgG
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antibodies within three hours. A newer version of Typhidot test is Typhidot-M, which has 
recently been developed to detect only specific IgM antibodies. Evaluation studies show 
that Typhidot-M is superior to the culture method with a sensitivity of more than 93% 
(Choo et al. 1997). Another serodiagnosis of typhoid fever is the IgM dipstick assay. 
This was developed based on the binding of S. typhi-specific IgM antibodies to S. typhi 
LPS antigen, and then the staining of bound antibodies by an anti-human IgM antibody 
conjugated to colloidal dye particles. Evaluations of this test were carried out in 
laboratories in Indonesia, (Gasem et al. 2002; Hatta et al. 2002), Vietnam (House et al. 
2001b), and Egypt (Ismail et al. 2002). These evaluations showed consistent results that 
the sensitivity of this test is 65% to 77%, and the specificity is 95% to 100%. Molecular 
diagnostics including DNA probes and PCR protocols (Song et al. 1993) have also been 
developed to detect S. typhi directly from blood, however these tests have not yet been 
applied to routine diagnosis.
1.1.5. Treatment and drug resistance
The use of antibiotics is the most effective treatment for typhoid fever. Chloramphenicol 
was widely used until the 1970s in the treatment of typhoid fever, even though resistance 
to the antibiotic was detected in S. typhi in 1940 (Mirza et al. 1996). From the 1970s 
chloramphenicol resistant S. typhi were widely spread in Latin America (reviewed by 
(Rowe et al. 1997; White and Parry 1996)). Following chloramphenicol, ampicillin, 
amoxycillin, and trimethoprim-sulphamethoxazole were the drugs of choice to treat 
typhoid fever. However, since the 1980s S. typhi has developed resistance to these three 
drugs (Mirza et al. 1996; Rowe et al. 1997). The fluoroquinolones are the third generation 
of drugs for the treatment of multi-drug resistant typhoid fever, which is defined as S. 
typhi which is resistant to chloramphenicol, ampicillin and trimethoprim- 
sulphamethoxazole. Ciprofloxacin is currently an effective drug for treatment of typhoid 
fever. Ciprofloxacin reduces the rate of stool carriage compared to the traditional first
line drugs (Vinh et al. 1996; White et al. 1996). Another fluoroquinolone, Ofloxacin is 
known as a cheap and highly effective drug in the treatment of multidrug resistant typhoid 
fever (Tran et al. 1995; Vinh et al. 2005). Ofloxacin was shown to be more effective than 
other cephalosporins such as Cefixime or Ceftriaxone. Patients treated with Ofloxacin 
have shorter fever clearance times than patients treated with Cefixime or Ceftriaxone (Cao 
et al. 1999; Smith et al. 1994).
However, in 1997 it was reported that clinical response to fluoroquinolones was limited in 
patients infected with nalidixic acid resistant (NAR) S. typhi (Wain et al. 1997). In India, 
infection with NAR S. typhi was associated with poor clinical outcomes (Kadhiravan et al. 
2005). These patients have longer fever duration, a higher frequency of hepatomegaly, 
higher levels of aspartate aminotransferase and an increased minimum inhibitory 
concentration (MIC) of ciprofloxacin. In general, the total duration of illness was 
significantly longer in patients infected with NAR S. typhi compared to patients infected 
with sensitive strains (Kadhiravan et al. 2005). In Vietnam from 2002 to 2003 
approximately 90% of S. typhi strains are reported to be resistant to nalidixic acid 
resulting in a poorer clinical response to the older generation fluoroquinolones (Christiane 
Dolecek personal communication). Thus, the treatment of typhoid fever has become 
limited with patients infected with NaR S. typhi. A study at the Hospital for Tropical 
Disease in Ho Chi Minh City showed that 33.3% of NaR S. typhi infected patients did not 
respond to treatment with ofloxacin (Wain et al. 1997). The poorer response to the 
fluoroquinolones could be resolved by using cephalosporins such as Ceftriaxone or 
Cefixime (Cao et al. 1999; Girgis et al. 1999; Smith et al. 1994). However, both 
Ceftriaxone and Cefixime are expensive and the former requires parenteral administration. 
Azithromycin has emerged as a new antibiotic for treating uncomplicated typhoid fever 
patients infected with multidrug resistant and NaR strains. This treatment has been 
successful in Egypt and India (Butler et al. 1999; Girgis et al. 1999). In Vietnam,
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Azithromycin has been reported as being more effective than Ofloxacin (Chinh et al. 
2000). Recently, clinical trials investigating the efficacy of a new flouroquinolone, 
Gatifloxacin, have been undertaken in the Mekong Delta, Vietnam and in Kathmandu 
Nepal. These unpublished findings suggests that Gatifloxacin performs at least as well as 
Azithromycin, but is cheaper and can be given once a day (C. Dolecek, personal 
communication). Although typhoid fever now can be treated by antibiotics, the 
emergence of new resistant strains may lead to a real risk o f complete drug resistant 
typhoid fever, and the options for treatment would then be very limited.
1.1.6. Vaccination
Due to the potential emergence of fully antibiotic resistant S. typhi strains, vaccination is 
an important and necessary approach for the control of typhoid fever, especially in 
endemic areas. A variety of typhoid vaccines have been developed and three have been 
licensed for use in humans; the Whole-Cell Killed vaccine, the live attenuated oral 
vaccine Ty21a, and the Vi capsular polysaccharide (Vi-CPS) vaccine (Levine and Noriega 
1995; Lindberg 1998).
The Whole Cell Killed vaccine showed an efficacy of 51 -  67% but with frequent adverse 
reactions (WHO 2000). Vi-CPS and Ty21a are currently the licensed vaccines to replace 
the old whole cell killed vaccine. However, in some parts of the world the whole cell 
killed vaccine is still used for economic reasons (WHO 2000).
Vi-CPS is a vaccine based on the purified Vi polysaccharide of S. typhi. This vaccine 
shows a protective efficacy of 55% five years after a single dose in endemic areas (WHO
2003). However, in two large studies in Nepal and South Africa, this vaccine has a 
reported efficacy of 64-72% in school-age children and adults (Acharya et al. 1987; Arya
1997).
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Ty21a is an empirically derived live attenuated vaccine that is administered orally in 
three doses within two days. The protective efficacy of this vaccine is 67% up to seven 
years after the final dose (WHO 2003). Ty21a has been reported with a protection of 78% 
over five years (Levine et al. 1999).
The advantage of the Vi-CPS vaccine is that only a single dose is required compared to 
Ty21a which requires three doses. It is stable at raised ambient temperature while the 
Ty21a vaccine needs to be kept at a cold temperature. However, Ty21a is an oral vaccine, 
which can be administered easily and it has been used as a part of a school-based 
vaccination program (Levine et al. 1999). Although this vaccine has shown a high 
efficacy in school-children, the protective efficacy of this vaccine has not been 
extensively evaluated in infants (less than 12 months of age). However, there is a study 
which shows that this vaccine might not be effective in groups of young children 
(Lindberg 1998). The Vi-CPS vaccine also has limitations related to age. However, to 
overcome the limitations of the Vi-CPS vaccine, many vaccine development programs 
have been performed. At least 2 kinds of Vi-CPS vaccines have been developed to 
improve the immunogenicity of the polysaccharide vaccine, one using tetanus toxoid (Vi- 
TT) and another using recombinant Pseudomonas aeruginosa exoprotein A (Vi-rEPA) 
(Szu et al. 1994). Vi-TT and Vi-rEPA are well tolerated and more immunogenic than Vi- 
CPS (Dumas et al. 1997). Recently, Vi-rEPA, a conjungate vaccine, demonstrated 91.5% 
efficacy over 27 months, and 89% over 46 months, in children aged 2 to 5 years in Dong 
Thap Province, Vietnam (Canh do et al. 2004; Lin et al. 2001).
Developing live oral vaccines by mutagenesis of S. typhi strains which can be 
administered orally as a single dose is the main approach for vaccine improvement. 
Several vaccines were developed based on mutations in the aro genes (Brennan et al.
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1994; Cooper et al. 1992; Dougan et al. 1988; Jones et al. 1991; Smith et al. 1984; Tacket 
et al. 1992a). One vaccine developed from the aro deletion strain, CVD 908, has been 
shown to not produce febrile or other significant adverse reactions in adult volunteers. 
After just a single oral dose of 5x107 colony-forming units, the CVD 908 strain induced 
IgG seroconversion to S. typhi LPS in 83% of vaccines and stimulated specific IgA- 
secreting gut-derived lymphocytes in 100% of the vaccines (Tacket et al. 1992b). 
Another vaccine strain, CVD 90S-htrA, was developed by deletion of the htrA  gene, 
which encodes a heat-shock protein. CVD 908-htrA was attractive as a live oral vaccine 
candidate in a Phase I clinical trial (Levine et al. 1996), and a Phase II clinical trial 
(Tacket et al. 2000). CVD 90%-htrA is considered a potential live oral single dose 
vaccine.
Another approach in typhoid vaccine development is investigation of the Ty2 S. typhi 
strain containing mutations in pho?/phoQ , Ty800 (Miller 1991). Ty800 was evaluated in 
Phase I clinical trials in young adults and is considered to be a safe, requires a single oral 
dose and is highly immunogenic (Hohmann et al. 1996).
Recently, a Phase II trial of an oral typhoid vaccine, M01ZH09, was performed in HCMC, 
Vietnam. M01ZH09 is a live attenuated vaccine derived from the virulent S. typhi strain 
Ty2 containing aroC and ssaV  deletions. This vaccine has also been shown to be well- 
tolerated with no bacteremia and no serious adverse events in a human trial in the USA 
(Kirkpatrick et al. 2006).
1.2. Host immune responses to Salmonella infection
Our understanding of the host immune response to Salmonella infection is based mainly 
on studies using the animal model of human typhoid fever. Infection of mice with 
Salmonella enterica serovar Typhimurium is one of the best-characterized models of
systemic and lethal infection (Xu and Hsu 1992), (reviewed by (Langermans and van 
Furth 1994). The host usually employs at least three stages of host defence to overcome 
bacterial infections such as Salmonella. Firstly, the epithelium provides a physical barrier 
blocking entry of potential pathogens. The second phase of host defence is non-specific, 
or innate immunity. This includes the action of neutrophils, macrophages and natural 
killer (NK) cells which lyse infected cells. After contact with innate immunity cells the 
infectious agents are rapidly internalized, partially phagocytosed and neutralized. The 
macrophage cells, which are specialized epithelial cells originating from the intestinal 
epithelial cells, overlie the Peyer’s patches. Receptors on the macrophage surface can 
recognize bacterial pathogens and in terms of Salmonella infection, bacterial pathogen 
components are recognized by specific TLR receptors, e.g. TLR4, TLR5. The recognition 
of bacteria initiates an intracellular signaling cascade, and then induces the expression of 
pro-inflammatory and bactericidal genes. The third phase of host defence is specific or 
adaptive immunity. After killing bacteria, macrophages present bacterial antigens to 
initiate a specific immune response. The mechanism of specific immunity is a main step 
for recovery and clearance of the infection. However, in the primary infectious process, 
the development of this phase is delayed as it requires activation, proliferation, and 
differentiation of antigen-specific T and B lymphocytes. A number of bacteria escape the 
first epithelial barrier and reach the well-developed lymphoid follicles (Peyer’s patches), 
which are formed mainly of mononuclear cells such as T lymphocytes, as well as 
dendritic cells. Dendritic cells present bacterial antigens which promote T and B 
lymphocyte activation. T cell-mediated immunity is critical for effective clearance of the 
bacteria (Hess et al. 1996). The acquired immune response to S. typhimurium takes some 
weeks to fully develop, and it has been shown that Salmonella can suppress the host 
response (Schwacha et al. 1998).
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1.2.1. Innate immunity: Natural resistance to Salmonella infection
The innate immune response is known as the first line of host defense against microbial 
pathogens (Aderem and Ulevitch 2000; Fearon and Locksley 1996; Janeway and 
Medzhitov 2002). The responsiveness of an individual innate immune system has a 
complex genetic background and depends on the virulence of given pathogens. A critical 
role of the innate immune system is to detect and recognise invaders. Innate immunity is 
important in the control of Salmonella infection, including typhoid fever. The ability of 
macrophages to be activated and secrete cytokines, chemokines and other bactericidals, 
plays an important role in innate immunity.
Recently, a family of Toll-like receptors (TLRs) was identified, and the crucial roles of 
these receptors in recognition of microbial components have been determined (Akira et al. 
2001; Chow et al. 1999; Zarember and Godowski 2002). Activation of these receptors 
results in the release of antimicrobial peptides, inflammatory cytokines, and co­
stimulatory molecules that drive innate immunity but also initiate adaptive immunity.
1.2.1.1.ToIl-like receptors (TLRs) and pathogen component recognition
Toll-like receptors (TLRs) are evolutionarily conserved proteins that recognize microbial 
molecules and initiate host defense. TLRs on macrophages are one of the most sensitive 
mechanisms by which the innate immune system senses the invasion of pathogenic 
microorganisms (Weiss et al. 2004). Through TLRs, specific molecular patterns that are 
present in microbial components can be recognised. The recognition requires the binding 
of pathogen associated molecular pattern molecules (PAMPs), such as Salmonella LPS, to 
receptors referred to as pattern recognition receptors (PRR) on macrophages such as TLRs 
(Medzhitov et al. 1997). Stimulation of different TLRs induces distinct patterns of gene 
expression, which not only lead to the activation of innate immunity, but also instruct the
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development of antigen-specific acquired immunity (reviewed by (Aderem and Ulevitch 
2000; Werling and Jungi 2003).
Currently, eleven Toll-like receptors have been identified in humans, TLR1-11. The TLR 
has been described as a type I transmembrane (TM) pattern recognition receptor (PRR) 
that possesses varying numbers of extracellular N- terminal leucine rich repeat (LRR) 
motifs, followed by a cysteine-rich region, a TM domain, and an intracellular Toll/IL-IR 
(TIR) motif (Du et al. 2000; Medzhitov et al. 1997). The LRR domain is important for 
ligand binding and associated signaling and is a common feature of PRRs (Kobe and 
Deisenhofer 1995; Modlin 2002). The TIR domain is important in protein-protein 
interactions and is typically associated with innate immunity (Aravind et al. 2001; Dunne 
and O'Neill 2003). With such structure characterization, several pieces of evidence show 
that TLRs play an important role in innate immunity (Janeway and Medzhitov 2002; 
Modlin 2002). TLRs activate immune response genes, which are initiated by the 
activation of MyD88 by the intracellular domains of the TLRs (Dunne et al. 2003; 
O'Neill et al. 2003). Different TLRs recognise different types of microbial particles. 
TLR2 is known to be inactive in monomeric structure. The collaboration of TLR2 and 
TLR1 or TLR6 can discriminate between the molecular structures of diacyl and triacyl 
lipopeptides (Takeda et al. 2003). TLR2 in heterodimeric complex with either TLR1 or 
TLR6 and possibly TLR10, recognise a wide range of PAMPs. TLR2 complexes respond 
to bacterial peptidoglycan, lipoproteins (PGN), lipoarabinomannan (LAM), 
lipopolysaccharised (LPS) lipoteichoic acid (LTA), and other glycolipids, glycoproteins, 
and lipoproteins. TLR2 complexes are also capable of detecting viruses, including 
measles virus (MV), human cytomegalo virus (HCMV), hepatitis C virus (HCV) and 
fungal PAMPs, including zymosan (Barton and Medzhitov 2002; Compton et al. 2003; 
Duesberg et al. 2002; Dunne and O'Neill 2003; Heine and Lien 2003; Janeway and 
Medzhitov 2002; Medzhitov 2001; Modlin 2002). TLR1 and TLR6 form a heterodimer
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with TLR2 and function to specify or enhance the PAMP sensitivity of TLR2 and 
contribute to its signaling capabilities (Hajjar et al. 2001; Ozinsky et al. 2000; Wyllie et 
al. 2000). TLR4 is considered to be the LPS receptor, although TLR2 complexes are 
capable of recognizing LPS. TLR4 recognises LPS through CD 14 and LPS binding 
protein (LPB) (Barton and Medzhitov 2002; Dunne and O'Neill 2003; Heine and Lien 
2003; Janeway and Medzhitov 2002; Medzhitov 2001; Modlin 2002). TLR5 forms a 
homodimer as well as heterodimer with TLR4 and functions to recognize the flagellin 
protein of flagelled bacteria (Hayashi et al. 2001). While other TLRs are expressed on the 
cell surface, TLR3 may be localized intracellularly, perhaps to the lysosomal 
compartment (Zhang et al. 2002a). TLR3 recognises viral double stranded RNA 
(dsRNA) generated during virus replication (Alexopoulou et al. 2001; Barton and 
Medzhitov 2002; Heine and Lien 2003; Medzhitov 2001). TLR3 has a role against viral 
infection (Tabeta et al. 2004). TLR7 and TLR8 resemble TLR3, and may be localized 
intracellularly (Zhang et al. 2002a). TLR7 and TLR8 are responsible for virus detection, 
and they mediate the recognition of imidazoquinolines, antiviral compounds (Dunne and 
O'Neill 2003; Heine and Lien 2003; Zhang et al. 2002a). Moreover, TLR7 and TLR8 are 
also known to be functional in recognizing single strand (ss) RNA (Diebold et al. 2004; 
Heil et al. 2004). TLR9 also appears to be internal, perhaps in lysosomic or endocytic 
compartments. It forms a homodimer and recognizes unmethylated 2’-deoxyribo 
(cytidine-phosphate-guanosine) (CpG) bacterial and viral DNA (Hemmi et al. 2000). 
TLR9 also recognizes non-DNA pathogenic components (Coban et al. 2005). However, 
the precise mechanism of how TLR9 recognises both DNA and non-DNA crystal is 
unclear. Little is known about the TLR10 ligands. However, some studies speculate that 
it is likely TLR10 and TLR6 may form a heterodimer with TLR2 and function to specify 
or enhance the PAMPs sensitiviy of TLR2 (Barton and Medzhitov 2002; Hajjar et al. 
2001; Ozinsky et al. 2000; Wyllie et al. 2000) . Recently, mouse TLR11 has been 
discovered and is expressed abundantly in the kidney and bladder. TLR11-deficient mice
have consistently been shown to be susceptible to uropathogenic bacterial infection, 
indicating that TLR11 senses the products of these bacteria (Zhang et al. 2004). In 
humans, however, TLR11 is thought to be nonfunctional, owing to the presence of a stop 
codon. All eleven TLRs and their ligands are summarized in Figure 1.2 below.
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Figure 1.2: Structures of Toll-like receptors and their ligands. TLR2, in collaboration with TLR1 
or TLR6, discriminates between the molecular structures of triacyl and diacyl lipopeptides, 
respectively. TLR4 recognises bacterial LPS. TLR5 recognises bacterial flagellin. TLR11 
recognises uropathigenic bacteria products. TLR3, TLR7, TLR8 and TLR9 reside in endosomal 
compartments and recognize nucleic acids; TLR3 recognises viral dsRNA, whereas TLR7 and 
TLR8 recognise viral ssRNA. TLR9 recognises bacterial and viral CpG DNA motifs. TLR9 also 
recognises non-nucleic acids, such as hemozoin. Figure reproduced from Kawai et al (Kawai 
and Akira 2005).
1.2.1.2.TLR4 is the principal receptor of LPS
In Gram-negative bacteria such as S. typhi, LPS is an integral component of the outer
membrane and can provoke a life-threatening condition called endotoxic shock (Ulevitch
and Tobias 1995). LPS is a complex glycolipid composed of a hydrophilic
polysaccharide and a hydrophobic domain, known as lipid A, which is responsible for the
biological activity of LPS. LPS is the major virulence factor of Gram-negative bacteria.
Recognition of LPS is initialized by the cooperative interplay between LPS-binding
protein (LBP), the membrane-bound or soluble forms of CD 14 and the TLR4-MD-2
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complex (reviewed by (Aderem and Ulevitch 2000)). In response to LPS, host cells 
secrete a number of cytokines and induce adhesion molecules that result in activation of 
the killing activities of phagocytes, migration of host cells to sites of inflammation, and 
elimination of invading bacteria.
1.2.1.3.Macrophages are of central importance to the response against LPS and 
Salmonella infection
Macrophages are of central importance to the response against LPS (Freudenberg et al. 
1986; Michalek et al. 1980). They are the principal source of TNF-a elicited by LPS in 
vivo (Mannel et al. 1980). Macrophages can be activated by the recognition of LPS 
through TLR4 (Hayashi et al. 2001), leading to the rapid activation o f an intracellular 
signaling pathway, resulting in the release of pro-inflammatory mediators through the 
expression of cytokine genes and bactericidal genes (figure 1.3). The recognition of LPS 
through TLR4 initiates the secretion of cytokines for resistance to Salmonella infection 
(see in 1.2.2). Weiss et al, (Weiss et al. 2004) showed that TLR4 is critical for early 
cytokine production and the killing of bacteria by murine macrophages. A number of 
mouse studies suggest that several inflammatory cytokines produced by macrophages and 
lymphocytes, including IL-12, interferon-gamma (IFN-y), and TNF-a, also play an 
important role in early response to Salmonella infection (see in 1.2.2). Bactericidal 
capacities of macrophage include production of reactive oxygen and nitrogen 
intermediates (Vazquez-Torres et al. 2000). Macrophages isolated from mice deficient in 
both phagocyte oxidase (phox) and reactive nitrogen intermediates produced by inducible 
nitric oxide synthase (.NOS2) demonstrated reduced killing of Salmonella typhimurium 
(Shiloh et al. 1999).
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1.2.2. Role of antimicrobial molecules and cytokines in response to Salmonella 
infection
Following Salmonella infection, through the recognition by receptors such as TLRs on the 
membrane of the macrophage, intracellular signaling proceeds to the nucleus of the cell, 
and triggers the expression of various genes, such as cytokine genes (e.g. IL-1, IL-6, TNF- 
a  or IL-12) or bactericidal genes. These genes are involved in antigen presentation (e.g. 
MHC class II) or in bactericidal function [(e.g. inducible nitric oxide synthase (iNOS)]. 
The expression of these genes leads to the secretion of cytokines such as IL-12, IL-1, IL-6 
and TNF- a, which activate natural killer cells (NK) or T cells to induce IFN-y. In turn 
IFN-y helps the macrophage in the activity of killing the intracellular bacteria. The 
secretion of cytokines from macrophages and the interaction between macrophages and 
NK cells or T cells through cytokine signalling is associated with the acquired and 
cognate immune response mediated by T and B cells according to the helper T cell (TH) 
commitment type. Macrophage activation can be negatively regulated by IL-10 from 
type-2 TH cells (TH2) (figure 1.3) (Lalmanach and Lantier 1999).
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Figure 1.3: Cytokines secretion in response to Salmonella infection. Following 
Salmonella infection the macrophage is activated leading to cytokine secretion and 
bactericidal activity. Interaction between cytokines secreted from macrophages and other 
cells (NK, T, TH) leads to efficient macrophage activation contributing to resistance to 
bacterial invasion. Figure reproduced from Lalmanach et al (Lalmanach and Lantier
1999).
1.2.2.1.Production o f antimicrobial molecules in response to Salmonella infection.
In order to limit intracellular replication of pathogens, professional phagocytic cells 
express a number of antimicrobial molecules such as superoxide, hydrogen peroxide and 
nitric oxide (NO) to inhibit or kill intracellular Salmonella (Mastroeni et al. 2000b; 
Vazquez-Torres and Fang 2001). NO is considered to be one of the most versatile 
players in the immune system. It is a critical host effector molecule involved in defence 
against S. typhimurium and is involved in both the pathogenesis and control of infectious 
diseases. In the murine infection of S. typhimurium NO has been shown to play an
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important antimicrobial role (Mastroeni et al. 2000b). Production of NO is by activation 
of inducible NO synthase (iNOS) and two other enzymes: eNOS and nNOS. iNOS is 
not present in resting cells, but in activated cells it synthesizes 100 -  1000 times more NO 
than other enzymes for prolonged periods. iNOS activity is positively regulated by 
cytokines essential for host response against Salmonella (Everest et al. 1998; Fang 1997; 
Mastroeni et al. 1998).
1.2.2.2.Production of cytokines in response to Salmonella infection
Cytokines are intercellular regulatory proteins produced by one cell that subsequently 
binds to other cells and influence their activity in some manner. Cytokines are important 
in resistance to infectious agents when considering therapeutic plans and vaccine 
strategies. Tumor necrosis factor-a (TNF-a), interleukin-1 (IL-1) and interleukin-6 (IL-6) 
are pro-inflammatory cytokines. The chemokine interleukin 8 (IL-8) promotes an 
inflammatory response by enabling white blood cells to leave the blood vessels and enter 
the surrounding tissue, chemoactically attracting the white blood cells to the infection site, 
and triggering neutrophils to release agents for extracellular killing. Cytokines are the key 
communication molecules between host cells in the defense against Salmonella. In 
animal models, protective roles have been shown for IL -la , TNF-a, IFN-y, IL-12, IL-18 
and IL-15, whereas IL-4 and IL-10 inhibit host defenses against Salmonella (reviewed by 
(Lalmanach and Lantier 1999)).
TNF-a, IL-1, IL-6, and IL-8 are induced by macrophages and then bind to cytokine 
receptors on various target cells. They normally function to promote body defenses such 
as inflammation, fever, innate immune responses, and phagocytosis. However when 
released in excessive amounts during severe Gram-negative infections, these same 
cytokines can result in harmful effects including blood vessel damage, respiratory distress, 
tissue destruction, hypotension, shock, organ failure and death.
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Three cytokines IFN-y, IL-12 and TNF-a are considered to be important in the first line of 
anti -Salmonella defence. IL-12 produced by macrophages is an inducer of IFN-y 
production, which in turn activates the macrophage antibacterial activity and synergizes 
its effects with TNF-a (Lalmanach and Lantier 1999).
IFN-y plays a central role in controlling Salmonella infection. The most likely mechanism 
by which IFN-y exerts its functions in host defence against Salmonella is by activating the 
ability of macrophages to kill Salmonella (Kagaya et al. 1989). IFN-y is expressed by 
only a few cell types in the body (T cells, NK cells), but can affect a wide range of cells 
and cellular functions. IFN-y expression is upregulated rapidly in the intestinal mucosa, 
Peyer’s patches, mesenteric lymph nodes, spleen, and liver in response to Salmonella 
infection. Increasing levels of circulating IFN-y are readily detectable in infected mice 
(Eckmann et al. 1996; Ramarathinam et al. 1991). IFN-y is involved in resistance to 
Salmonella infection during the first week of infection. Elevated levels of IFN-y mRNA 
are found very early in the gut-associated lymphoid tissue and spleen of mice which are 
orally challenged with S. typhimurium (Ramarathinam et al. 1991). Elevated levels of 
plasma IFN-y are recorded at day 3 in post intraperitoneal infection with S. typhimurium 
(Kumazawa et al. 1991). Antibody depletion of IFN-y in mice or IFN-y receptor (IFN-yR) 
knock-out mice leads to increased bacterial numbers in the spleen and liver and decreased 
survival time following Salmonella infection (Bao et al. 2000; Gulig et al. 1997; Nauciel 
and Espinasse-Maes 1992). Conversely, systemic administration of this cytokine during 
the first few days after challenge with a virulent strain reduces the severity o f Salmonella 
infection in mice and rats (Edwards et al. 1992; Muotiala and Makela 1990). 
Furthermore, IFN-y treatment of infected mice decreased bacterial counts and increased 
host survival (Matsumura et al. 1990). In vitro IFN-y production by lymphocytes from
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human volunteers, who were orally immunized with attenuated S. typhi vaccines, 
increased in response to purified S. typhi flagella stimulation (Sztein et al. 1994). IFN-yR 
ligand binding chain (IFN-y R l) or signaling chain (IFN-y R2) deficiency can predispose 
humans to severe Salmonella infections owing to a severe impairment in IFN-y-dependent 
antimicrobial mechanisms (Altare et al. 1998).
Interleukin-12 (IL-12) is secreted by activated macrophages. It consists of two subunits, 
p35 and p40, which are encoded by IL12A and ILJ2B, respectively. The role of IL-12 as 
a proximal stimulator of IFN-y release during endotoxemia has an important role in 
resistance to Salmonella infection (Heinzel et al. 1994). The interaction between IL-12 
and IFN-y has a role in the restriction of Salmonella infection (Mastroeni et al. 1998). 
Research in the murine model of infection with an attenuated aroA Salmonella strain 
showed that IL-12 neutralization induced a higher bacterial load in liver and spleen. It is 
also associated with an infiltration of mononuclear cells rather than granuloma formation, 
and also with reduced IFN-y production, MHC class II antigen expression, and NOS 
activity (Lalmanach and Lantier 1999). Conversely, IL-12 treatment of Salmonella 
infected mice increased their survival time (Kincy-Cain et al. 1996). IL-12 receptor
deficient patients are highly susceptible to severe Salmonella infection (de Jong et al.
1998). IL-12 receptor p i chain (IL-12Rpi) deficiencies as well as deficiencies in the IL- 
12 p40 subunit predispose humans to Salmonellosis (de Jong et al. 1998; Picard et al. 
2002).
TNF-a plays a central role in response to the pathogenesis of diverse array of
inflammatory, autoimmune and infectious diseases. It is intimately associated with the
mechanisms of inflammation and the response to infectious agents. It has been implicated
in the pathogenesis of sepsis caused by Gram-negative microorganisms. Several studies
have demonstrated the beneficial effects of TNF-a in resistance to intracellular bacterial
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infections (Liew et al. 1990b; Nakano et al. 1990; Silva and Foss 1989). TNF-a 
expression is increased during murine infection of S. typhimurium in all organs that have 
been studied (Eckmann et al. 1996; Klimpel et al. 1995). The serum level of TNF-a 
increased after intraperitoneal challenge with S. typhimurium in mice (Jotwani et al.
1995), and also in patients with typhoid fever (Keuter et al. 1994). In human pro- 
monocytic in vitro cell lines TNF-a was produced in response to different Salmonella 
serotypes or in response to their released products (Ciacci-Woolwine et al. 1997). TNF-a 
could also play an important role in host defence against Salmonellosis through its 
cytotoxic activity against Salmonella infected cells (Klimpel et al. 1990). Either 
exogenous or endogenous TNF-a production plays a role in the host response to S. 
typhimurium infection. Treatment with TNF-a can increase resistance to S. typhimurium 
infection and increase survival of mice after Salmonella infection (Morrissey et al. 1995; 
Nakano et al. 1990). Administration of anti-TNF-a antibodies decreased resistance to the 
infection (Nauciel and Espinasse-Maes 1992; Tite et al. 1991). Neutralization of TNF-a 
by genetic or pharmacological approaches increased the severity of Salmonella infection 
and decreased survival of mice (Gulig et al. 1997; Nauciel and Espinasse-Maes 1992). 
TNF-a is also important in the specific recall of immunity to virulent Salmonella 
conferred by immunization with live vaccines (Mastroeni et al. 1992). Furthermore, TNF- 
a  p55 receptor deficient mice had increased susceptibility to Salmonella infection. They 
succumbed earlier to virulent S. typhimurium challenge and were not protected by an 
aroA- vaccine strain against the virulent strain (Everest et al. 1998).
1.2.3. Presentation of Salmonella antigens to T cells
Protection against Salmonellosis requires both innate and acquired immunity. Antigen
presentation is the bridge connecting innate and acquired immunity. Macrophages are
considered to be the principal cell types involved in the activation of the immune system.
They respond to Salmonella infection by producing bactericidal antimicrobials and a
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variety of cytokines. Macrophages also have the ability to process and present Salmonella 
T-cell epitopes in the context of major histocompatibility complex (MHC) class I and 
class II molecules (Martin-Orozco et al. 2001; Wick et al. 1994; Wick et al. 1995). In 
addition to macrophages, dendritic cells (DCs) are also critical sentinels in the 
antimicrobial immune response, and are an important link between the innate and adaptive 
immune responses. They are also the key antigen presenting cells for triggering specific 
immunity. On the one hand, Salmonella can survive and replicate in phagocytic cells 
including macrophages and DCs. On the other hand, macrophages and DCs can kill 
bacteria and present bacterial antigens to initiate a specific immune response. During 
Salmonella infection, there is evidence that DCs can take up Salmonella and present 
antigens to T-cells (Marriott et al. 1999; Schoppet et al. 2000). The specific role of DCs 
as antigen presenting cells (APCs) in Salmonella infection has also been described (Kirby 
et al. 2001; Yrlid et al. 2001). Some in vitro experiments in mice showed that immature 
DCs, such as freshly isolated splenic DCs or those derived from bone marrow, can 
process Salmonella for peptide presentation on MHC class II as well as MHC class I 
(Svensson et al. 2000; Svensson et al. 1997; Yrlid and Wick 2002). Presentation of 
Salmonella antigens on MHC class I or MHC class II by infected DCs requires active 
internalisation and processing of bacteria (Yrlid et al. 2001; Yrlid and Wick 2002). All 
three splenic DC subsets (CD8a+, CD8a‘CD4+ and CD8a'CD4') internalise Salmonella 
following a brief co-culture, and both CD8a+ and CD 8a' DC process Salmonella for 
peptide presentation on MHC class I and MHC class II (Yrlid and Wick 2002). Thus, DC 
and splenic DC subsets can process Salmonella-snooded. antigens to CD4+ and CD8+ T 
cells.
1.2.4. Acquired immunity in response to Salmonella infection
Although the innate immune system can restrict replication of Salmonella to a certain 
degree, in spite of effective control and eradication of bacteria, acquired immunity is
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essential. The response to Salmonella involves both T and B cell-mediated immunity, and 
mechanisms mediated by both lymphocyte populations are important for control of the 
primary infection and protection against the secondary infection. The interaction between 
T and B cells is important for the establishment of acquired immunity to Salmonella 
infection.
Acquired immunity to Salmonella relies on both specific cellular immune response and 
the presence of Salmonella-specific antibodies. The secretion of specific immunoglobulin 
A (IgA) plays a role in acquired immunity to Salmonella infection. Single monoclonal 
secretory IgA is sufficient to confer protection of mice against an oral challenge with the 
highly invasive bacterial pathogen S. tyhimurium (Michetti et al. 1992). T cells are shown 
to modulate humoral responses during immunization with live attenuated Salmonella 
vaccines (Mittrucker et al. 1999; Sinha et al. 1997). CD4+ and CD8+ T cell depletion 
increased bacterial translocation in mice. It also increased the translocation to the 
mesenteric lymph node (MLN) of certain indigenous gastrointestinal (GI) flora bacteria 
(Gautreaux et al. 1994). This indicates that T-cell-mediated immunity is involved in the 
host defense against bacterial translocation from the GI tract. Several studies have shown 
the function of T cells in acquired immunity to Salmonella. Studies in athymic mice, 
nu/nu (T cell deficient) and CD28"7’ (impaired T cell activation and reduced T cell -  B cell 
co-operation) showed that the production of IgM and IgG3 is low, and levels of IgGl, 
IgG2a or IgG2b antibodies against Salmonella LPS or protein antigens is low (Mittrucker 
et al. 1999; Sinha et al. 1997). The clearance of Salmonella from host tissue in the late 
stage of infection was dependent on T cells (Mastroeni et al. 1993; Nauciel 1990). T cell- 
deficient, IL-12-deficient or IFNy-deficient mice were severely systemically infected with 
live attenuated Salmonella vaccine strains containing an aroA  mutation, a htrA  mutation 
or aroA htrA  double mutations (Hess et al. 1996; Mastroeni et al. 1998; Sinha et al. 
1997). Although the central role of cytokine production is from TH1 CD4+T cells, some
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studies have shown that CD8+T cells also participate in acquired immunity to S. 
iyphimurium (Gautreaux et al. 1994; Lo et al. 1999).
T cells are important in the specific recall of immunity to virulent Salmonella (Mastroeni 
et al. 1992). Mice lacking both ap  and y8 T cells showed higher bacterial counts in their 
livers than did ap  T cell-deficient mice. Studies in these mice showed that ap  T cells are 
required for clearance of Salmonella, and y5 T cells, although not critical, can also 
contribute to acquired immunity against Salmonella (Weintraub et al. 1997). H2I-Ap"/_
mice (lacking mature CD4+TCR-ap+ T cells) and TCR-P'/_ mice (lacking TCR-aP+ T 
cells) did not eliminate the bacteria from tissues but showed progressive, usually fatal 
increase in bacterial loads in the late stages of infection (Hess et al. 1996). TCR-y5 T 
cells appear during infection and probably play a role in resistance to Salmonellosis in 
NRAMP1susceptlb,e mice (Hess et al. 1996; Mixter et al. 1994; Weintraub et al. 1997).
B cells can be infected by Salmonella in vitro and in vivo, raising the possibility that, 
besides antibody production, B cells may have additional functions in the initiation and 
modulation of immune responses to Salmonella (Sztein et al. 1995; Yrlid et al. 2001). 
This is further supported by the fact that CD4+ T cells obtained from B cell-deficient Igh- 
6_/" mice immunized with live attenuated Salmonella reduced the ability to release the 
THl-type cytokines IL-12 and IFN-y (Mastroeni et al. 2000a). These immunized Igh-6‘/_ 
mice failed to control the growth of virulent Salmonella in secondary infections 
(Mastroeni et al. 2000a; Mittrucker and Kaufmann 2000).
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1.3. Host genetics of susceptibility to infectious diseases
1.3.1. The role of host genetics in infectious disease
Identifying human genetic factors contributing to infectious disease resistance has been a 
challenge for scientists as it is most likely that the effects of multiple genetic variants or a 
combination of variants (epistasis), combined with environmental conditions, is 
responsible for the resistance phenotype. Although the overall identification of human 
genetic factors influencing infectious disease has not been clarified, there is evidence that 
human genetic variation plays a role in the development of diseases and that genetic 
factors are important in common disease. For example, the risk o f developing 
tuberculosis, leprosy or malaria has been demonstrated to have a significant heritable 
component by comparing monozygotic twins (who are genetically identical) with 
dizygotic twins (who are genetically related but not identical) (Comstock 1978; Fine 
1981; Jepson et al. 1995). The variation in the risk of acquiring infection and the 
variation in the risk of developing severe complications in an exposed population suggest 
that factors such as genetic variation within the host or within the pathogen could be 
responsible. It is perhaps a common misconception that developing a serious infection is 
mostly due to environmental and social factors. Genetic factors may play a role in almost 
all human disease, even if the primary cause is environmental. Genetic variation may 
partly explain why one child develops fatal cerebral malaria, while other children that 
have equivalent living conditions and are equally exposed to malaria parasites do not 
develop severe clinical disease. Cooke et al (Cooke and Hill 2001) reviewed that people 
vary in their resistance to infection, and several studies have indicated that resistance is at 
least partly determined by our genetic makeup (Comstock 1978; Fine 1981; Jepson et al. 
1995; Sorensen et al. 1988).
Host genetic factors may be at least as important in determining the outcome of infection
as they are in other complex diseases. Sorensen et al (Sorensen et al. 1988) reported that
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the host genetic component of susceptibility to premature death from infection was greater 
than that for cancer or cardiovascular disease. In the majority of human infectious and 
non-infectious diseases, many more people may be exposed to the disease-causing agent 
than actually develop overt disease. For example, 10% of people infected with 
Mycobacterium tuberculosis will develop clinical tuberculosis during their life times 
(Murray et al. 1990), while about 11% of tobacco smokers ultimately develop lung cancer 
(Amos et al. 1999).
Today many scientific studies have been conducted investigating different genetic factors 
which may influence susceptibility to common diseases, in the hope that this will provide 
fundamental insight into molecular pathogenesis and ultimately lead to better methods of 
disease prevention. Most importantly, the identification of essential host genes, the 
susceptibility or resistance alleles and the mechanisms by which they influence the 
disease may contribute to the design of new therapeutic strategies for preventive or post­
infection intervention.
1.3.2. Evidence of host genetic factors influencing Salmonellosis
Host genetic factors may be important in determining the outcome of infections caused by 
intracellular pathogens. There is evidence to suggest that genetic factors influence 
resistance to other intracellular pathogens, such as Mycobacteria (Bellamy 2003), 
however in Salmonella this has been poorly characterised. With typhoid fever, little is 
known about host genetic factors influencing disease. Most of the evidence for host 
genetic factors influencing typhoid fever is extrapolated from studies of Salmonellosis in 
mice.
Genes within the major histocompatibility complex such as H-2 have been shown to be 
related to the ability of mice to clear S. typhimurium during infection (Hormaeche et al.
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1985). H-2 linked genes play a major role in bacterial clearance in mice with three 
different group of genotypes among H-2 indicated for three rates of bacterial clearances; 
high (H-2-1, H-2q, H-2U), intermediate (H-2d, H-2f, H-2k, H-2P, H-2r, H-2S, H-2v)and low 
(H-2b) (Nauciel et al. 1988).
Some inbred mice strains are naturally more resistant to S. typhimurium than others. 
Alleles of the Ity locus on mouse chromosome 1 play a major role in innate susceptibility 
or resistance to early S. typhimurium infection (Plant and Glynn 1979). The Ity locus was 
found to be equivalent to the Beg and Lsh loci, which control resistance to Mycobacterium 
bovis BCG and Leishmania donovanii infection, respectively (Skamene et al. 1982). Beg 
encodes for a membrane phosphoglycoprotein designated Nrampl (natural resistance- 
associated macrophage protein 1) (Vidal et al. 1993). Several studies have shown that 
macrophages from Nrampl deficient mice lack a number of functions (reviewed by 
(Blackwell 1996)). Nrampl deficient mice are less able to control the early growth of 
bacteria within the reticulo-endothelial system (RES) than normal mice (Nauciel et al. 
1988; Pashine et al. 1999). A study investigating the function of Nrampl in Salmonella 
clearance during the late stages of infection using mice with a null allele at Nram pl, 
showed that null mice had a significantly lower spleen bacterial load compared with wild 
type mice (Caron et al. 2002). The genetic background of the Nrampl gene affects the 
H-2 complex. The effect of the H-2b haplotype on bacterial clearance appeared to be 
fully expressed only in mice carrying the Nrampl susceptibility allele (C57BL/6) but not 
in mice with the Nrampl resistance allele (A/J) (Nauciel et al. 1988).
The Lps loci on mouse chromosome 4 determines responsiveness to LPS and controls 
natural resistance to S. typhimurium in mice. C3H/HeJ mice carrying a functionally 
inactive Lps gene are hyporesponsive to LPS and have increased susceptibility to 
Salmonella infection, while normal C3H mice are resistant to Salmonella (O'Brien et al.
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1980). Recently, the Lps gene has been identified as encoding murine Tlr4 (Poltorak et al. 
1998b), a receptor for LPS which plays a fundamental role in pathogen recognition and 
activation of innate immunity. Mice deficient in Tlr4 are more susceptible to Salmonella 
infection than normal mice either in vitro or in vivo (Li and Cherayil 2003; Weiss et al.
2004).
An X-linked gene that is carried by CBA/N mice, Xid, is associated with the ability of 
mice to clear bacteria. Mice homozygous for the mutant Xid  allele are highly susceptible 
to S. typhimurium infection. They are unable to clear the bacteria from the RES and die 
late in the infection (O'Brien et al. 1979).
Evidence for host genetic factors influencing human Salmonella infection exists, but are 
few and not entirely convincing. There was a report by Katz et al (Katz et al. 1987) of a 
complication of typhoid fever in humans, typhoid nephritis, that was linked to certain 
families. MHC class I has been shown in a small study to be associated with descendants 
of typhoid epidemic survivors (de Vries et al. 1979). Another study has shown the 
association of a HLA allele (HLA-DRB 1*12) with protection against complicated typhoid 
fever, although in a small number of patients (Dharmana et al. 2002). In terms of 
cytokine or cytokine receptor genes, individuals with complete and partial IFNGR1, IL-12 
and IL-12R deficiency have been shown to be more susceptible to disseminated non- 
typhoidal Salmonella infection (Ottenhoff et al. 2000). An association between alleles of 
MHC class II genes (HLA-DRB 1 and HLA-DQB1) and TNFA in patients with typhoid 
fever in the Vietnamese population has been identified (Dunstan et al. 2001). More 
recently, there is evidence that the cystic fibrosis transmembrane conductance regulator 
(CFTR) gene is associated with typhoid fever. It is thought that S. typhi uses CFTR for 
entry into epithelial cells as a deletion mutation of CFTR (F508del) internalizes and 
translocates less S. typhi than the wild type CFTR (Pier et al. 1998). In typhoid fever
patients, van de Vosse et al (van de Vosse et al. 2005) found an association between 
CFTR alleles and susceptibility to disease.
1.3.3. Methods to study host genetics
Studying the host genetic susceptibility to infectious disease is not new. Some of the 
largest twin studies were performed around 60 years ago (according to (Hill 1998)). There 
are several approaches used to perform host genetic studies. Recent approaches have 
been developed in the hope of increasing the efficiency and power to detect the effect of 
genetic factors on disease.
To examine the relationship between genetic variation and disease susceptibility the 
methods of genetic association or genetic linkage can be used. With linkage analysis, the 
particular alleles analysed at two loci are not of interest in themselves. They are used only 
as a tool for assessing the linkage properties of these loci. In association analysis, the 
particular alleles are the subject of study, and in some cases it is considered possible that 
they are themselves the cause of the phenotype (Ewens and Spielman 2001).
1.3.3.1.Linkage analysis
Linkage analysis has been used to determine disease susceptibility loci. In linkage 
studies, related individuals such as siblings or extended pedigrees are examined. Linkage 
is present when a genetic marker tends to co-segregate with a disease within a family 
(Strachan et al. 1996) and DNA samples from sibling pairs or multicase families can be 
used. Twin studies also involve linkage analysis. Monozygotic (MZ) twins share all 
genes while dizygotic (DZ) twins share half of their genes on average. If a disease has a 
strong genetic component, MZ twins should be more concordant for a disease phenotype 
than DZ twins (Strachan et al. 1996).
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1.3.3.2.Association studies
Association studies are used to fine map or pinpoint disease susceptibility loci. 
Association analysis tests whether presence of a specific genetic variant increases risk of 
disease. This approach includes case/control association studies and familial association 
studies.
a) Case/control association study
Case/control study is an analytical and comparative method of an observational nature to 
test the causal hypothesis. Case/control association studies compare the frequency of SNP 
alleles or genotypes in a series of cases and controls. Association is considered present if  a 
particular allele is found more (or less) frequently in individuals with a disease than in 
unaffected controls (Strachan et al. 1996).
In case/control studies, selection of controls is crucial. For a case/control study it may be 
more efficient to match cases and control for exposure to confounders, either on an 
individual basis (for example by pairing each case with a control of the same age and sex) 
or in groups (for example, choosing a control group with an overall age and sex 
distribution similar to that of the cases). However, sometimes the confounding factors are 
unknown therefore it is not possible to obtain appropriate matching. Problems 
encountered with proper matching of cases and controls for an association study can be 
addressed by using controls matched by their ethnicity (Jenkins et al. 1994; Strachan et al.
1996).
For extra stringency, disease associations identified by case/control genetic association 
studies can be followed up by familial association studies, or by performing a case/control 
association study in a second confirmatory sample set of a different ethnicity. The follow 
up studies are to safe guard the suitability of the controls used in the first study. The
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selection of controls is crucial as ethnic admixture can lead to the identification of false 
positive disease associations.
b) Familial association study
In a family-based method a large number of families are required to obtain enough power 
to detect a disease association. Within the family-based association method the 
Transmission Disequilibrium Test (TDT) is commonly used (Spielman et al. 1993). TDT 
uses the genotype data of a single affected offspring and both parents to reduce the effect 
of population stratification on association studies. The distortion of the inheritance of 
alleles from the parents to the affected offspring is measured, and if an allele associates 
with the disease it is expected to be preferentially transmitted to the affected child. 
Case/Pseudo control analysis can also used within a family-based association method 
(Cordell and Clayton 2002). Based on the genotypes of the parents and the affected child 
in the family trio, the pseudo genotypes are generated and are used as controls which are 
then compared to the cases (the affected children). If parental DNA is not available, a 
sibling-based TDT (S-TDT) can be applied to the family-based association method 
(Spielman and Ewens 1998). This test uses the genotypes of the unaffected siblings as a 
control for the affected person. For this type of study, a greater number of families are 
required compared to the original parental TDT.
1.3.4. Approaches to identifying disease gene loci
Approaches to identify infectious disease susceptibility genes include investigating 
candidate genes, using a haplotypic approach or a whole genome approach.
1.3.4.1.Candidate gene approach
Investigating candidate genes has been the most common approach to identify infectious 
disease susceptibility genes to date. It is useful for quickly determining the association of 
a genetic variant with a disorder and for identifying genes of modest effect. In candidate
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gene association studies, genes potentially involved in disease development are selected. 
The major difficulty with this approach is that in order to choose a potential candidate 
gene, researchers must already have an understanding of the mechanisms underlying the 
disease (i.e. disease pathophysiology).
The first critical step in conducting candidate gene studies is the choice of a suitable 
candidate gene that may play a relevant role in the disease under investigation. Candidates 
genes may be chosen (1) because the genes may encode enzymes or molecules that act in 
various pathways of the disease pathophysiology, (2) based on genes or gene regions 
identified using genetic linkage in murine studies, (3) as the genes were associated or 
linked to similar human disease or (4) because the genes encode proteins that are known 
to play an important role in the host innate and acquired immune response.
In the scientific literature many candidate gene association studies have been conducted 
investigating the relationship between a variety o f genes and diseases. HLA genes, for 
example, have been shown to be associated with many diverse diseases, including 
infectious diseases. HLA class II alleles DRB1*1501, DQB1*0601, DQA1*0103, 
DQA1*0102, DRB1*0701, DQB1*0201, DQA1*0201 and DQB1*0503 are associated 
with leprosy (Rani et al. 1993) whereas HLA-A10, HLA-B8 and HLA-DR2 are associated 
with tuberculosis (Brahmajothi et al. 1991). The HLA class II allele DRB1*1302 is 
associated with protection against persistent hepatitis B infection in the Gambia (Thursz et 
al. 1995) and the HLA class II alleles DRB1*11 and DQB1*0301 are associated with 
clearance of circulating hepatitis C (Minton et al. 1998). The HLA class II haplotype 
DRB1*1302-DQB 1*0501 is common in West Africans but rare in other racial groups and 
this haplotype is associated independently with protection from severe malaria (Hill et al.
1991). The HLA class I allele, HLA-B53 is also associated with severe malaria (Hill et al.
1992).
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Polymorphisms in cytokine genes have also been extensively studied as candidate genes 
and have been shown to be associated with the development of a variety of diseases. A 
promoter polymorphism of the pro-inflammatory cytokine TNF-a (TNFA-308) is 
associated with a multitude of diseases including cerebral malaria (Knight and 
Kwiatkowski 1999; McGuire et al. 1994), scarring trachoma (Conway et al. 1997), 
chronic hepatitis B (Hohler et al. 1998), severe symptoms of rheumatoid arthritis (Vinasco 
et al. 1997), chronic hepatitis C infection (Hohler et al. 1998), typhoid fever (Dunstan et 
al. 2001) and several other diseases (Bidwell et al. 1999). Whether this mutation affects 
expression levels of TNF-a is controversial (Bouma et al. 1996; Turner et al. 1995; 
Westendorp et al. 1997). A polymorphism in the interferon gamma gene, IFNG +874A-- 
>T, was shown to be associated with susceptibility to tuberculosis (Rossouw et al. 2003) 
and IFNG +2109 and IFNG +3810 are associated with severe hepatic fibrosis in human 
hepatic schistosomiasis (Chevillard et al. 2003).
Polymorphisms in genes involved in different processes of immunity have also shown 
association with infectious diseases. For example, a polymorphism at codon 52 in the 
gene encoding Mannose Binding protein was associated with persistent hepatitis B virus 
infection (Thomas et al. 1996) and a macrophage related gene, NRAMP1, was associated 
with a higher risk of pulmonary tuberculosis (Bellamy et al. 1998). Variation in the 
vitamin D receptor gene, a polymorphism at codon 352, is associated with tuberculosis 
and hepatitis B infection (Bellamy et al. 1999) and a polymorphism K29/M in 
Intercellular adhesion molecule 1 (ICAM-1) is associated with cerebral malaria 
(Fernandez-Reyes et al. 1997).
Even though a large number of candidate gene studies exist in the literature, one must 
assess these results with caution. A number of reported studies have not been replicated
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in confirmatory studies. One reason may be due to the inadequacy of the study design of 
the original study. If case control association studies are underpowered to detect a 
significant disease association, this can lead to the identification of false positive 
associations. Another reason that a number of reported studies have not been replicated 
may be that previous candidate gene studies may have just investigated a very small 
number of polymorphisms within the candidate gene (one or two). Therefore it is quite 
possible that replication of studies did not occur as polymorphism frequency and 
haplotypic structure can vary across ethnicity, and a polymorphism that is associated with 
disease in one ethnicity, is not necessary associated with disease in another. This does not 
mean that the original study did not identify the susceptibility gene, but the associated 
marker in one population may not be a marker of the causative disease loci in another 
population. Therefore it is now known that it is important to assess a much larger number 
of polymorphisms across a gene, or a gene region to be assured that the association that is 
identified is indeed real. Using a haplotypic approach is one way to achieve this.
1.3.4.2.Haplotypic approach
Using a haplotypic approach one constructs haplotypes across the gene region of interest 
from genotypes of a large number of polymorphisms. The haplotpyes can span several 
genes and are based on the linkage disequilibrium between polymorphisms. Once the 
haplotype structure of a gene region is determined, one can interrogate this haplotypic 
structure, and look for associations between causal mutations and haplotypes and hence 
gain a greater understanding of the genetic influences on disease (Ackerman et al. 2003a). 
This approach is also cost efficient. Haplotypes can be determined using a relatively small 
size of family samples (case/mother/father trios) and then only the informative SNPs (tag- 
SNPs) need be genotyped in the complete case/control sample set. In addition, once a 
haplotype structure has been constructed for a genomic region in a particular population, 
it can be applied to several disease association studies in that same population.
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Recently, several studies have been reported using a haplotypic approach. A study by 
Johnson et al (Johnson et al. 2001) highlighted the efficiency of the method. The 
haplotype structure of 122 SNP genotypes spanning a 135kb genomic region in European 
individuals was determined, and this lead to the selection of 34 tag-SNPs that capture the 
haplotypic diversity of the region (Johnson et al. 2001). Others have used a haplotypic 
approach to study the haplotype diversity and linkage disequilibrium in five widely 
studied cancer-susceptibility genes. These haplotypes were assessed at each locus in four 
populations; African American, Asian American, Hispanic American and European 
American (Bonnen et al. 2002). Other haplotypic studies have shown associations 
between a gene region and disease, e.g. Bronchiolitis (Hull et al. 2004) and malaria 
(Tishkoffet al. 2001).
I.3.4.3.Genome-wide approach
The genome-wide approach has the potential to systematically identify the contributions 
of common genetic variants to human disease. Genome-wide scans can be performed 
using linkage methods (genome-wide linkage analysis) or association methods (whole 
genome SNP microarrays or genome-wide association analysis). Genome wide scans can 
be used to identify previously unknown susceptibility genes or gene regions, as well as 
identifying multiple susceptibility genes throughout the genome. Genome-wide linkage 
analysis is usually performed using initial linkage analysis in a large number of multicase 
families or sib-pairs. Typically, a few hundred microsatellite markers are used to identify 
genomic regions where there is evidence of increased sharing of parental alleles identical 
by descent in affected sibling pairs or multicase families. Regions of the genome which 
show high levels of linkage are then usually fine mapped by candidate gene association 
studies to pinpoint the disease loci and causative mutation. The main limitation o f a 
genome-wide linkage scan is that the power to detect linkage can be low. Therefore this
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method requires a large sample size, high quality genotyping and mapped makers to 
adequately improve power.
Genome-wide association analysis can also be performed by genotyping a large number 
of SNPs across the entire genome. This can performed using a whole genome SNP 
microarray and it has been suggested that as many as 250,000 -  800,000 SNPs can be 
incorporated (Carlson et al. 2004; Gabriel et al. 2002). This is the most recent approach 
and will soon be available to use as an adjunct to traditional linkage analysis with much 
more promise to identify variants responsible for complex traits (Aranzana et al. 2005; 
Cheung et al. 2005; Ohashi and Clark 2005; Zhu et al. 2005). However, the execution and 
analysis of such studies requires great care (Hirschhorn and Daly 2005) due to the current 
bioinformatic and statistical hurdles that need to be overcome with this new technology. 
An advantage of this method is that it can be performed using association methods in both 
case/control and family sample sets. Few studies have appeared in the literature to date 
using this genome-wide association method to identify disease susceptibility genes, e.g 
esophageal cancer (Hu et al. 2005), Kofendrerd personality disorder (Carter et al. 2005) 
and myocardial infarction (Ozaki and Tanaka 2005).
1.4. Aims of study
The clinical manifestations of typhoid fever, particularly the severity of the disease vary 
widely. Factors which may contribute to the variation observed in clinical typhoid fever 
include health care standards, access to health care, public health conditions, drug 
resistance, but there is also increasing interest in the contribution made by bacterial and 
host genetic factors. Although typhoid fever has been treated effectively by antibiotics in 
the past, in Vietnam drug resistance has emerged. The fluoroquinolones, are known to be 
effective in treatment of typhoid fever, however recently resistance has been observed. 
Increasing drug resistance worldwide is problematic leading to treatment failure. Besides
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improving health and sanitation conditions, and introducing vaccination programs, there is 
a need to develop novel therapeutics. Identification of host genes that contribute to 
disease susceptibility or resistance could provide greater insight into the host - pathogen 
interaction and unravel the mechanism of disease protection. This essential information 
may eventually enable the design of novel therapeutics. The general hypothesis we are 
pursuing is that naturally occurring variation in essential immune response genes has an 
important role in human susceptibility to typhoid fever. For this reason, this project is 
conducted with the purpose of; (1) identifying associations between particular host 
immune response genes and typhoid fever in the Vietnamese population, (2) investigating 
host genes that may be associated with resistance or susceptibility to typhoid and (3) 
through host genetics, learn more about the host immune response to S. typhi infection 
which may potentially lead to the design of novel therapeutics in the future.
This project is concerned with the role o f the innate immune system in typhoid fever. 
Genes encoding molecules of the innate immune system that are important in the first line 
of defence against bacterial invasion were investigated. Specifically the studies presented 
here aimed to (1) identify mutations within the TLR4 gene and examine the association of 
novel TLR4 mutations with typhoid fever (2) fully understand a preliminary association 
of typhoid fever with the HLA region by determining the haplotypic structure of the HLA 
class III region and using a haplotypic and tag-SNP approach to investigate the 
associations of this genomic region with disease and (3) determine the role of the 
chromosome 17ql 1.2-q22 region in typhoid fever susceptibility, a region which contains 
several genes involved in the secretion and up-regulation of antimicrobial molecules in 
defense against bacteria. This project utilized both population based case/control 
association and familial genetic association methods. Candidate genes as well as 
haplotypic approaches were applied to clarify the role of genetic factors in a Vietnamese 
typhoid fever population.
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Chapter two
2. Subjects and Methods
2.1. Study subjects
2.1.1. Typhoid fever cases
During the ten years from 1992 to 2002, there were 18 clinical and epidemiology studies 
investigating typhoid fever in Ho Chi Minh City and other provinces in the southern 
region of Vietnam. Within these studies, 1554 typhoid fever cases were enrolled with 
suspected typhoid fever. Most patients were residents of Ho Chi Minh City and provinces 
surrounding Ho Chi Minh City, Vietnam. The age range of these subjects was from 1 year 
to 68 years old. The ratio between male and female was approximately 1(808 (52%) male 
and 746 (48%) female). Thirty cases were confirmed to be infected by S. paratyphi A 
(1.93%), 14 cases were negative in culture (0.9%) and 1510 cases (97.17%) were culture 
positive for S. typhi. Table 2.1 summarises the overview of typhoid fever cases in the 
southern region of Vietnam from 1992 to 2002.
Table 2.1: Typhoid fever cases in the southern region of Vietnam from 1992 to 2002.
Number of subjects 1554
Year 1992-2002
Age
Mean 14.23
range 1 -68
Sex
Male 808 (52%)
Female 746 (48%)
Out of 1554 typhoid fever cases, 737 cases confirmed to be blood culture positive for S. 
typhi were selected and arranged into two overlapping sets of 400 cases for this genetics 
study. All samples were collected from 3 hospitals; (1) the Hospital for Tropical 
Diseases, Ho Chi Minh City, a 500-bed tertiary referral hospital for southern Vietnam, (2) 
Dong Thap Provincial Hospital, Cao Lanh, Dong Thap province, a provincial hospital
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with 350-beds situated in the Mekong Delta, 180km south of Ho Chi Minh City, and (3) 
Dong Nai Pediatric Centre, Bien Hoa City, Dong Nai province, a pediatric referral 
hospital. At the time of these clinical studies typhoid fever was endemic in Dong Thap 
and Dong Nai provinces.
Within the typhoid genetics sample set (N=737), samples were collected from the 
Hospital for Tropical Disease within two clinical trials. Typhoid patients in the TY 
studies (N=90) were defined as adult patients (>15 years old) with uncomplicated disease. 
The TY studies were performed from 1997 to 1998 to assess the treatment of multidrug 
resistant typhoid fever (Chinh et al. 2000). Typhoid patients in the IPT study (N=96) were 
children with uncomplicated disease. The IPT study was performed from 1995 to 1998 to 
investigate the use of adjunctive ibuprofen and paracetamol in the treatment of 
uncomplicated typhoid fever in children (Vinh et al. 2004).
Samples from typhoid fever patients were collected from Dong Thap Hospital within 
three separate studies. The ET study (N=147) investigated epidemiological risk factors 
associated with typhoid fever from May 1995 to July 1997 (Luxemburger et al. 2000). 
The DTY study (N=292) included typhoid fever cases with uncomplicated disease, and 
investigated the treatment of multidrug resistant typhoid fever from 1995 to 2002 (Parry, 
PhD thesis, The Open University, United Kingdom, 2005) (Parry 2005).
Samples from typhoid fever patients were collected from one study in Dong Nai 
Paediatric Centre. The DNTY study (N=112) enrolled children with uncomplicated 
typhoid fever to compare the use of ofloxacin and cefixime for the treatment of typhoid 
fever and was conducted between July 1995 and April 1996 (Cao et al. 1999).
The Dong Nai Paediatric Centre is located in Southern of Vietnam however most of 
population in this area is come from the North. For this reason we have suspect the
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stratification in the typhoid fever group which may affect the analysis result. We did 
compare the distribution of allele in the population between three group of sample from 
Dong Nai and Dong thap and Ho Chi Minh City. The result showed that there is no 
difference about distribution of allele between these groups of sample. This demonstrated 
that the samples used for this study is the sample population.
For this genetics study, the 737 cases can be defined as hospitalized patients with 
uncomplicated typhoid fever. All patients had a positive blood culture for S. typhi and 
were of the Kinh ethnic group, the majority ethnic group in Vietnam. Figure 2.1 shows 
the southern region of Vietnam and indicates where the clinical or epidemiological studies 
were conducted between 1995 and 2002. Table 2.2 summarises the typhoid cases 
selected for the genetics study.
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Figure 2.1: Map of the southern provinces of Vietnam. Red dots indicate provinces and cities 
where the blood samples were collected.
Table 2.2: Typhoid fever cases used in the host genetic study.
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Number of subjects 737
Mild disease 737 (100%)
Positive culture for Salmonella typhi 737 (100%)
Age
Mean 11.86
Range 1-68
Sex
Male 374 (50.7%)
Female 363 (49.3%)
Ho Chi Minh City 161 (21.8%)
Residence
Dong Nai Province 110 (14.9%)
Dong Thap Province 427 (57.9%)
Others 39 (5.4%)
Ofloxacin 550 (74.6%)
Ampicillin 109 (14.8%)
Antibiotic Cephalexin 45 (6.1%)
treatment Cefotaxime 26 (3.5%)
Ciprofloxacin 7 (0.9%)
Gentamicin 17 (2.3%)
All venous blood collected from typhoid patients was centrifuged to separate plasma from 
the cell pellet at the hospital site where the sample was collected. The cell pellets were 
then frozen at -20°C and transported to OUCRU for DNA extraction. Informed consent 
was obtained from all patients enrolled into the clinical studies. Studies in Dong Thap 
hospital were approved by Dong Thap Hospital and the Health Services of Dong Thap 
Province. For the study in Dong Nai, ethical approval was obtained by the institutional 
review board of Dong Nai Pediatric Center and the Ethical and Scientific Committee of 
the Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam. For studies in the 
Hospital for Tropical Diseases, Ho Chi Minh City, ethical approval was obtained by the
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Ethical and Scientific Committee of the Hospital for Tropical Diseases and the Health 
Service of Ho Chi Minh City. Using archived samples for genetics studies of infectious 
diseases was approved through the study entitled ‘Understanding the protective 
mechanisms of immunity to infectious diseases through studies of the human genome; to 
include Malaria, Dengue, Typhoid, Tuberculosis and Influenza’. This protocol was 
approved by the Ethical and Scientific Committee of the Hospital for Tropical Diseases, 
Ho Chi Minh City.
2.1.2. Case/mother/father family trios
Family samples of typhoid cases were collected from the Hospital for Tropical Disease 
and Dong Thap Hospital. 112 hospitalised patients with uncomplicated typhoid fever, 
confirmed by positive blood culture of S. typhi, were enrolled in this study. Blood : 
samples were also collected from the parents of the typhoid patients (N=224). 2ml to 5ml 
of venous blood from each person was taken and centrifuged to separate plasma and the 
cell pellet. The cell pellets were stored at -20°C until the DNA extraction was performed. 
The family samples collected through the family based study of host genetics in typhoid 
fever was approved by the Scientific and ethical committee of Dong Thap Hospital and 
the Scientific and Ethical Committee of the Hospital for Tropical Disease, Ho Chi Minh 
City.
2.1.3. Controls
Cord blood samples taken from the umbilical cord of babies bom in either Hung Vuong 
Obstetric Hospital, Ho Chi Minh City or Dong Thap Provincial Hospital, were used as 
population controls in this genetics study. Post delivery of the baby, the baby’s blood 
was collected from the umbilical cord prior to disposal. Women admitted to the delivery 
room of the hospital were included in the study if they fulfilled the following criteria. 
They were of Kinh ethnicity, resided in Ho Chi Minh City, aged from 18 to 45 years, in
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good health, were free from life-threatening diseases, had a singleton pregnancy, had a 
full term delivery (gestation of 38-42 weeks), had infants who displayed an APGAR score 
at 1 minute >7 and their babies were free from major malformations or any malformation 
suggesting an inborn or congenital abnormality. Samples from HIV positive mothers were 
excluded. Post delivery, the cord blood was taken. For samples from Dong Thap 
Hospital, 2ml of cord blood was taken by draining the cord into a commercial tube with 
EDTA as anti-coagulant (Greiner bio-one, Stonehouse, Gemany). From Hung Vuong 
hospital 10ml samples of cord blood were collected from 1000 umbilical cords and then 
transferred into 15ml falcon tubes with EDTA (400ul of 4% EDTA). All cord blood 
samples taken from babies were then centrifuged to separate the plasma and the blood cell 
pellets. The blood cell pellets were stored at -20°C until DNA extraction was performed.
In Dong Thap Provincial Hospital, between March 2002 and April 2003, 200 cord blood 
samples were collected through the family based study of host genetics in typhoid fever. 
This study was approved by the Scientific and Ethical Committee o f Dong Thap 
Provincial Hospital. In Hung Vuong Hospital, from April 2003 to April 2004, the program 
to collect 1000 cord blood samples was part of the study entitled ‘Host Genetics Factors 
Important in Infectious Diseases in Vietnam’. This study was approved by the Scientific 
and Ethical Committee of Hung Vuong Hospital, Ho Chi Minh City.
The cord blood samples were selected to be used as control samples in this typhoid host 
genetic study due to several reasons; (1) cord blood samples are easy to collect in a large 
number of individuals that are of the one ethnic group, Vietnamese Kinh, (2) large 
volumes of blood are collected and therefore a large resource of DNA can be archived for 
multiple genetic studies, (3) cord blood samples collected from the general population can 
represent the genetic background of the general population as a whole and can reduce bias 
as selection of controls is limited, (4) matched control samples can attempt to match for
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confounding factors, however a number of important confounders are likely to be 
“unknown”, therefore matching for only ‘known’ confounders may not be adequate and 
introduce bias into the ‘matched’ controls that are collected, (5) collecting ‘matched’ 
controls is also practically more difficult and as such it is harder to collect large numbers, 
unlike cord blood controls. Ideally to overcome identification of false positive 
associations in genetic studies it is essential that large numbers of samples are used. 
With typhoid fever genetics studies in particular, the use of cord blood control samples 
may be more adequate than using ‘matched’ controls. As the clinical symptoms of 
typhoid fever are not very distinct it may be unknown whether potential selected control 
individuals have had mild typhoid fever. As the rate of typhoid fever in this region of 
Viet Nam is approximately 198/100,000 population (Lin et al. 2000), in a collection of 
1000 cord blood samples approximately 2 babies in this group may get typhoid fever in 
the future. As we are using a large number of samples in our genetics studies this level of 
control ‘misclassification’ is very small and as such should not lead to the identification of 
false positive associations.
2.1.4. DNA samples
Two different kinds of DNA samples were used for this thesis. In chapter 3 we used the 
original genomic DNA. In chapter 4 and 5 we used the amplified DNA samples which 
were reamplified from the original genomic DNA using the PEP method (see 2.2.4.1). In 
chapter 6 we used the applified DNA samples which were reamplified from genomic 
DNA using the MDA method (see 2.2.4.2).
2.2. Laboratory methods
2.2.1. DNA extraction
DNA was extracted from blood cell pellets using either the QIAamp Kit (QIAGEN Ltd,
West Sussex, UK) or the Nucleon Kit (Tepnel Life Sciences, Manchester, UK) as per the
49
manufacturer’s specifications. The major difference between the two extraction methods 
is how the DNA is collected. In the Nucleon Kit the DNA is precipitated using ethanol, 
while in the QIAamp Kit, the DNA binds to a column and is then eluted.
2.2.2. DNA quantitation
During this project two methods for double stranded DNA (dsDNA) quantitation were 
used. Initially UV absorbance was used, and later the picogreen method was used.
2.2.2.1. Ultraviolet (UV) absorbance at 260nm
DNA samples were diluted by a factor of 1:100 in water and then quantified by 
absorbance at 260nm using a spectrophometer (Eppendorf BioPhotometer; Eppendorf, 
Germany). The nucleotide bases absorb UV light of approximately 260nm in wavelength. 
This absorption method is routinely used to measure the concentration of nucleic acids in 
solution and 50ng of double stranded DNA has an absorbance of 1 at 260nm. Proteins 
absorb UV light at 280nm better than they do at 260nm. The ratio of absorbance at these 
two wavelengths is used to determine the purity of DNA solutions. Pure DNA exhibits a 
260/280 ratio of 1.8.
2.2.2.2. PicoGreen™  Kit (Molecular Probes, Leiden, Netherlands)
PicoGreen is a dye that gives a fluorescent signal when intercalated into the DNA double 
helix, and can be used for detection and quantitation of DNA. The PicoGreen assays were 
arranged in 96 well microplates and performed according the manufacturer’s instructions. 
DNA measurement was performed using a fluorescent microplate reader at 485/535nm 
(GENios or SPECTRAFluor Plus, TECAN, United States) and DNA concentrations were 
calculated using the reader software (when available) or a simple spreadsheet template.
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In this study, stock genomic DNA samples and whole genome amplified DNA samples 
were quantified using the Picogreen method. Samples were diluted by a factor of 1:100 
while the PicoGreen solution was diluted either by a factor of 1:100 or 1:200 in TE buffer. 
Diluted PicoGreen™ solution was then mixed to the diluted DNA in MicroAmp Optical 
96-well plates (Costar, Corning Incoporated, USA) in a volume to volume ratio of 1:1. 
Each plate contained a duplicate set of standards ranging from 0 to lOOOng/ml (0, 25, 50, 
100, 300, 500, 700, lOOOng/ul). Each sample was assayed in duplicate. The level of 
fluorescence was measured and the concentration of each sample was then calculated 
based on the standard curve in an Excel spread sheet or was automatically calculated by 
the reader software. If the standard curve was not linear, the process would be repeated 
(figure 2.2).
( n g / m l )
Standard curve (with 95%C L i n e a r
( ( n g / m l ) )1200
y =0.6234x- 0.3567 
R2 =0.99971000 - -
80 0  --
60 0  --
40 0  --
200  - -
500 1000 1500 2000-200
Mean intensity
Figure 2.2: The standard curve for estimation of DNA concentration. Blue line indicates the 
DNA standard curve. The red line indicates the linear line. X-axis corresponds to mean 
intensity. Y-axis corresponds to DNA concentration.
2.2.2.3. Comparison of UV absorbance and PicoGreen for determining DNA  
concentration
During this study 807 DNA sample concentrations were measured by the UV method then
re-measured using the PicoGreen method. We compared DNA concentrations determined
by the two methods by the average concentration of all measured samples. Results were
significantly different between the average concentrations in two methods. Measuring by
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the PicoGreen method gives a lower concentration than measuring by the UV absorbance 
method in each sample and certainly in the average concentration of all samples. The 
average concentration o f all DNA samples measured by UV is 348ng/pl, while this 
number in PicoGreen is 57.9ng/pl. On average, DNA concentration which was measured 
by PicoGreen is 6 fold lower than that measured by UV absorbance.
One advantage of the PicoGreen method is that it is time efficient as multiple samples can 
be measured (in 96 well plates) instead of measuring individual samples. In addition, the 
PicoGreen method has been shown to be 10,000-fold more sensitive than the UV 
absorbance method. PicoGreen exhibits very low affinity for single-stranded DNA or 
RNA, therefore affording high sensitivity to the assay.
The PicoGreen method was was used to measure 1169 genomic DNA samples in this 
study which were prepared for whole genome amplification. DNA samples (N=T24) 
with a concentration lower than 5ng/pl were excluded from the sample set. Therefore, 
1045 DNA samples with a concentration higher than or equal 5ng/pl were selected for 
whole genome amplification and prepared for high-throughput genotyping.
2.2.3. Polymerase chain reaction (PCR)
2.2.3.1. Standard PCR
In this thesis a standard PCR reaction mix normally contained lOOng of genomic DNA, 
lOmM Tris pH 8.3, 50mM KC1, l-3m M  MgCb, 200 pM dNTPs, 200nM of each primer 
and 0.5unit of DNA polymerase. The standard PCR program used in this thesis involved 
an initial denaturation step of 5 -12  minutes at 95°C depending on the DNA polymerase 
used in the reaction, followed by 30 -  35 cycles of 30 seconds at 95°C, 30 seconds at 50 -  
68°C depending on the melting temperature (Tm) of the primers, 30 seconds at 72°C, and a
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final extension step of 5 minutes at 72°C. The annealing temperature for each PCR 
reaction was detemined experimentally using a gradient of temperatures around the Tm of 
the primers. The selected annealing temperature usually was approximately 3°C below the 
calculated Tm of the primer. Experimental optimization was still necessary for each 
experiment, such as altering the PCR cycle number, the amount of DNA or the total 
volume of reaction. A negative control (dH^O instead of DNA template) was included to 
ensure that there was no genomic DNA contamination of the reagents. The PCR were 
performed using Eppendorf Mastercycler (gradient) (Eppendorf, Germany) or DNA 
Tetrad Thermal Cycler (MJ Research, Waltham, MA, USA).
2.2.3.2. Touch down PCR
Touchdown PCR is normally used to get a very specific PCR product. In this study 
touchdown PCR was applied to the mutation detection experiments (chapter 3). 
Touchdown PCR helps to reduce the mistakes which could be generated by chance or by 
using Taq polymerasase during a standard PCR. With touchdown PCR, the annealing 
temperature decreases slowly in each PCR cycle instead of remaining constant. 
Normally, the annealing temperature starts at a very high temperature compared to the Tm 
of primers and it slowly decreases each PCR cycle to an annealing temperature based on 
the Tm of the primers. PCR cycles then continue at this annealing temperature. An 
example of a touchdown PCR used in chapter 3 started at an annealing temperature of 
65°C slowly decreasing to an annealing temperature of 59°C. During touchdown PCR the 
first DNA strands are synthesised at the highest permissible temperature for the primers, 
making it more specific and therefore a good template for further PCR amplifications.
2.2.3.3. Agarose Gel Electrophoresis.
Agarose gels (2- 4%) were used to visually check DNA amplification. The concentrations 
of the agarose within the gel varied inversely with the size of the product expected i.e. for
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expected products under lOObp, a 3-4% gel was used. Normally, PCR products were run 
in 2% agarose gels with 1 mg/ml ethidium bromide and visualized under UV light.
2.2.4. Increasing the quantity of DNA samples by whole genome amplification
For genetic studies, the quality and quantity of genomic DNA samples is critical. High 
throughput genetic analysis of multiple gene variants can require significant amounts of 
DNA template for testing. Collecting samples from patients and controls can be time- 
consuming and costly and the yield of DNA finite. To increase the longevity of a DNA 
resource whole-genome amplification methods have been developed to generate a large 
amount of amplified DNA from small amounts of genomic DNA using random or 
degenerate oligonucleotide-primed PCR. During this project, two whole genome 
amplification methods were used; Primer Extension Pre-amplification (PEP) and Multiple 
Displacement Amplification (MDA).
2.2.4.I. Primer Extension Pre-amplification (PEP)
The PEP method uses a mix of random primers 15 bases in length (N15). These random 
base sequence primers anneal at random locations to the complementary strand of the 
DNA during a PCR process. Amplification occurs between the random primers facing 
each other on complementary DNA strands. The regions between primers vary in length 
and are likely to overlap in many places. Due to the random nature of the primer 
positions the whole genome is amplified. With a 25pi volume of PEP reaction 2.5ng 
genomic DNA is used. The 25pi PEP product then can be diluted up to 500pl as a 
working concentration of DNA. Thus, DNA amplified from one PEP reaction can be used 
for 250 individual PCR reactions.
For PEP, a 25pl reaction consists of 2.5ng of genomic DNA with 0.4mM of N15 primers, 
0.2mM of each dNTP, IX NH4 buffer, MgCE at 2.5mM, and 1.25units of Taq
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polymerase (Bioline, London, UK). All reactions were performed in 96-well plates on a 
Tetrad thermal cycler (MJ Research, Waltham, MA, USA). The PCR conditions consist of 
an initial denaturation step at 94°C for 3 minutes, and 49 cycles of 94°C for 1 minute, 
37°C for 2 minutes, increase 1°C per second up to 55°C, and at 55°C for 4 minutes. The 
repeated cycles was followed by a final extension step at 72°C for 5 minutes. To check 
the quality of PEP products, a control PCR was performed using 1.5p,l PEP DNA in a 
15pi reaction volume consisting of 0.4mmol total dNTPs, 16.6mmol ammonium sulphate, 
1.9mmol magnesium chloride, 67.9mmol tris-base (pH 8.9), 0.1% v/v tween 20, 5ng of 
each control primer {Primer 63: 5’ TGC CAAGTGGAGCACCCAA 3’ and Primer 64: 5’ 
GCATCTTGCTCTGTGCAGAT 3’), and 0.25 units of Bioline taq. The cycling 
parameters included three rounds; (1) 96°C for 1 minute then 4 cycles of 96°C for 35 
seconds, 70°C for 45 seconds and 72°C for 35 seconds, (2) 20 cycles of 96°C for 25 
seconds, 65°C for 50 seconds and 72°C for 40 seconds, and (3) 5 cycles of 96°C for 35 
seconds, 55°C for 60 seconds and 72°C for 90 seconds, and then the PCR reaction was 
held constant at 15°C. The reaction was performed on MJ tetrad thermocycler. The PCR 
products were run on a 1% agarose gel at 200volts for 30 minutes and photographed using 
a Multiimage Light Cabinet UV imager (Bio-rad, USA). The expected band was at 796bp.
Genomic DNA samples (N=1045) of 380 typhoid fever cases, 380 cord blood controls 
and 95 family trio samples (N=285) were amplified to increase the quantity of DNA. The 
quality of PEP products was checked by the control PCR to exclude failed samples from 
the sample sets which were setup for high through put genotyping. The control PCR failed 
for 14/1045 (1.3%) PEP products. Figure 2.3 displays the control PCR results used to 
check the quality of the PEP products.
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Figure 2.3: Checking the quality o f the PEP products by the control PCR. Bright bands are PCR 
products amplified from the control PCRs. Arrow indicates negative sample. Black square 
indicates PEP negative. Black circle indicates failed sample.
2.2.4.2. Multiple Displacement Amplification (MDA)
By using a specific primer and a D N A  polym erase the M D A  method can am plify lOng or 
less o f  genom ic D N A  into thousands o f  nanograms o f  D N A  greater than lOkb in length. 
M D A  uses the cp29 D N A  polym erase and random exonuclease-resistant primers to 
am plify the entire genom e (Dean et al. 2002). Dean el a l  (Dean et al. 2002) show ed that 
phosphorothioate m odification o f  primers dramatically stim ulates the M D A  reaction  
allow ing am plifications o f  104 to 106 fold (Dean et al. 2002). The phosphorothioate 
nucleotides protect primers from degradation by the 3 ’- 5 ’ exonuclease proofreading  
activity o f  the cp29 D N A  polym erase.
The REPLI-g -  w hole G enom e A m plification kit w as used to am plify all D N A  sam ples
used in chapter 6 o f  this thesis. For each M D A  reaction, lOng o f  D N A  w as used. D N A
sam ples ( l pl )  were dispensed into 96-w ell PCR plates and made up to a vo lum e o f  2 .5p l
with IX TE buffer. The fresh “Denaturation Solution” was prepared by dilution o f
“Solution A ” at a ratio o f  1:8 with distilled de-ionized (d/d) water. The fresh
“Neutralisation buffer” was prepared by dilution o f  “Solution B ” (provided in the kit) at a
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ratio of 1:10 with d/d water. The “Reaction Mix” consisted of 13.5}.il of d/d water, 6.25pl 
of 4X Mix (provided by the kit) and 0.25 pi of DNA Polymerase.
For MDA, 30pl reaction mixes of 2.5pi of genomic DNA, 2.5pi of the Denaturation 
Solution, 5pl of the Neutralisation Buffer and 20pl of the Reaction Mix were made. The 
reactions were incubated in a MJ Thermocycler at 30°C for 16 hours, then 65°C for 10 
minutes. The amplified products then were stored in -20°C until required.
The quality of MDA products was checked by running on agarose gel to see the presence 
of a smear. MDA products (2pl) diluted by a factor of 1:100 were ran on agarose gel. 
When MDA-DNA was observed on agarose gel the DNA concentration was measured by 
Picogreen and then diluted to 20ng/pl. The diluted MDA DNA samples were used for a 
PCR to check the quality of the MDA-DNA. MDA-DNA samples (15ng) were used as a 
template for a control PCR. The amplified products then were stored in -20°C until 
required.
2.2.5. Identification of novel polymorphisms
To identify new mutations in the TLR4 gene we used denaturing High Performance 
Liquid Chromatography (dHPLC). Figure 2.4 summarises the process of mutation 
detection using dHPLC (Transgenomic Wave® DNA Fragment Analysis System).
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Amplicon design
Primers design
Touchdown PCR M elting temperature profile
Hybridization M elting curve
Select temperature
Set up program
Run samples 
In WAVE
Grouping samples iby different traces
Sequencing
Analysis 
Identify position of mutation
Figure 2.4: Flowchart showing the process of mutation detection using dHPLC.
2.2.5.I. Denaturing High Performance Liquid Chromatography (dHPLC)
dHPLC is a large scale chromatographic method to detect sequence polymorphisms. This 
method efficiently detects single nucleotide and insertion/deletion variations in PCR 
products directly without purification. Direct sequence analysis can be used to confirm 
dHPLC results.
a) The Transgenomic Wave® DNA Fragment Analysis System (W AVE system)
To perform dHPLC the Transgenomic Wave® DNA Fragment Analysis System was used. 
WAVE technology is based on temperature-modulated dHPLC with a high-resolution 
matrix (Kuklin et al. 1997). The WAVE system can be used to detect SNPs or mutations
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in the PCR products o f  individuals heterozygous for a genetic variant. H om ozygous  
mutations are detected by m ixing the sam ple with w ild  type hom ozygous reference 
samples.
Polym orphism s within the TLR4 gene (chapter 3) were detected by dHPLC using the 
W A VE system . A target region o f  D N A  was am plified from a single individual, and the 
PCR products were denatured and slow ly  re-annealed. If an individual carries a 
polym orphism  within the target D N A  normally they have a 1:1 ratio o f  w ild  type and 
mutant D N A . Heating to 95°C, then slow ly  cooling, hybridizes the PCR products and a 
mixture o f  hom o- and hetero-duplex D N A  is formed (see figure 2 .5). Thus, the 
hom oduplex D N A  consists o f  two com pletely com plem entary strands o f  D N A , w hilst the 
heteroduplex D N A  consists o f  two com plem entary strands, which carry a single base 
m ism atch at the site o f  the polym orphism .
heterozygote
A/G
heteroduplex homoduplex
hea t
cool
+
A T G C
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\
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Figure 2.5: The presence o f homoduplex and heteroduplex DNA within a heterozygous sample 
after the hybridization process. (Figure reproduced from the ‘Guide for the WAVE, 
Transgenomic, transforming the world’)
The hybridized PCR products are injected into the colum n o f  the W A V E  m achine. The 
phosphate ions o f  the D N A  interacts electro statically with the p ositive am m onium  ions o f  
triethylam m onium  acetate (TEA A ), which interacts with the colum n (com posed  o f  
polystyrence- d ivinylbebzene copolym ers). The tim e for eluting D N A  through the
59
Chapter 2: Subjects and Methods
column is based on size, sequence and analysis temperature. At a given optimal 
temperature (which can be calculated from the GC content of the DNA sequence) and an 
acetonitrile concentration the heteroduplex DNA is washed from the column first then the 
homoduplex is eluted. The eluted DNA fragments are detected by UV light. An example 
of a dHPLC trace of a heterozygous sample with a single base pair change is shown in 
figure 2.6.
Figure 2.6: An example of a dHPLC trace of a heterozygous sample with a single base pair 
change resulting in 4 DNA populations. Each peak in the diagram indicates the presence of 
each DNA population. The first 2 peaks indicate 2 DNA populations of heteroduplexes, and the 
second 2 peaks indicate 2 DNA populations of homoduplexes. (Figure reproduced from the 
‘Guide for the WAVE, Transgenomic, transforming the world’ with modification).
b) Amplicon design
Amplicon design is a critical factor in successful mutation detection using the WAVE 
System. Optimizing amplicon design prior to conducting PCR can significantly reduce 
analysis time and increase mutation detection efficiency. Sequences of the gene or 
fragment were entered into the software (WAVEMAKER) and amplicons (generally 
ranging from 150 -  700bp) with fairly uniform melt domains were chosen for further 
analysis with a primer-design software. A well-designed amplicon ideally should have a 
single melt domain, and the entire fragment should melt (the percent helical fraction of the
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fragment should change from 100 to 0%) within a temperature interval of 5°C. This 
allows fragments to be analyzed at a minimum number of temperatures.
c) Primer design
The primers for each amplicon were designed based on the WAVE primer design criteria. 
Primers were designed to be 18 -  30bp in length, with a GC content ranging from 44- 
60%. The Tm of each primer was around 56°C and the difference between the primers’ 
Tm was less than 2°C. Each set of two primers for an amplicon were checked for no self­
complementarity (e.g. hairpin loops) and no complementarity between primers (e.g. 
primer dimers).
d) Preparing samples for mutation detection
PCR products used for mutation detection by the WAVE machine were amplified by 
using AmpliTaq gold (Applied Biosystem, Forter city, USA) and Pfu Turbo (Stratagene, 
Texas, USA) at a ratio of 2:1. This combination gives the best available proof reading 
ability for the lowest cost. The PCR buffer used was 10 x KCL, supplied with AmpliTaq 
gold.
Touchdown PCR conditions were optimized for each amplicon based on the melting 
temperature. The touchdown PCR was performed as stated in table 2.3. PCR reactions 
were performed in 96-well plates. The PCR products were then denatured at 95°C for 1 
minute and annealed slowly by decreasing the temperature for 35 cycles by -2°C for each 
cycle. After amplification and hybridization PCR products were stored at -20°C until 
mutation detection by WAVE was performed.
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Table 2.3: Touchdown PCR program for amplification of DNA samples prepared for mutation 
detection.
Step Temperature UC Time Note
1 95 12 minutes
2 95 30 seconds
3 64 1 minute Decrease 0.5°C for each cycle
4 72 1 minute Repeat step 2 to 4 for 10 cycles
5 95 30 seconds
6 59 1 minute
7 72 1 minute Repeat step 5 to 7 for 20 cycles
8 72 5 minutes
e) Running samples through the Trangenomic WAVE machine
Before detecting mutations, the purification and size of the hybridized samples were 
checked by either agarose gel electrophoresis or by running samples through the WAVE 
system using the double stranded-multiple fragments method. Samples were run through 
the WAVE machine according to the manufacturer’s specifications.
2.2.5.2. Sequencing
In this thesis, the CEQ8000 was used for capillary electrophoresis sequencing together 
with the CEQ™ DTCS Quick Start Kit to generate the sequencing reactions (Beckman 
Coulter, Singapore). PCR products were used as templates in the sequencing reactions 
after an initial purification process,
a) Template preparation
DNA templates used for sequencing in this thesis were PCR generated. The QIAquick 
PCR purification Kit (QIAGEN Ltd, West Sussex, UK) was used to purify PCR products 
generated by a standard PCR in a volume of 25pi. The concentration of purified PCR
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products was estimated by 2% agarose gel electrophoresis using a molecular weight 
ladder (Biorad, Hercules, USA). Purified PCR products were diluted into ~50ng/pl and 
approximately 50 -  lOOng of PCR product was used for one sequencing reaction.
b) Preparation of the DNA sequencing reaction
Two strands of each DNA sample were sequenced so therefore 2 sequencing reactions 
were carried out for each sample using only one primer (forward or reverse) for each 
reaction in a 0.2ml thin-wall tube. Each sequencing reaction contained 50-lOOng of 
purified PCR product, 3.2pM of primer (2pl of 1.6pM/pl primer), 8pl of DTCS Quick 
Start Master Mix (Beckman Coulter, Singapore) and dH20 to make a total volume of 
20pl. The thermal cycling was carried out using an ‘X thermocycler’ following a 
program of 30 cycles of 96°C for 20 seconds initially, followed by 55°C for 20 seconds, 
and then 60°C for 4min. Finally the PCR reactions were held at 4°C.
c) Ethanol precipitation of sequencing products
Following the sequencing PCR reaction the unused PCR reagents are removed from 
solution by ethanol precipitation in the presence of sodium acetate. The precipitation was 
performed in 0.5ml tubes for each sample. 4pl of Stop solution (3M NaOAc and lOOmM 
EDTA) and 1 pi of 20mg/ml glycogen (supplied in DTCS Quick Start kit) was aliquoted 
into 0.5ml tubes and then 20pl of each sequencing reaction was added. 60pl of cold 95% 
(v/v) ethanol/dH20 (-20°C) was added and mixed thoroughly. The mixture was 
immediately centrifuged at 14 000 rpm for 15 minutes and the supernatant was removed 
with a micropipette. The collected pellet was rinsed 2 times with 200pl of 70% (v/v) 
ethanol/dH20 (-20°C). For each rinse, samples were centrifuged immediately at 14 000 
rpm for a minimum of 2 minutes, and after each centrifugation the supernatant was 
carefully removed with a micropipette. The pellet was dried under vacuum for 40 minutes
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then resuspended in 40pl of Sample Loading Solution (supplied in DTCS Quick Start kit). 
The resuspended samples were then ready for analysis using the CEQ8000 sequencer.
d) Sequence data analysis using CEQuence Investigator_ CEQ2000XL
Sequencing samples were loaded and electrophoresed on the CEQ8000 capillary 
sequencer according to the manufacturers’ instructions. Using the CEQuence Investigator 
software the sequence data was compared to the known reference sequence. The software 
automatically determines and matches the orientation of the sequences, forms the 
consensus (from the sequence data from both DNA strands), aligns the consensus with the 
reference sequence, and provides a detailed report of the differences.
2.2.6. Genotyping methods
2.2.6.1. Sequenom M assExtend/ MassArray
The Sequenom MassEXTEND/MassARRAY System is a single nucleotide polymorphism 
(SNP) typing procedure based on an allele-specific primer-extension reaction allowing for 
the differentiation of homozygous wild-type, heterozygous mutant and homozygous 
mutant samples. The MassEXTEND primer anneals to the polymorphic site and 
extension is dependent on the presence or absence of the polymorphism. Figure 2.7 
summarises the underlying principle of the method.
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Figure 2.7: MassEXTEND Primer Extension Reaction principle. The green striped box indicates 
the 23-mer primer. The reaction includes dCTP and a termination mix ddTTP/ddATP/ddGTP. 
The SNP to be detected is a T/G polymorphisms. When the primer anneals to the template, the 
presence of the T allele leads to a one base pair extension (addition of ddATP). The presence of 
the G allele leads to a two base pair extension (addition of dCTP and ddGTP). The difference of 
mass generated by the different alleles can be detected by a mass spectrometer.
High throughput genotyping was performed by allele-specific MALDITOF mass 
spectrometry using the Sequenom MassArray system. Briefly, a fragment of 
approximately lOObp containing the SNP site was first amplified by PCR (Tetrad thermal 
cycler, MJ Research, Waltham, USA). Multiplex PCR reactions (5pl) were performed in 
a 384-well PCR plate by mixing 2pl of PEP DNA (1:20 dilution) with 800pM of dNTP, 
IX  NH4 buffer, 2mM MgCl2, 0.025 units of BioTaq (Bioline, Bath, UK), and 0.2 pM of 
each primer. The cycling parameters were 96°C for 1 min then 5 cycles of 94°C for 45 
sec, 56°C for 45 sec and 72°C for 30 sec, then 29 cycles of 94°C for 45 sec, 65°C for 45 
sec and 72°C for 30 sec, then 72°C for 10 minutes once. Following PCR the 
unincorporated dNTPs were removed by treatment with shrimp alkaline phosphatase, the
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extension reaction performed and the subsequent products were desalted. Fifteen 
nanolitres of the reaction mixture were then “spotted” onto a SpectroCHIP. The CHIP was 
read in the Bruker Biflex III Mass spectrometer system, and the data analysed by 
SpectroTYPER.
22.62.  Invader Assay
The invader assay is a SNP genotyping assay based on “structure dependent cleavage”. 
This endonuclease based genotyping method can discriminate SNP alleles through the 
cleavage of a structure specific target sequence. The assay can be carried out in either a 
uniplex format that allows one to determine only one allele in an assay, or in a biplex 
format that allows one to determine two alleles at the same time. Both uniplex and biplex 
formats have been used in this study with PCR amplicons as template in both cases.
a) Invader assay mechanism
The Invader technology is based on the digestion of overlapping oligonucleotides 
hybridized to a certain template sequence. A SNP specific Invader oligonucleotide, an 
allele specific primary probe and an allele-specific fluoresence resonance energy transfer 
(FRET) probe were designed for each Invader assay. If the DNA target sequence is 
recognized the probe, a three-dimensional structure is created. This structure is recognized 
and cut at a specific site by the cleavage enzyme and releases the 5’ flap of the primary 
probe. The released 5’ arm of the allele specific primary probe is recognized by the FRET 
cassette and forms the three-dimensional structure again. The cleavage of the 5’ arm of 
the FRET cassette results in separation of a flourophore from a quenching receptor 
fluorophore and a fluorescent signal from the donor dye is detected (figure 2.8). If the 
DNA target sequence is not recognized by the probe or if the other allele is present, then 
the three-dimensional structure formed is not recognized by the Cleavage VIII enzyme 
and the release of the 5’ flap does not occur. In this situation the secondary cleavage
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reaction is unable to proceed and fluorescence is not detected (see figure 2.9). For uniplex 
assays each allele is interrogated individually whilst the biplex assay allows both alleles to 
be interrogated simultaneously using two alternative fluorophores.
5’ Flap
Cleavage
Invader Oligo
\
Released 5’ Flap T
\ Cleavage
5’ Flap
1
Primary Probe 1
Target sequence 
Allele 1
FRET Cassette
Fluorescence
Detected
Figure 2.8: Genotyping by the Invader assay and detecting the presence of the A allele with a T 
primary probe. Annealing of the Invader oligonucleotide (N nucleotide) and primary probe (T 
nucleotide) to the correct target DNA (with A allele) forms a three-dimensional structure which 
results in the cleavage of the 5 ’ Flap. The released 5 ’ flap then participates in a second cleavage 
reaction with the FRET cassette leading to the release of a fluorescent signal.
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Figure 2.9: Genotyping by the Invader assay and not detecting the presence of the A allele with 
a C primary probe. If the invader oligo and primary probe do not form the correct three- 
dimensional structure [i.e. the allele A in the target sequence is not complementary to the 
nucleotide in the primary probe 2(C)] then cleavage and release of 5 ’ flap does not occur and the 
secondary cleavage reaction cannot proceed, resulting in no fluorescent signal.
b) Preparing probe and PCR products for Invader assay
All probe sets for both uniplex and biplex assays were designed and synthesized by Third
Wave Technologies. PCRs were carried out in 384-well plates (Abgene, Epsom, UK) with
all liquid handing done using a BiomekFX robotics system (Beckman Coulter, High
Wycombe, UK). PCR conditions were optimized by varying the annealing temperature
between 55°C and 65°C and all were carried out in a 6pl reaction volume containing 7.5ng
of DNA template, lOOng/pl forward and reverse primers, 5mM dNTPs, NEB buffer, 1/20
dilution of B-mercaptoethanol (Sigma, Dorset, UK), 1/10 dilution of 5% Bovine Serume
Albumin (BSA) (Sigma, Dorset, UK), 28% solution sucrose and cresol red and 0.12pl
AmpliTaq Polymerase (Applied Biosystems, Warrington, UK). Water control and known
DNA controls were included on every plate. PCRs were carried out using a MJ Research
PTC-225 Thermocycler with cycling parameters of 95°C for 5 minute then 35 cycles of
94°C for 30 seconds, annealing at 55°C (or 56°C) for 30 seconds and 72°C for 30 seconds,
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and then 72°C for 5 minutes. Presence of a clean PCR product was confirmed on agarose 
gels stained with a lOmg/ml solution of Ethidium Bromide and visualized under UV. The 
PCR product was then used for the Invader assay.
c) Performing Invader assay
For uniplex assays, two separate universal uniplex dry down 96 well plates were used 
(supplied by Third Wave Technologies, London, UK). Each plate contained the Cleavage 
VIII enzyme and the FRET probe. The PCR product was initially diluted with 25 pi of 
deionized water and 3 pi of the diluted PCR product was used for each reaction in each 
plate. For each reaction, 6pl of allele-specific uniplex assay mix containing the primary 
invader probe and 7.5mM MgCL were added. Plates were sealed and incubated at 95°C 
for 5 minutes followed by 10-40 mins at a universal uniplex annealing temperature of 
65°C. Optimal annealing time was determined during an initial optimization step carried 
out for each assay.
For biplex assays, only one plate was used for detection of both alleles. Universal biplex 
drydown plates (Third Wave Technologies, London, UK) containing the Cleavage VIII 
enzyme and two FRET probes, one labeled with a FAM fluorophore and the other a RED 
fluorophore were used. The PCR product was diluted with 20pl of deionized water and 
then 3 pi of diluted PCR product, 3pi of locus-specific biplex assay mix containing 
relevant probes, and 15mM MgCL was added to each reaction. Plates were sealed and 
incubated at 95°C for 5 minutes followed by 10-20 mins at a universal biplex annealing 
temperature of 63 °C. Again optimal annealing time was determined in an initial 
optimization step.
After the incubation time both uniplex and biplex assay plates were read immediately on a 
Wallac Victor fluorescent plate reader (Applied Biosystems, Warrington, UK). Data were
69
analysed for genotype clustering using macros implemented in Microsoft Excel. 
Individual genotypes were calculated by the signal strength ratio between allele 1 and 
allele 2 at a given locus. There are defined genotype clusters for the calculation. Any 
individual genotypes falling between defined genotype clusters were marked as equivocal 
and omitted from further analyses. Absence of signal from either allele was classed as an 
assay failure.
2.2.6.3. Amplification Refractory Mutation System Polymerase Chain Reaction 
(ARMS-PCR)
ARMS-PCR is based on the principle that unless exact complementarity exists at the 3 
prime ends o f the primer, a PCR product will not be formed. With the use of two primers, 
one specific for each SNP allele, homozygotes and heterozygotes can be determined. Two 
reactions were performed for each sample, one for each allele specific primer.
For each PCR reaction lOOng DNA was used. The reaction volume was 20pl and 
consisted of 0.2mM total dNTPs, 0.75M Betaine, 5% DMSO, 1.5mM magnesium 
chloride, 0.4pM of the allele specific primer, 0.4pM of the conserved primer, 0.165pM of 
each positive control primer (HGH I 5’-CAGTGCCTTCCCAACCATTCCCTTA-3’ and 
HGH II 5’ ATCCACTCACGGATTTCTGTTGTGTTTC-3 ’), and 1 unit o f HotStarTaq 
(QIAGEN Ltd, West Sussex, UK). The cycling parameters were 95°C for 12 minute then 
30 cycles of 95°C for 1 minute, annealing for 30 seconds and 72°C for 30 seconds, then 
72°C for 5 minutes. The reaction was performed on a MJ tetrad thermocycler. PCR 
products were then kept at 4°C.
For analyzing PCR products, agarose gel was prepared by using Boric acid medium 
containing 8% NaOH and 1 % Boric acid. Two PCR products from two PCR reactions 
for each sample were loaded into the two adjacent wells in the agarose gel. The
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genotypes were read by the presence or absence o f bands of a certain size on the gel 
depending on the size of the PCR products and the presence of the control band (at 
position of 439bp).
2.3. Statistical packages and analytical methods
2.3.1. Haplotype construction and analysis
To construct and analyse haplotypes several programs were used through a PISE web 
interface in gMap (www.gmap.net). The following programs were used for haplotype 
construction and haplotype analysis.
2.3.1.1. QUICKSTART
QUICKSTART is a program that produces a common data format from which you can 
run different programs. Data are entered in the form of a pedigree file, which contains 
data on genotypes of different individuals, one individual on each row. The columns of 
this data file are; Family identification (id), Person id, Father id (i.e. the id of the father of 
the case or 0 if the father is absent), Mother id, Sex (l=male, 2=female), and Disease 
status (0=unknown, l=unaffected, 2=affected). The remaining columns of the file are 
columns in pairs giving the genotype of the individual at each marker. Zero (0) denotes 
missing data. To be able to analyse the future haplotype results, we listed markers in the 
same order as they occur on the chromosome. It is necessary to specify on the 
QUICKSTART webpage whether disease data are present, how many markers are present 
and specify which program is run next. QUICKSTART does not actually run the program 
but reformats the data and provides an output that can be sent to the selected program.
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2.3.1.2. PHASE and PHAM ILY
PHASE is a statistical software program, which infers phase and reconstructs haplotypes 
from population data (Stephens et al. 2001). PHASE was used for multilocus haplotype 
construction. Typically PHASE should be used with unrelated individuals, as it uses 
population frequencies in its calculations. However, where additional family members 
have been genotyped, their genotypes can be used to infer the known haplotypes before 
running PHASE. This provides PHASE with more information enabling both more 
reliable results and faster execution. PHASE cannot analyse family data itself, but it has 
an option to enter known phase information that may be available from family or 
experimental studies.
PHAMILY (Hans Ackerman, DPhil thesis, University of Oxford, Oxford, UK, 2001) is 
designed to use prior to the PHASE program to utilize family data. When a family"trio", 
one child and its two parents have been genotyped, the genotypes of parents can be 
considered as two unrelated individual genotypes. However the knowledge of the 
childrens' genotypes enables us to logically infer some of the parental haplotypes, which 
would not be possible without this additional data. The current PHAMILY analysis takes 
a set of family trios, and in the first stage uses logical methods to infer all the known 
haplotypes in the parents. The childrens’ genotypes are then discarded, and the parental 
genotypes and known haplotypes are passed to PHASE as a set of unrelated individuals. 
PHASE is used to estimate the most probable remaining haplotypes using statistical 
methods. When running PHAMILY from the PISE interface, PHASE is run automatically 
as part of the analysis. It is also possible to run PHAMILY through QUICKSTART.
2.3.1.3. HaploXT
HaploXT (Abecasis and Cookson 2000) cross tabulates states from marker haplotypes. 
The input for HaploXT is a set of haplotypes which could be one of the outputs from 
PHAMILY. Following PHAMILY, several programs can be selected for the next analysis.
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HaploXT can be selected to determine the LD pattern between SNPs across the 
investigated region of chromosome. The output consists of the following measures for 
each pairwise comparison; delta squared, standardised disequilibrium coefficient (D'), Chi 
squared value (% ), and the Chi squared probability (P value). The output file of HaploXT, 
LD.XT can be used for a graphical interface.
2.3.1.4. GOLD and M ARKER beta (http://www.gmap.net/marker/)
Graphical Overview of Linkage Disequilibrium (GOLD) is a graphical summary of 
pairwise measures of LD. The input is in the form of founder haplotype estimates. GOLD 
calculates pairwise disequilibrium measures and displays the results in an easy to interpret 
graphical form. The LD parameters that can be estimated are D, D', r2 and the P  value 
corresponding to these pairwise measures.
MARKER beta is a program under development based on GOLD written by Dominic 
Kwiatkowski and Kirk Rocket in The Wellcome Trust Centre for Human Genetics, 
Oxford University. The input consists of the HaploXT output and the list of markers. 
MARKER beta displays the selected parameters from the HaploXT file [typically delta 
squared (82), D', %2 and the P  value].
2.3.1.5. HaploBlockFinder
HaploblockFinder is a computer program (http://cgi.uc.edu/cgi- 
bin/kzhang/haploBlockFinder.cgi) utility for the analysis of haplotype blocks based on a 
greedy algorithm. This program uses the constructed haplotypes in a region and divides 
that region into blocks of haplotypes. This program is another way to visualise the LD 
pattern of the genomic region. From the blocks of haplotypes the tag-SNPs can be 
selected from each block.
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2.3.1.6. ENTROPY
ENTROPY is a tool for selecting tag-SNPs in an unstructured way, which requires far 
fewer SNPs than haplotype block methods. The entropy program was written by Dr 
Richard Mott fhttp://www. well.ox.ac.uk/~mott/SNPS/). The objective of this program is, 
given a set of SNPs and associated haplotypes with haplotype population frequencies, to 
choose a subset of SNPs that best approximate the haplotypic diversity in the population. 
The idea is to compute the tag-SNP subset with the maximum entropy.
For haplotype datasets, MARKER uses an ENTROPY routine to choose an economical 
set of markers from the dataset, which describe the full information content of the set. The 
algorithm starts by picking the most informative marker, which has allele frequency 
closest to 0.5. It then repeatedly adds new markers from the set, each time choosing the 
one marker which most increases the logical entropy of the system. Eventually enough 
markers are chosen to distinguish all the haplotypes.
2.3.1.7. Error rate estimation
Using tag-SNPs as a way of screening regions of the genome for association with disease 
is a common approach. The objective of this approach is to genotype the tag-SNPs in a 
study population, and to use this information to draw inferences about each individual's 
haplotypic makeup including SNPs that were not directly genotyped. Following 
ENTROPY for tag-SNP selection, the error rate estimation 
(h ttp : //gman.net/marker/app/how to do error rates) can be performed to test the validity 
of the tag-SNPs before their use in further association studies. The accuracy of haplotype 
inference varies, depending on the method of selecting the tag-SNPs, the LD structure of 
the region, and the amount of missing data.
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2.3.2. Association analysis
2.3.2.1.Hardy W einberg Equilibrium  (HWE)
A fundamental principle in population genetics states that the genotype frequencies and 
gene frequencies of a large, randomly mating population remain constant provided 
immigration, mutation, and selection do not take place. In a large, random-mating 
population, the proportion of dominant and recessive genes tends to remain constant from 
generation to generation unless outside forces act to change it. Forces that can disturb this 
natural balance are selection, mutation, gene flow, and natural selection. Certain gene- 
controlled traits are selected for or against by the partners involved. The HWE law is used 
to determine whether the number of harmful mutations in a population is increasing. 
Under certain conditions, after one generation of random mating, the genotype 
frequencies at a single gene locus will become fixed at a particular equilibrium value. It 
also specifies that those equilibrium frequencies can be represented as a simple function 
of the allele frequencies at that locus.
In the simplest case of a single locus with two alleles A and a with allele frequencies of p  
and q, respectively, the HWE predicts that the genotypic frequencies for the AA 
homozygote to be p 2, the Aa heterozygote to be 2pq  and the other aa homozygote to be 
q . The Hardy-Weinberg principle is an expression of the notion of a population in 
"genetic equilibrium" and is a basic principle of population genetics. Thus, p 2 + 2pq + q2 
should be equal 1.
We performed HWE testing on our genotyping data. The genotyping data was considered 
fixed or correct if the P value when comparing the null hypothesis to the real data is > 
0.05. HWE was applied in this thesis to validate the genotyping of SNPs for use in 
association analysis. For this thesis HWE testing was performed using STATA software
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2.3.2.2.Power and sample size calculation.
The power of a study is its ability to detect a true difference in outcome between the 
standard or control arm and the intervention arm. This is usually chosen to be 80%. By 
definition, a study power set at 80% accepts a likelihood of one in five (that is, 20%) of 
missing a real difference. The power is calculated for a study based on the sample size 
used for that study. In an association study, power is calculated based on the sample size 
and allele frequencies. A large sample size and a high allele frequency increase the power 
of the study. Power calculations were used in this thesis to omit SNPs where there was 
little or no chance to detect a disease association. In addition, the power was also 
calculated to determine whether a disease association could be detected for a selected 
SNP. In this thesis, power calculations were performed based on unrelated individual 
genotype data and family data by using two different excel spread sheet which were 
written by Dr Heather Cordell, Cambridge Institute of Medical Research, Cambridge, UK.
2.3.2.3. Case/control comparisons 
a) Logistic regression
For case/control comparisons, logistic regression in the STATA SE8.0 software package 
(Stata Corporation, College Station, Texas, USA, http://www.stata.com) was used which 
compares allele-wise (ldf) and genotype-wise (2df) associations seen at each locus. 
When a large number of polymorphisms in a particular region or gene have been typed in 
a certain case/control data set, the consideration of overall combination of genotypes 
across a number of loci is performed. This method is of particular use when determining 
which polymorphism, or combination of polymorphisms within a candidate region or 
gene plays a role in disease, and which are associated with disease due to the difference 
between frequencies in two groups.
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b) Stepwise analysis
The case/control data sets can also be used in stepwise conditional logistic regression to 
model the effects seen at each locus conditional on the alleles present at the second locus. 
In other words, the stepwise analysis is testing for the main disease contributory effect at 
one locus whilst controlling for confounding at the second locus. This is done by 
comparing a model containing the main effects at both loci to a model containing the main 
effects at one locus only. This procedure can be adopted to look at variants within and 
between candidate genes of interest. For this thesis stepwise analysis was performed using 
STATA software.
2.3.2.4. Family analysis -  Transmission Disequilibrium Test (TDT)
Family-based allelic association tests were performed using TDT within this thesis. The 
basic premise of the TDT is that certain alleles at a locus are disproportionately 
transmitted from parents to an affected offspring; therefore the basic sampling unit for the 
TDT is a nuclear family with at least one affected offspring (i.e. father, mother & affected 
off-spring).
In TDT the untransmitted alleles are used as an internal control for the transmitted allele 
and their transmissions to the affected child are compared. The TDT test calculates 
whether this transmission of alleles from heterozygous parents to affected offspring 
differs significantly from that expected under Mendelian segregation with no linkage or
• • 9association. The TDT test can denote (T-U) /(T+U), where T is the number of times an 
allele is transmitted and U the number of times it is not transmitted. This has 
approximately a % distribution under the null hypothesis with one degree of freedom. For 
this thesis TDT was performed using STATA software.
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2.3.2.5.GENEBPM  -  disease association analysis of haplotypes
GENEGBPM is a novel method for the analysis of population-based association studies 
using unphased SNP genotype data directly, which was developed by Andrew Morris 
(Morris 2005). The maximum likelihood was estimated for the relative frequencies of 
haplotypes consistent with the observed SNP genotypes via implementation of the 
expectation-maximisation algorithm. The consistent SNP haplotypes were specified as 
“cluster centers”, with each cluster allocated a disease odds parameter. Output from the 
algorithm can be used to, (1) estimate relative-risks of disease for each haplotype 
consistent with the observed unphased genotype data, treating the most common 
haplotype as baseline, (2) identify clusters of haplotypes with similar disease risks, (3) 
identify groups of cases carrying the same high-risk variants and (4) estimate the posterior 
probability of a haplotype association with the disease. This method was used in analysis 
the tag-SNPs haplotype in chapter 5.
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Chapter three
3. Polymorphisms in the Toll-like receptor 4 gene and 
their association with Typhoid fever
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3.1. Introduction
The innate immune system is the first line of defense against infectious disease. TLR4 is a 
member of the Toll-like receptor family, which plays a fundamental role in pathogen 
recognition and activation of innate immunity. Human TLR4, a transmembrane 
glycoprotein, is constitutively expressed by monocytes and endothelial cells. It has been 
implicated in signal transduction events induced by LPS the major component of the outer 
cell membrane of Gram-negative bacteria (Poltorak et al. 1998a; Ulevitch and Tobias 
1995). As a central component of the human endotoxin sensor, TLR4 functions in the 
early detection and response to Gram-negative infection. In Salmonella infections, LPS is 
the main source of inflammation, and TLR4 is a crucial signal transducer for LPS.
Recognition of the LPS component of Gram-negative bacteria involves several host 
proteins. The first molecule involved in the recognition of LPS is LPS-binding protein 
(LBP) (Schumann et al. 1990). LBP is an acute-phase protein, which brings LPS to the 
cell surface by binding to LPS and forming a ternary structure with the membrane 
associated LPS receptor molecule, CD 14. The LPS-LBP-CD14 complex then triggers 
signalling through TLR4. In the presence of MD-2, homodimerization of TLR4 activates 
the transcription factor NF-kB through a signalling cascade leading to the production of 
several important mediators of innate immunity, such as cytokines and chemokines (Akira 
and Takeda 2004; Hsu et al. 2004). The TLR4 signalling cascade is initiated by 
recruitment of the TIR-domain-containing adaptor molecule (TIRAP) to the cytoplasmic 
domain of the receptor. Other adaptor molecules include myeloid differentiation factor 88 
(MyD88), MyD88 adaptor-like protein (Mai, also called TIRAP), TIR-containing adaptor 
inducing IFN/? (TRIF, also called TIRAP-1 or TICAM-1), and TRIF-related adaptor 
molecule (TRAM, also called TIRAP-2 or TICAM-2). Activation of TLR4 leads to 
stimulation of both MyD88-dependent and MyD88-independent pathways. During 
MyD88-dependent signaling, MyD88 is recruited to the TLR4 receptor through
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interaction with the TIR domain of TLR4. This complex in turn facilitates the recruitment
of IRAKI and IRAK4 activating NF-kB and leading to the production of inflammatory
cytokines such as TNF-a, IL-6 and IL-12. The MyD88-independent signaling begins with
recruitment of the adaptor molecule TRAM to the cytoplasmic domain of TLR4 (Oshiumi
et al. 2003). TRAM forms heterodimers with TRIF, which has been shown to play an
essential role in IFN regulatory factor 3 (IRF3) activation and production of IFN/?
(Yamamoto et al. 2003) (figure 3.1). The complexity of the networking between,
molecules of the response to LPS through TLR4 pathway suggest that genetic changes in
any of the molecules in the TLR4 signaling pathway could detrimentally affect the first
line of defense against Gram-negative pathogens such S. typhi. In this study we focus on
the TLR4 gene, encoding the TLR4 receptor, which functions in the direct recognition of
Salmonella LPS and contributes to the first line of defense against Salmonella invasion.
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Figure 3.1: LPS receptors and the TLR4 signaling pathway: LPS is recognized by the 
CD14/TLR4-MD-2 complex and triggers the signaling pathway which leads to the regulation of 
transcriptional activators of a variety of immune response genes. TLR4 signals via MyD88- 
independent and MyD88-dependent pathway to produce cytokines, (reproduced from Akira et 
al, 2004 (Akira and Takeda 2004).
TLR4 is a critical element required in the appropriate induction of the innate defense 
system. TLR4 has been reported to play an important role in recognition of LPS in 
Salmonella infection in mice (Huber et al. 2006; Muroi and Tanamoto 2002). TLR4 
deficient mice are susceptible to Salmonella infection to a similar level as that seen in 
animals lacking functional NRAMP-1, which is widely known as the principal murine
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resistance factor to Salmonella (Bernheiden et al. 2001). In addition, mice lacking TLR4 
function were more susceptible to Salmonella infection than normal mice either in vitro or 
in vivo (Li and Cherayil 2003; Weiss et al. 2004). Mutations in murine TLR4 have been 
shown to completely prevent LPS signal transduction in vitro (Du et al. 1999), and the 
C3H/Hej mouse strain, which carries a functionally inactive TLR4 gene, has marked 
impairment of TNF-a secretion in response to Salmonella infection (Li and Cherayil 
2003). Moreover, macrophages and B-cells from TLR4 knockout mice are 
hyporesponsive to LPS to a similar extent as C3H/Hej mice (Akira 2000).
The human TLR4 gene sequence length is 11,467bp located on chromosome 9q32-q33. 
There are 3 exons and one predicted exon (positioned between the first and second 
introns) that have been identified in the human TLR4 gene (Rock et al. 1998). The 
sequence and the polymorphic spectrum of the gene have been elucidated (Smirnova et al. 
2000). Mutations in the TLR4 gene have been associated with differences in LPS 
responsiveness in humans (Arbour et al. 2000; Michel et al. 2003). There is evidence that 
co-segregating missense mutations (Asp299Gly and Thr399Ile) that affect the 
extracellular domain of the TLR4 receptor are associated with a blunted response to 
inhaled LPS in humans (Agnese et al. 2002; Arbour et al. 2000; Schwartz 2002). Arbour 
also showed that Asp299Gly, but not Thr399Ile, interrupts TLR4-mediated LPS signaling 
(Arbour et al. 2000). Following the initial report of Arbour et al (Arbour et al. 2000), a 
number of studies investigating the potential impact of the co-segregating missense 
mutations (Asp299Gly and Thr399Ile) on various infectious diseases were reported (table 
3.1). These studies have shown that the mutations are present in approximately 10% of 
white individuals and are positively correlated with some diseases (septic shock, RSV, 
Legionnaires’ disease) however they are not associated with others (meningococcal 
disease, severity of atopy in asthmatics or asthma and atopy related disease (Raby et al. 
2002)). Interestingly, it seems that these SNPs show protection from non-infectious
83
Chapter 3 ; P olym orphism s in she T oll-like recepior -4 ami (heir association with Typho id  fever 
disease such as atherosclerosis, acute coronary events, diabetic neuropathy and premature
birth and possibly myocardial infarction (Ameziane et al. 2003; Balistreri et al. 2004;
Edfeldt et al. 2004; Lorenz et al. 2002a; Rudofsky et al. 2004) (summarised in table 3.1).
Controversially, a more recent study demonstrated that homozygosity for the Asp299Gly
mutation does not confer hyporesponsiveness to stimulation with TLR4 stimuli (van der
Graaf et al. 2005). Although there is some evidence that the Asp299Gly and Thr399Ile
alleles influence susceptibility to infectious and other disease (reviewed by (Schroder and
Schumann 2005)), the question of whether these SNPs really have an impact on human
health is still much debated.
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Table 3.1: Studies investigating the association of TLR4 SNPs with infectious disease.
Association study SNP Number of 
case/control
Allele frequency (%) 
in patients vs controls
P
value
Reference
Septic shock Asp299Gly
Thr399Ile
91/73 5.5 vs 0 Asp299Gly only 0.05 (Lorenz et al. 
2002b)
Systemic 
inflammatory 
response syndrome
Asp299G!y Patient 94 Increased mortality in patient carrying 
mutation allele 
(19.0 vs 5.0)
0.076 (Child et al. 2003)
Server sepsis 
following bum injury
Asp299Gly Patient 159 SNP develop risk of severe sepsis 0.01 (Barber et al. 
2004)
Respiratory syncytial 
virus infection
Asp299Gly
Thr399Ile
9 9 /8 2
9 9 /9 0
20.2 vs 4.9
20.2 vs 5.6
0.003
0.004
(Tal et al. 2004)
Legionnaires’ disease Asp299Gly
Thr399Ile
108/508 4.9 vs 12.9 0.025 (Hawn et al. 2005)
Meningococcal
disease
Asp299G!y
Thr399Ile
252/251 20.2 vs 20.3 0.9
NS
(Allen et al. 2003)
Meningococcal
disease
Asp299Gly 1047/879 5.9 vs 6.5 NS (Read et al. 2001)
Severity of atopy in 
asthmatics
Asp299Gly 320/179
309/179
0.62 vs 0.5 
0.32 vs 0.5
NS
NS
(Yang et al. 2004)
Acute myocardial 
infarction
Asp299Gly 105/55 Participants with SNP have lower 
incidence of myocardial infarction
0.002 (Balistreri et al. 
2004)
Myocardial infarction Asp299Gly
Thr399Ile
1213/1561 10.7 vs 7.9 Men with SNPs have 
increased incidence of myocardial 
infarction
0.004 (Edfeldt et al. 
2004)
Acute coronary events Asp299Gly 183/216 7.7 vs 12.8 Participants with SNP have 
lower incidence o f acute coronary events
0.037 (Ameziane et al. 
2003)
Diabetic neuropathy Asp299Gly
Thr399Ile
530/246 Participants with SNPs have lower 
incidence of diabetic neuropathy
0.0002 (Rudofsky et al. 
2004)
Premature birth Asp299Gly
Thr399Ile
440/351 23.8 vs 15.9 0.028 (Lorenz et al. 
2002a)
NS: not significant
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A study to identify the presence of the TLR4 Asp299Gly mutation in a population of 
Vietnamese kinh has been previously undertaken (S J . Dunstan, personal communication). 
Asp299Gly was completely absent in a subset of Vietnamese typhoid cases and controls 
indicating a frequency of below 1 % in this population. As this polymorphism was not 
common in the Vietnamese we chose to identify which TLR4 polymorphisms exist in the 
Vietnamese Kinh ethnic group. This chapter describes the detection and genotyping of 
mutations in the TLR4 gene, and examines the frequency of these mutations in a large 
collection of patients with typhoid fever and a cord blood control population.
3.2. Results
3.2.1. Amplicon and Prim er design
In this study we designed primers and amplicons for dHPLC using the Wave® DNA 
Fragment Analysis System (hereafter referred to as the WAVE). According to the 
recommendations by Transgenomic (refer to chapter 2). DNA fragments designed for 
mutation detection should be approximately 400 -  500 bp in length. When detecting 
mutations across a longer genomic region, for example an exon, adjoining DNA 
fragments should overlap by lOObp at each end of the fragment. This overlap is 
important, as the Transgenomic dHPLC is unable to detect mutations in the first or last 
50bp of a DNA fragment. Primers for each fragment should be between 18-22bp long 
and have a melting temperature (Tm) of approximately 56°C. All primers for this study 
were designed using Primer Prediction and Analysis programs found at 
http://www.hgmp.mrc.ac.uk/GenomeWeb/nuc-primer.html). To get the final primers for 
fragment generation, the melting temperature of each fragment has to be predicted using 
the WAVEMARKER 2000 software. Based on the predicted melting temperature GC 
clamps are added to the primer if the original primer cannot bring the whole fragment to 
melting point at the same temperature.
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The 5’ upstream region (containing regulatory elements) and 3 exons of the TLR4 gene 
were divided into 11 fragments (figure 3.2). The length of the fragments ranged from 
338bp to 506bp (table 3.2 and figure 3.2). The length of primers ranged from 18bp to 
25bp and each primer Tm was approx. 56°C. A GC rich clamp had to be added to 4 
primers (table 3.2) to improve the melting temperature profile of the fragment. Each 
fragment was designed to overlap with the adjoining fragments by approximately lOObp.
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Table 3.2: TLR4 primers used for fragment generation.
Fragm ent Size Prim ers Tm GC%
T4_ prom oter 421 bp
F 5 ’ - A A AAT G AAT GTCTG TTG TTT AAG C-3 ’ 56.72 29.17
R 5’-GTGTCTTCTCTTCCTCGAGC- 3’ 56.73 55
T4_ El 338bp
F 5’-AAGTCCAGAATGCTAAGGTTG-3’ 56.14 42.86
R 5’-GCAGAAGTGAGGGAAAGTTC-3’ 56.54 50
T 4 E 2 . 1 338bp
F 5’-AGCAAGCACGATATTGGATA-3' 55.94 40
R 5’-GTCCATCCTTCCATCCATAT-3’ 56.13 45
T4_ E2.2 432bp
F 5’-AGCATGAATTGAGTGAATGG-3’ 56.11 40
R 5’-CAAACCAAGCTTTCCAGTC-3’ 55.87 47.37
T4_ E3.1 438bp + lObp
F 5’-ATGAAGAGCTGGATGACTAGG-3’ 56.08 47.62
R 5’-CCCCCGCCCGAGGGGCATTTGATGTAGAAC-3’ 56.59 45
T4_ E3.2 502bp
F 5 ’ -TGAGTATTTT TCTAATCT GACCAATC-3 ’ 57.17 30.77
R 5 ’ -TAAATGTTG CCATCCG AA-3 ’ 55.94 38.89
T4_ E3.3 484bp + lObp
F 5 ’-GCCCC CG CCG GCAT ACTTAG ACT ACT ACCTCG ATG -3 ’ 55.77 44
R 5 ’-GGT AAAT G AGGTTTCTG AGTG AT A-3 ’ 56.56 37.5
T4_ E3.4 477bp + lObp
F 5’-GCCCCCGCCGAACCAGCCTAAAGTATTTAGATCTG-3’ 56.62 36
R 5 ’-ATT ATG TG ATTG AG ACT GT AAT C A AG -3 ’ 55.84 30.77
T4_ E3.5 462bp
F 5’-CACTCTCCAGTCTTCAGGTACTAA-3 ’ 56.89 45.83
R 5’-TTTCACCTCTACCATACTTTATGC-3’ 56.7 37.5
T4_ E3.6 400bp + lObp
F 5’-GCCCCCGCCGATTGGTGTGTCGGTCCTC-3’ 56.65 55.56
R 5 ’-TGATACCAGCACGACTGC-3 ’ 56.67 56.67
T4_ E3.7 506bp
F 5 ’-GTTTCCATAAAAGCCGAAAG-3 ’ 56.57 40
R 5’-GGAAGCTCCTTGAGATTAGC-3’ 55.85 50
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3.2.2. Optimization of PCR condition
To decrease the number o f  steps needed to detect mutations across all the TLR4 fragments 
a PCR using one set o f  conditions had to be developed. A  gradient PCR was performed to 
identify the appropriate annealing temperature for touchdow n PCR for all TLR4  
fragments. The standard PCR as stated in chapter 2 w as set up w ith a volum e o f  12 .5pi. 
With the Tm o f  primers ranging from 55°C to 57°C (table 3 .2) a temperature gradient 
from 54°C to 62°C was used to determine the m ost appropriate annealing temperature 
using an Eppendorf M astercycler Gradient. PCR products were checked by 
electrophoresis on a 2% agarose gel to select the best annealing temperature for all 
fragments. Figure 3.3 show s the gradient PCR for the two fragments. A ll temperatures 
were adequate for am plification so w e selected the m idw ay temperature (59°C) to use as 
the main annealing temperature, w ith the first annealing temperature o f  the touchdown  
PCR being 64°C. Touchdown PCR w as carried out on all 11 fragm ents using these  
conditions (figure 3.4). Fragments T 4_E 3.2 and T 4_E3.5 did not am plify as w ell as the 
remaining fragments using the standard conditions.
Figure 3.3: Gradient temperature testing to determine appropriate annealing temperatures for 2 
DNA fragments (T4_E1 and T4_E2.1) for 3 samples. Numbers 1 to 8 in each panel corresponds 
to the annealing temperatures 62.4°C, 62°C, 61.4°C, 60.5°C, 59.5°C, 58.4°C, 57.3°C, 56.2°C.
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Figure 3.4: Touchdown PCR carried out with the annealing temperature at 59°C. Lanes 1 to 11 
correspond to the 11 TLR4 fragments named T4_promoter, T4_E1, T4_E2.1, T4JE2.2, 
T4JE3.1, T4JE3.2, T4_E3.3, T4JE3.4, T4_E3.5, T4_E3.6, T4_E3.7 respectively. Fragment 
size is shown in table 3.2. Lane Ld refers to lOObp ladder.
3.2.3. Predicted and selected fragm ent melting tem perature
It is crucial that the precise m elting temperature o f  each fragment is known to enable 
successful mutation detection using dHPLC. Based on the fragment m elting temperature, 
hom oduplex and heteroduplex populations are eluted through the cartridge at different 
rates, the basis o f  detecting sequence changes. The sequence o f  each fragment w as 
entered into the W A V E M A R K ER  software (Transgenom ic, Omaha, U S A ) to predict the 
m elting temperature o f  the fragment. A ccording to Transgenom ic the m elting temperature 
used for mutation detection should be the predicted temperature where 75% o f  the 
fragment is helical. The actual temperature used for mutation detection is then determined  
experim entally by performing a melt curve based on the predicted temperature profile.
To precisely determine the m elting temperature, a m elt curve for each fragment w as  
performed. D N A  from 8 individuals was used as tem plate for PCR. The products were 
then pooled in equal volum e. The pooled sam ple w as denatured and annealed slow ly . 
Hybridization occurs during denaturation and annealing to generate heteroduplexes and 
hom oduplexes in the pooled  sample. The PCR reaction w as performed fo llow in g  the
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standard PCR method (chapter 2) with the annealing temperature taken from the
optimization experiment above. After denaturing and slow annealing, a melt curve was
run on the pooled sample using the WAVE. The melt curve consisted of at least 5
temperatures around the predicted temperature, to identify the actual temperature that can
separate heteroduplexes from homoduplexes.
3.2.3.l.Predicting the melting temperature for the T4_promoter fragment
Entering the DNA sequence of the T4_promoter fragment into the WAVEMAKER 
software, the predicted melting temperature was in a temperature range from 56.5°C to 
58.5°C (figure 3.5b). Figure 3.5a shows that at 55°C the fragment is 100% helical while 
at 60°C the whole fragment is denatured. The fragment therefore goes from 100% to 0% 
helicity within 5 degrees, a condition necessary for mutation detection. However the 
optimal temperature for mutation detection is when 75% of the fragment is helical. We 
predict that the mutation detection temperature for this fragment should be in the middle 
of the temperature range (55 to 60°C). Figure 3.5b shows that at 56.5°C nearly 100% of 
the fragment is helical, at 57.5°C approximately 75% is helical and at 58.5°C 
approximately 25% is helical. Figure 3.5c shows the melting temperature across the whole 
fragment is quite consistent. The melt curve for this fragment was then performed in the 
temperature range from 56.5 to 58.5°C.
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Figure 3.5: Predicted melting profile of T4_promoter fragment using the WAVEMAKER 
software, (a) helical fraction versus temperature (b) helical fraction versus base position (c) 
temperature versus base position.
3.2.3.2.Selecting the melting temperature for the T4_promoter fragment
Based on the predicted temperature above, the melt curve for fragment T4_promoter was 
carried out using five temperatures (56.5, 57, 57.5, 58, 58.5°C). The result is shown in 
figure 3.6. At 57.5°C (the blue curve) the unspecific heterozygous peak is visualized as a 
“shoulder” compared to “no shoulder” at the other temperatures. 57.5°C was therefore the 
temperature selected to enable mutation detection in the T4_promoter fragment.
>E
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Figure 3.6: Melt curve generated for the T4_promoter fragment by using pooled PCR products 
at different temperature. From top to bottom the curves correspond to the temperatures of 
56.5°C (pink), 57°C (gray), 57.5°C (blue), 58°C (black), and 58.5°C (red).
93
C hapter 3: fh4v>o(>rpinsni:i hi ihe  Toif-iikc reoepior 4 a m i /heir associa tion  'whh T yp h o id  fever
The same approach described above for the T4_promoter fragment was used to predict 
and select the best temperatures to detect mutations for the remaining 10 DNA fragments 
of TLR4. The final temperatures that were determined are shown in table 3.3, and the 
details for each fragment can be found in appendix 1 and 2. The results in table 3.3 also 
include the results for three fragments (T4_E3.2, T4_E3.5 and T4_E3.7) that required 
further optimization (described below).
Table 3.3: The temperatures used for mutation detection in TLR4 fragments based on the 
predicted melt profiles generated by the WAVEMARKER program and performing melt curves.
Fragment
Temperature  
100% to 0% 
helicity (°C)
Temperature range 
that includes 75%  
helicity (°C)
Temperature that melt curve  
performed (°C)
Selected 
temperature (°C)
T4_promoter 55 - 6 0 56.5 - 58.5 56 .5 ,57 , 57 .5 ,5 8 ,5 8 .5 57.5
T4_E1 59 - 6 5 6 0 . 5 - 6 2 . 5 60, 60 .5 ,6 1 ,6 1 .5 ,  62 62
T4JE2.1 53 - 6 4 5 5 . 5 - 5 7 . 5 55 ,55 .5 ,  5 6 ,5 6 .5 ,5 7 56
T4_E2.2 55 - 6 0 5 7 - 5 9 57, 57.5, 58, 58.5, 59 58
T4_E3.1 53 -61 5 6 - 5 8 55 .5 ,56 , 56 .5 ,57 ,  5 7 .5 ,5 8 ,5 8 .5 57
T4_E3.2 53 - 5 8 5 4 - 5 6 54, 5 4 .5 ,5 5 ,5 5 .5 ,5 6 55.5 & 56
T4JE3.3 55 - 5 8 5 5 . 5 - 5 7 . 5 5 5 ,5 5 .5 ,5 6 ,5 6 .5 ,5 7 56
T4_E3.4 56 - 5 9 5 7 - 5 9 5 7 .5 ,5 8 ,5 8 .5 ,5 9 ,5 9 .5 58
T4JE3.5 55 - 6 0 55.5 - 5 7 .5 55.5 ,56 ,  56 .5 ,5 7 ,5 7 .5 56.5 & 57
T4_E3.6 57 - 6 0 5 7 . 5 - 5 9 . 5 57 .5 ,58 ,  58.5, 59, 59.5, 60, 60.5,61 59.5
T4JE3.7 57 - 6 2 5 8 . 5 - 6 0 . 5 58 ,58 .5 ,  59, 59.5, 60 59 & 59.5
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When we used a primer containing a GC clamp (added to primers to improve melting
profiles) to amplify T4_E3.2, T4_E3.5 and T4_E3.7 fragments the quantity of the PCR
products was small (see figure 3.4 for T 4 E 3 .2  and T4_E3.5) or inconsistent (T4 E3.7).
PCR fragments of this quantity cannot be used for mutation detection on the WAVE
system. To rectify this problem we removed the GC clamps from the primers and
predicted the melting temperature again. The profile for T4 E3.2 with a predicted
temperature range of 54°C to 56°C is shown in figure 3.7. Figure 3.7.a shows the fragment
could be helical and it could denature completely in 5 degree from 53 to 58. Figure 3.7.b
shows that the middle of fragment is not helical and could not denature at the same
temperature at the ends of fragment. Therefore, only one melting temperature for this
fragment is difficult to select. The predicted melting temperature with 75% helicity is in a
range of 54°C to 56°C. However, figure 3.7.c shows that the whole fragment can be
melted at the same temperature.
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Figure 3.7: WAVE MAKER predicted melting profile of the T4 E3.2 fragment amplified using 
a primer without a GC clamp (a) helical fraction versus temperature (b) helical fraction versus 
base position (c) temperature versus base position
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Based on the new predicted temperatures the melting curve for T4_E3.2 was carried out in
the following temperatures 54, 54.5, 55, 55.5, 56 °C (figure 3.7). Figure 3.8 shows that at
55.5°C (the pink curve) and 56°C (the green curve) of the melt curve the unspecific
heterozygous peak is visualized as a “shoulder” next to the main peak. It was therefore
necessary to use these two temperatures to detect mutations in fragment T4_E3.2.
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Figure 3.8: Melt curve generated for TLR4 E3.2 by using pooled DNA at different 
temperatures. From top to bottom the curves correspond to temperatures of 54°C (yellow), 
54.5°C (blue), 55°C (gray), 55.5°C (pink) and 56°C (green) respectively.
Further optimization was required for fragments T4 E3.5 and T4_E3.7 (see appendix 1 
and 2). As for T4_E3.2, it was necessary to perform mutation detection at 2 temperatures 
for both of these fragments, to ensure that all mutations were identified throughout the 
length of the fragment (see table 3.3 for temperatures).
3.2.4. Polymorphisms in TLR4 gene
In this study, 372 Typhoid fever cases and 372 cord blood controls were arranged into 8 
separate 96 well plates. Each plate included 93 DNA samples, 2 positive control samples 
and 1 negative control (no template DNA).
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Initially mutation detection by dHPLC was performed for 1 plate of typhoid cases (N=93) 
and 1 plate of control samples (N=93) for each of the 11 fragments spanning TLR4. If a 
different dHPLC trace was identified in 2 out of 186 samples, then mutation detection was 
continued in the remaining 558 case and control samples. If no sample generated a 
different dHPLC pattern, or only 1 sample generated a different pattern, then mutation 
detection for that individual fragment was discontinued.
Eleven fragments covering TLR4 were screened to identify mutations based on the 
appearance of altered dHPLC traces generated using the WAVE. To confirm that a 
different dHPLC trace actually represents a mutation, all dHPLC patterns identified were 
grouped and the DNA of 2-3 samples from each group was DNA sequenced. If the group 
only contained one sample with that particular dHPLC pattern, then only one sample was 
sequenced. For six fragments (T4_E1, T4_E2.1, T4_E3.2, T4_E3.4, T4_E3.5 and 
T4_E3.7), no different trace was identified in 186 samples. For the remaining five 
fragments a total of 11 mutations were found in the TLR4 gene, three in the promoter 
fragment, two in exon 2, and 6 in exon 3.
3.2.4.1.PoIymorphisms in T4_ prom oter fragm ent
Four distinct dHPLC patterns were detected in the T4_promoter fragment designated P ip , 
P2p, P3p and “wild type” (WT). Pattern P ip  was distinguished by two unequal peaks 
(figure 3.9 A), P2p by two equal peaks (figure 3.9 B), and P3p by 3 peaks (figure 3.9 C). 
The 3 patterns identified were rare when compared to the frequency of the 4th pattern, 
WT, which was distinguished by 1 peak (figure 3.9 A, B, C, D). Two DNA samples of 
each pattern (Pip, P2p, P3p and “wild type”) in this fragment were sequenced. No 
sequence change was identified in the samples displaying the “wild type” pattern when 
compared to the NCBI sequence (accession number A F177765) (figure 3.9 D). Sequence 
changes were identified in samples displaying patterns P ip  (A-271G), P2p (T-441C) and
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P3p (T-441C) (figure 3.9 A, B, C). The positions of the sequence changes are 
designated based on the translational start (ATG) being +1 of the TLR4 sequence (NCBI 
accession number A F177765)
As mentioned in chapter 2, dHPLC can only identify individuals that are heterozygous for 
the mutation. Traces identified by dHPLC that are different to the wild type trace 
represent the DNA from individuals who are heterozygous for the mutation.
For the T4_promoter fragment, a total of 414 typhoid cases and 358 cord blood control 
samples were analsysed by dHPLC. 18/414 typhoid cases and 14/358 cord blood controls 
displayed pattern P ip, representing individuals heterozygous for G-260C. Pattern P2p 
(individuals heterozygous for A-271G) was found in 4 typhoid cases but not identified in 
the cord blood control group. 4/414 typhoid cases and 5/358 cord-blood controls 
displayed pattern P3p, representing individuals heterozygous for T-441C.
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Figure 3.9: dHPLC patterns and sequence changes in the T4_promoter fragment.
Left: (A) Pip pattern (2 peaks, green) compared with wild type (1 peak, red). (B) P2p pattern (2 
peaks, yellow) compared with wild type (1 peak, black). (C) Pip pattern (3 peaks, red) compared 
with wild type (1 peak, green). (D) wild type pattern.
Right: The DNA sequence around the position of sequence changes at -260 (A), -271 (B) and -  
441 (C) from the ATG translation start site. No change in DNA sequence (D). The two pink lines 
show the position of the sequence change. Two peaks in this position demonstrate a heterozygous 
individual.
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3.2.4.2.Polymorphisms in T4 E2.2 fragm ent
Three dHPLC patterns were detected in the T4_E2.2 fragment designated Ple2.2 P2e2.2 
and WT, displaying 2, 3 and 1 peaks respectively (figure 3.10 A and B). DNA sequence 
of two samples representing each pattern confirmed that samples displaying pattern 
Ple2.2 have a sequence change in intron 2 at position T4025A (figure 3.10 A), P2e2.2 
have a missense mutation at C4215G in the TLR4 gene (figure 3.10 B), and samples 
displaying the WT pattern have no sequence variation present.
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Figure 3.10: dHPLC patterns and sequence changes in the TLR4 E2.2 fragment.
Left: (A) dHPLC pattern P le2.2  (2 peaks, yellow) compared with wild type (1 peak, green). (B) 
dHPLC pattern P2e2.2 (2 peaks, red) compared with wild type (1 peak, green).
Right: The DNA sequence around the position of sequence change at T4025A (A) and C4215A  
(B) from the ATG translation start site. The two pink lines show the position of the sequence 
change. Two peaks in this position demonstrate a heterozygous individual.
After initial investigation 9/345 typhoid cases and 6/358 cord blood controls displayed
pattern Ple2.2, representing individuals heterozygous for T4025A, and 18/345 typhoid
cases and 4/358 cord blood controls displayed pattern P2e2.2, representing individuals
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heterozygous for C4215G. However, in some samples where the PCR product was of low
quantity or poor quality, the dHPLC traces were unclear, and the pattern type could not be
distinguished easily (figure 3.11).
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Figure 3.11: Variation in dHPLC pattern traces in fragment T4 E2.2. The blue dHPLC trace 
displays a 3 peaks pattern (P2e2.2). It not clear how many peaks the pink dHPLC trace 
displays. The gray trace indicates a wild type sample.
ARMS-PCR of the two mutations (T4025A, C4215G) was performed to determine the 
genotype of the samples displaying indistinguishable dHPLC pattern types. In addition, 
genotyping all samples by a second established genotyping method was performed to gain 
confidence in the dHPLC method of assigning genotypes by observing pattern variation.
3.2.4.3.Confirming polymorphisms in the T4 E2.2 fragm ent by ARM S-PCR
ARMS-PCRs was designed for the two polymorphisms that were identified by dHPLC 
(T4025A, C4215G). For ARMS-PCR, 372 Typhoid fever cases and 372 cord blood 
controls were arranged into 16 96-well plates with each plate containing 45 samples in 
duplicate, 1 positive control (heterozygotes for T4025A or C4215G), 1 wild-type sample 
(which have been sequenced) and 1 negative (no DNA template) control.
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For SNP C 4215G  a set o f  three primers, TLR4 73C (5 ’ggcatttaggcagctatagC 3 ’), 
TLR4 73G (5'ggcatttaggcagctatagG  3 ’), and TLR4 73R  (5 ’ gagaatagaggtagcttgct 3 ’) 
were designed. For SNP T 4025A  a set o f  three primers, E 2.2i_T  (5 ’ ctctccaccatctctggT  
3 ’), E 2 .2 i_A  (5 ’ ctctccaccatctctggA  3 ’), and E 2.2i_R  (5 ’ tagctgcctaaatgcctca 3 ’) were 
designed.
Figures 3.12 and 3.13 show  typical A R M S-PC R  agarose gels for genotyping SN Ps 
C 4215G  and T 4025A . Internal control primers for human growth horm one are included  
in every reaction generating a band o f  439bp whereas the size o f  specific bands are 230bp  
for C4215G  and 204bp for T 4025A  (figures 3.12, 3.13).
439bp
230bp
Figure 3.12: Genotyping C4215G by ARMS-PCR. The internal control primers for human 
growth hormone generate a band of 480bp in every PCR reaction. “C” designates an allele 
specific PCR reaction containing the C allele primer TLR4_73C, whereas “G” designates an 
allele specific PCR reaction containing the G allele primer TLR4 73G. The molecular weight 
marker is a 1 OObp ladder.
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439bp
204bp
Figure 3.13: Genotyping T4025A by ARMS-PCR. The internal control primers for human 
growth hormone generate a band of 480bp in every PCR reaction. “A” designates an allele 
specific PCR reaction containing the A allele primer E2.2i_A whereas “T” designates an allele 
specific PCR reaction containing the T allele primer E2.2i_T. The molecular weight marker is a 
1 OObp ladder.
Figure 3.12 show s an exam ple o f  a hom ozygous w ild-type CC genotype (C specific band 
present lane 1, G specific band absent lane 2), and a heterozygous CG genotype (C and G 
present, lanes 11. 12) for SNP C 4215G . Figure 3.13 show s a hom ozygous w ild-type TT 
genotype (lanes 1, 2) and a heterozygous TA genotype (lanes 7, 8) for SNP T 4025A . 
U nlike the dITPLC m ethod, AR M S PCR can identify both heterozygote and h om ozygote  
mutants, how ever in this study no hom ozygotes mutants o f  C 4215G  or T 4025A  w ere 
identified by A R M S-PC R  due to low  mutant allele frequencies.
AR M S-PC R  identified that 21/332 typhoid cases and 12/358 controls contained SNP  
14025A and 6 /330 typhoid cases and 1/362 cord blood controls contained SNP C 4215G  
(table 3.4). N otably, one individual contained both variants.
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Table 3.4: The number of individuals heterozygous for SNP C4215G and SNP T4025A 
identified in the T4_E2.2 fragment by dHPLC and by ARMS-PCR.
dHPLC ARM S-PCR
Case Control Case Control
C4215G 18/345 4/358 6/330 1/362
T4025A 9/345 8/358 21/332 12/358
Failure rate 5% 5 - 6%
Mutation detection using dHPLC identified 18 typhoid cases which contain SNP C4215G 
(table 3.4), however 12 out of these 18 samples have unclear dHPLC patterns (see figure 
3.11, pink curve). ARMS-PCR showed that 6 out of these 18 typhoid cases had the 
C4215G mutation, whereas the 12 samples giving ambiguous traces actually contained 
SNP T4025A. This demonstrates that errors can be made when assigning unclear dHPLC 
patterns. Notably, all individuals that generate different patterns by dHPLC had either 
SNP C4215G or T4025A by ARMS-PCR (although ambiguous traces were difficult to 
assign to one or the other SNP). This demonstrates the sensitivity of dHPLC to detect 
these two SNPs. However, due to the low quality of the dHPLC traces for these SNPs in 
some samples, the specificity of dHPLC was poor, so the confirmation of genotyping by 
ARMS-PCR was necessary. The genotyping failure rate by the two methods was 
calculated as approximately five per cent (table 3.4).
3.2.4.4.Polymorphisms in T 4 E 3 . 1  fragment
T4_E3.1 fragment covers the first 438bp of exon 3 in TLR4 (figure 3.2). Three clearly 
different dHPLC patterns were identified in this fragment (Ple3.1, P2e3.1 and P3e3.1) in 
addition to the wild type pattern displaying 1 peak (figure 3.14). Sequencing fragment
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T4_E3.1 identified 3 missense mutations A7947G (Ple3.1), C7944T (P2e3.1) and 
A8177G (P3e3.1) (fig.3.14) 3/345 typhoid cases and 2/328 cord blood control samples
were heterozygous for A7944G. Heterozygous C7944T (2/345) and A8177G (1/345) 
individuals were only found in typhoid cases.
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Figure 3.14: dHPLC patterns and sequences changes in T4_E 3.1 fragment.
Left: dHPLC pattern (A) P le3.1 (purple), (B) P2e3.1 (blue), (C) P3e3.1 (brown) compared with 
wild type (green).
Right: The DNA sequence around the position of sequence change at A7947G (A), C7944T (B) 
and A8177G (C) from ATG translation start site. The two pink lines show the position of the 
sequence change. Two peaks in this position demonstrate a heterozygous individual.
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3.2.4.5.Polymorphisms in T4 E3.3 fragment
T4_E3.3 is in the third fragment in exon 3 of TLR4 (figure 3.2). Only one sample in the 
typhoid case group generated a different trace by dHPLC. Sequencing of this sample 
identified a heterozygous missense mutation at C8850T (figure 3.15).
T i -  k 3
y f  S c
U  lA ,A/yyy r M j
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Figure 3.15: dHPLC patterns and sequence change in T4_E3.3.
Left: dHPLC pattern P le3.3 (red) compared with the wild type pattern (pink).
Right: The DNA sequence around the position of sequence change at C8850T. The two pink 
lines show the position of the sequence change. Two peaks in this position demonstrate a 
heterozygous individual.
3.2.4.6.Polymorphisms in T4 E3.6 fragment
Two distinctly different dHPLC patterns were identified in fragment T4 E3.6. 
Sequencing confirmed one heterozygous missense mutation at position G9606T in the 
TLR4 gene (figure 3.16A). The second dHPLC pattern appeared in only one sample and 
for unknown technical reasons it was not possible to determine the DNA sequence of this 
fragment (figure 3.16B).
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32
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'm
Figure 3.16: dHPLC patterns and sequence changes in T4E3.6.
Left: (A) dHPLC pattern Ple3.6 (pink) compared with the wild type pattern (cyan). (B) dHPLC 
pattern P2e3.6 (blue) compared with the wild type pattern (pink).
Right: (A) The DNA sequence around the position of sequence change at G9606T. The two pink 
lines show the position of the sequence change. Two peaks in this position demonstrate a 
heterozygous individual.
3.2.5. Locating mutations in the TLR4 protein and in the TLR4 gene.
Table 3.5 summaries the eleven mutations identified in the Vietnamese population. The 
exact position of 1 mutation located in exon 3 could not be determined. Out of the 
remaining 10 mutations, 3 mutations were identified in the promoter region, 1 in an 
intronic region and 7 mutations were identified in the exonic region of the gene (figure 
3.17).
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Table 3.5: Nucleotide and amino acid positions o f  TLR4 mutations observed in the Vietnam ese 
population. The nucleotide positions are relative to the translational start site (ATG). (NCBI 
accession number A F 177765).
Fragment
gDNA Position 
(AF177765)
Amino Acid 
(AFF05316)
Exon Domain
T4_promoter G -2 6 0  C None Promoter -
T4_promoter A -271 G None Promoter -
T4_promoter T -441 C None Promoter -
T4JE2.2 T 4025 A None Intron -
T4JE2.2 C 4215 G Ser 73 Arg 2 Ectoplasmic
T4_E3.1 C 7944 T Ala 97 Val 3 Ectoplasmic
T4_E3.1 A 7947 G Tyr 98 Cys 3 Ectoplasmic
T4_E3.1 A 8177 G Thr 175 Ala 3 Ectoplasmic
T4_E3.3 C 8850 T Thr 399 lie 3 Ectoplasmic
T4JE3.6 G 9606 T Val 651 Phe 3 Plasma membrane
T4_E3.6 ND ND 3 ND
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Figure 3.18 shows the structure of the TLR4 protein with the positions of the 
extracellular domain, transmembrane domain and intracellular domain. The LRR motifs, 
TIR domain are indicated in the structure of TLR4 polypeptide. The positions of the 6 
coding region mutations in the TLR4 polypeptide sequence are also shown in figure 
3.18. Five non-synomynous polymorphisms were identified in the extracellular domain 
of TLR4, all o f these were in the LRR motifs, and one other mutation was located in the 
plasma membrane. At each mutation position, the chemical formulas, the side chain 
structures and the crystal structure are presented to investigate how much the polypeptide 
may change when each non-synomynous mutation occurs (figure 3.18).
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3.2.6. Frequencies of TLR4 mutations in the population and the power to detect 
their association with disease.
In total, ninety-seven mutations were identified in TLR4 in the Vietnamese population. 
Sixty three mutations were in the typhoid fever cases, and 34 were in the cord blood 
controls (table 3.6). The frequencies of all mutations identified in the Vietnamese 
population are low. The most common mutation in the population is T4025A with a 
frequency of 4.78% (table 3.6 and figure 3.19). It is also the most common mutation in 
the typhoid fever cases (6.33%), while the most common mutation in the controls is G- 
260C, with a frequency of 3.91% (table 3.6). Nine out of 10 polymorphisms identified in 
the Vietnamese population are novel, with only C8850T (Thr399Ile) being previously 
reported in several studies (Hawn et al. 2005; Smirnova et al. 2003). The previously 
reported A896G (Asp299Gly) was absent in the complete sample set of 744 typhoid cases 
and controls. Six out of 10 polymorphisms are non-synonymous SNPs and 2 of these 6 
SNPs are seen in both the cases and the controls, while the other 4 are only seen in the 
cases (table 3.6 and figure 3.19).
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Figure 3.19: The frequency of TLR4 mutations identified in Vietnamese typhoid fever patients 
and cord-blood controls.
The minor allele frequency of each mutation in the population was used for a power 
estimation. Power estimations were performed for a sample size of 372 cases and 372 
controls (table 3.7). The results showed that a sample size of 372 cases and 372 controls 
is underpowered when taking into account polymorphisms with such low allele 
frequencies. If a mutation that has a very strong effect on disease (OR=3) exists in the 
analysis the power to detect an association with this sample size is still less than 60.3 % 
for most of the detected mutations with a low stringency (P=0.05). Only two mutations, 
G-260C and T4025A were shown to have >97.3 % power to detect an association (OR=3, 
P=0.05). This power reduces to approximately 60% at a significance of P=0.001. If the 
effect of any TLR4 mutations on the disease is small (OR=1.5, P=0.05) the power to 
detect an association in this study is <26.7 %. Thus, the power to detect associations 
between TLR4 mutations and typhoid fever in this study is small.
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3.2.7. Association analysis between TLR4 mutations and typhoid fever
In this study we have used dHPLC to detect mutations that are present in individuals in 
the heterozygous state. By the dHPLC method we used we cannot distinguish between 
homozygote wild-types and homozygote mutants. An additional step of mixing all 
samples with a reference wild-type sample is necessary to detect mutations in the 
homozygous state by dHPLC. However, in this study, the frequency of individuals with 
heterozygous mutations in the population was very low (<5%) (table 3.6). Therefore it 
may be unnecessary to perform this secondary screen for individuals with homozygous 
mutations in this population, as they should be extremely rare, and it may not be time or 
cost effective to do so. To investigate this we performed two theoretical analyses, 1/ we 
estimated the sample size based on the current frequency of each mutation to determine at 
what theoretical sample size homozygous mutations could be detected (table 3.8), and 2/ 
the Hardy Weinberg Equilibrium (HWE) for each mutation was estimated to see at which 
theoretical frequency homozygous mutants may exist in this population (table 3.9).
Based on the genotype frequency in typhoid fever cases, the sample size was estimated to 
see at which sample size 1 homozygous mutation may theoretically exist in a population 
(table 3.8). The results show that a homozygous mutation could exist in this population if 
the sample size was increased. For the most frequent mutation (T4025A), 1 homozygous 
mutation may be seen in a sample size of 999. In others mutations, with lower 
frequencies, a homozygous may be detected in sample sizes varying from 2,116 to 
476,100. From these results we can conclude that it is not worthwhile to do a secondary 
screen for homozygous mutations in our sample size of 372 cases and 372 controls.
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HWE was calculated for 1/ the actual data with the assumption that there are no 
homozygous mutations present in the population and 2/ the actual data with the 
assumption that one or two homozygous wild-types were actually homozygote mutants 
but could not be detected by the dHPLC method used (table 3.9). Table 3.9 shows that 
each mutation is in HWE (P=T) when calculating from the actual data with no 
homozygous mutations present. When HWE equilibrium was calculated from the actual 
data containing 1 homozygous mutation in the control group, 2/11 mutations remained in 
HWE (table 3.9). When HWE equilibrium was calculated from the actual data containing 
2 homozygous mutations in the control group all mutations were out of HWE (table 3.9).
From the HWE results and the sample size calculation, we can confidently conclude that 
it is not worthwhile to do a secondary screen for homozygous mutations in our sample 
size of 372 cases and 372 controls. These combined results have provided evidence that 
it is highly unlikely that the dHPLC method we have used for genotyping has missed any 
homozygote mutants in our population. Therefore for the following analysis we have 
determined allele frequencies for each mutation based on the assumption that our 
population does not contain any homozygous mutants.
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Comparisons of genotypic and allelic frequencies of the TLR4 mutations in typhoid cases 
and controls are presented in tables 3.10 and 3.11, respectively. The genotypic 
comparison between cases and controls shows that the frequency of the C4215G 
(Ser73Arg) mutation is significantly higher in typhoid fever cases than in controls (OR
6.7, P=0.04; table 3.10). The allele frequency of C4215G (Ser73Arg) is also significantly 
higher in typhoid patients than controls (OR 6.67, 7M1.04; table 3.11). The risk of disease 
in individuals containing this mutation is 6.67 fold compared to individuals without this 
mutation. There is also an allele-wise association (OR=1.9, P=0.07; table 3.11) and a 
genotype-wise association (OR=1.9, fMl.06; table 3.10) between T4025A and disease 
with borderline significance. An odds ratio of 1.9 shows an increased risk of disease for 
individuals harbouring this mutation. However, in all of these cases the 95% CIs of the 
ORs cross 1. In the case of SNP C4215G (Ser73Arg), the 95% Cl is very wide (0.8-310; 
table 3.10).
It is also interesting to note that of the 6 SNPs that change an amino acid in the TLR4 
protein, 4/6 mutations are only seen in the typhoid fever group, and 1/6 is the typhoid 
associated SNP C4215G (Ser73Arg). However it is very important to highlight that the 
results described above and in tables 3.10 and 3.11 need to be interpreted with caution. 
As the frequencies of the majority o f these mutations in this population are extremely 
rare, statistical analysis has been performed on very small numbers and may not be 
considered robust.
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3.3. Discussion
Naturally occurring genetic variations in innate immunity genes may play an important 
role in human susceptibility to a variety of diseases that require an adequate and 
appropriate immune response. According to Lazarus et al (Lazarus et al. 2002), one main 
consideration to support the above hypothesis is that the innate immunity genes are 
critical for both triggering and sustaining inflammatory responses, and in providing cues 
necessary to program an adaptive, antigen-specific response (Lazarus et al. 2002). TLR4 
is one innate immunity gene which functions by triggering a signaling cascade inside cells 
to generate an innate inflammatory response as well as contributing to the development of 
adaptive immunity (Akira and Takeda 2004; Akira et al. 2001; Medzhitov 2001; Takeda 
and Akira 2001; Takeda et al. 2003). Common variants of TLR4 that change the function 
of the protein in the immune system have been previously reported (Arbour et al. 2000). 
This has lead to the hypothesis that other genetic variations of TLR4 may change the 
function of the protein and alter the efficiency of the immune response to an infectious 
disease.
Sequence analysis of the TLR4 gene in various species has revealed that TLR4 is highly 
polymorphic (Smirnova et al. 2001; Smirnova et al. 2000). Smirnova et al (Smirnova et 
al. 2003) reported 13 TLR4 polymorphisms in a Caucasian population and another 
different 13 TLR4 variants were identified in a Dutch population (Hawn et al. 2005). The 
common functional TLR4 mutation Asp299Gly described by Arbour et al (Arbour et al. 
2000) was not present in the Vietnamese population. Notably, out of the ten mutations 
identified in the Vietnamese population in our study nine are novel mutations compared to 
other published mutations. The extracellular ligand recognition domain of TLR4 is more 
variable than the cytoplasmic signaling domain (Smirnova et al. 2000). In this study, five 
mutations were identified in the extracellular domain, while three other mutations were 
located in the upstream regulatory region of the gene. The majority o f the mutations
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reported in this study are rare mutations hence it is difficult to establish their role in 
genetic susceptibility to infectious diseases in the Vietnamese. However these mutations 
may exist at higher frequencies in different ethnic populations and may be more useful as 
candidate SNPs for genetic association studies in other populations.
Besides the two reported common polymorphisms (Asp299Gly and Thr399Ile), most 
polymorphisms within TLR4 occur at low frequencies in populations (Hawn et al. 2005; 
Smirnova et al. 2001; Smirnova et al. 2003). Correspondent to those studies, all 
mutations detected in our study are also low in frequency (<5%). There is little doubt that 
common host genetic variation present at higher frequencies in the population (minor 
allele frequency of >5%) can influence the frequency and course of infectious diseases 
(Agnese et al. 2002; Barber et al. 2004; Burgner et al. 1998; Chevillard et al. 2003; Tal et 
al. 2004). It is also likely that low frequency SNPs (0.05-5%) may contribute to human 
disease susceptibility, although due to technical hurdles this is currently difficult to verify 
experimentally, but recent theoretical modeling provides evidence to support this 
hypothesis (Gibbs 2005; Pritchard and Cox 2002; Reich and Lander 2001). There is a 
report however where low-frequency (2% in African Americans, but <0.1% in European 
Americans) functional mutations of the PCSK9 gene are associated with a reduction in 
plasma levels of low-density lipoprotein (LDL) cholesterol which is related to heart 
disease (Cohen et al. 2005). There is also a study which supports the notion that rare as 
well as common variants of TLR4 may be associated with infectious disease susceptibility 
(Smirnova et al. 2003). Within a population with meningococcal disease, a group o f rare 
SNPs with frequencies between 0.003 and 0.0168 were collectively shown to be 
associated with disease (P ^ x lO ’6, odds ratio 27.0), while the frequencies of the common 
mutations Asp299Gly and Thr399Ile did not differ significantly between cases and 
controls (P -0.2) (Smirnova et al. 2003). Although this type of analysis may be thought of 
as controversial, it contributes by highlighting these often ignored rare variants and
('hu/jhfr >n she Tod-nke nwcpior -I ^ent> ar-d ihcir associuiian wilh Tvphoiii faver
reports an initial attempt to define the role o f rare missense mutations in disease 
susceptibility.
In our study, four low frequency missense mutations have been identified only in the 
typhoid fever group. However, it is not robust to perform statistical analysis with this data 
due to there being very few observations within each group to be compared. Due to the 
very low frequency of these mutations the sample size in our study was not sufficient to 
obtain a statistically significant result. Therefore it is unknown whether the presence of 
these mutations in typhoid fever cases plays a role in the disease. However, it is 
interesting that 3/4 mutations (Tyr98Cys, Thrl75Ala, Thr399Ile) change an amino acid 
and lie in the LRR of the ectoplasmic domain. The co-segregated mutations Thr399Ile 
and Asp299Gly, which also lie in the ectoplasmic domain, were shown to be significantly 
associated with a blunted response to inhaled LPS (Arbour et al. 2000) and a variety of 
diseases (Ameziane et al. 2003; Hawn et al. 2005; Lorenz et al. 2002b; Rudofsky et al.
2004). These mutations are common variants with a frequency of >10% in the Caucasian 
population (Edfeldt et al. 2004; Lorenz et al. 2002a; Yang et al. 2004). In contrast, 
Thr399Ile occurred in a low frequency in the Vietnamese population, and co-segregation 
with Asp299Gly was not observed. Thr399Ile was detected in only one typhoid fever 
case, and Asp299Gly was not identified in the Vietnamese population. It is currently 
unknown, whether the two previously unreported missense mutations identified in our 
study (Tyr98Cys, Thrl75Ala) alter the function of TLR4, as has been shown with 
Thr399Ile and Asp299Gly.
As a member of the toll-like receptor family, TLR4 has all the general functions of a 
pattern recognition receptor (PRR) in anti-microbial defence. First, constitutive 
expression allows the host to detect the pathogen regardless of its life cycle stage. 
Second, class specificity allows the host to distinguish between pathogens and thereby
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tailor its response. Third, mutation resistance allows the host to recognize the pathogen 
regardless of its particular strain (Barton and Medzhitov 2002; Gordon 2002; Janeway and 
Medzhitov 2002; Medzhitov 2001). More recently, the TLR family has been described as 
type I transmembrane PRRs that possess varying numbers of extracellular N-terminal 
leucine-rich repeat (LRR) motifs, followed by a cysteine-rich region, a transmembrane 
domain, and an intracellular Toll/IL-1 R (TIR) motif (Chaudhary et al. 1998; Du et al. 
2000; Medzhitov et al. 1997; Rock et al. 1998; Takeuchi et al. 1999). Several lines of 
evidence argue that TLRs play an important role in innate immunity (Janeway and 
Medzhitov 2002; Modlin 2002) thus, changes in TLR structure could potentially lead to 
functional changes. In our study, in addition to the 5 missense mutations identified in the 
ectoplasmic LRR domain and 1 missense mutation in the transmembrane domain, we also 
identified three polymorphisms in the TLR4 promoter region. Variations in TLR4 
expression levels caused by polymorphisms in the TLR4 regulatory region may impact on 
the efficiency of TLR4 to recognize and respond to a LPS containing pathogen.
It is unknown whether the 3 polymorphisms in the TLR4 promoter region identified in 
this study affect TLR4 expression. Two of the SNPs (G-260C and T-441C) were equally 
distributed between typhoid cases and controls, although due to the low frequency of 
these SNPs (3.9-1.4%) the numbers are too small for robust statistical analysis. One low 
frequency promoter polymorphism was slightly over-represented in cases compared with 
controls (A-271G). Although the three identified polymorphisms in the TLR4 promoter 
region (G-260C, T-441C and A-271G) were not located in consensus-binding sites, which 
have been previously identified in the TLR4 promoter region (Roger et al. 2005), it is still 
possible that they could affect transcription of the TLR4 gene.
The LRR domains of the TLRs are extracellular and are common features of pattern 
recognition receptors, important for ligand binding and associated signaling (Janeway and
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Medzhitov 2002; Kobe and Deisenhofer 1995). The extracellular domain of TLRs 
contains 19-25 tandem copies of the leucine-rich repeats (LRR) motif and are thought to 
be directly involved in the recognition of various pathogens (Akira and Takeda 2004). 
Genetic variation in the recognition domain could potentially alter the structure of the 
recognition site and consequently lead to altered recognition of LPS, such as the LPS 
hyporesponsiveness identified by Arbour (Arbour et al. 2000). Smirnova discovered 
many polymorphisms in the ectoplasmic domain, however their functional significance 
was not investigated as they presented in low frequency (Smirnova et al. 2003). 
Hyakushima et al (Hyakushima et al. 2004) reported that the extracellular TLR4 region of 
Glu24-Lys631 is the functional domain for LPS and MD-2 binding. In TLR2, the 
extracellular region containing Ser40-Ile64 is critical for recognition of peptidoglycan 
(Mitsuzawa et al. 2001). In our study, five low frequency missense mutations were 
located in the ectoplasmic domain, notably in the LRR region, which is extracellular. The 
amino acid substitutions may potentially lead to an alteration in protein structure and 
function as the structure and side chains of some of the substituted amino acids are 
different from wild-type TLR4. One of these, Ser73Arg, showed a slightly higher 
frequency in typhoid cases than controls. Potentially these LRR region mutations may 
disturb phosphorylation of TLR4 altering downstream signaling of inflammatory mediator 
activation, ultimately contributing to disease susceptibility.
The transmembrane domain of TLR4 has a critical role in the functional oligomerization 
of TLR4. A mutation in the hydrophobic region adjacent to the transmembrane domain of 
TLR4 did not respond to LPS (Nishiya et al. 2006). In our study, a missense mutation, 
Val651Phe, in the transmembrane domain of TLR4 was identified in the Vietnamese 
population however it appears at a low frequency. It may alter the function o f TLR4 in 
response to LPS, but this remains unknown.
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In conclusion, it is possible that the presence of rare missense mutations in the TLR4 gene, 
particularly in the extracellular domain, may affect the immune response to the disease. 
However case control genetic association studies of this size (400 cases and 400 controls) 
are inadequate to address the role of rare mutations in disease susceptibility. Currently 
there is no adequate genetic approach to studying the functional significance of rare 
mutations in disease susceptibility. The answer does not “simply” lie in increasing the 
sample size, and new approaches need to be devised.
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Chapter four
4. Haplotype construction of the TNF region in a
Vietnamese population
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4.1. Introduction
A greater understanding of the structure, and ultimately the functional interaction of 
genes, offers enormous potential to further our knowledge and understanding of protective 
disease mechanisms. Historically, host genetic susceptibility to disease has been studied 
by investigating the association between candidate genes (often suggested from animal 
models) and particular diseases. This has been extremely productive, as evidenced by 
many publications in the literature, and important discoveries have been made. However 
this approach only allows the investigation of single gene loci, and with complex diseases, 
such as an infectious disease, it is multiple genes and the interaction of these genes that 
determine genetic susceptibility to disease. Although single gene studies can accurately 
predict disease susceptibility in some instances, on the whole such studies may only 
reveal potential markers rather than the specific variation or gene of interest that underlies 
the susceptibility.
A haplotypic approach offers a novel and potentially much more powerful approach to the 
investigation of the influence of human genetic variation on disease susceptibility or 
protection. The technology for gene mapping is based on building up a “library” of 
knowledge based on the genetic make up of large cross sections of different human 
populations. With knowledge from the Human Genome Project it is possible to 
objectively divide the human genome into haplotype blocks. Once the structural assembly 
of many different genes within a haplotype is understood, it allows us to investigate this 
haplotypic structure and look for associations between causal mutations and between 
haplotypes, and hence gain a greater understanding of the genetic influences on disease.
There are several studies which focus on the construction of haplotype structure and the 
selection of tag-SNPs across large genomic regions. The haplotype of 25 loci in 864 
Caucasians described the LD pattern across the human Major Histocompatibility Complex
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(MHC) (Ahmad et al. 2003). The central MHC has a very high gene density and a large 
proportion of these genes are predicted to have a role in immunity and inflammation 
(Beck and Trowsdale 2000; 1999). The TNF gene is one of the candidate disease genes in 
this region. It has been associated with numerous infectious and inflammatory diseases 
(Cabrera et al. 1995; Conway et al. 1997; Dunstan et al. 2001; Fernandez-Arquero et al. 
1999; Knight and Kwiatkowski 1999; Knight et al. 1999; McGuire et al. 1994; McGuire 
et al. 1999; Moffatt and Cookson 1997; Nadel et al. 1996; Negoro et al. 1999). TNF is a 
pro-inflammatory cytokine that is an essential component of the immune response, but 
may be harmful in excess. The TNF promoter region is rich with single nucleotide 
polymorphisms (SNPs) (Richardson et al. 2001), some of which modify the expression of 
the TNF gene in vitro (Knight et al. 1999; Udalova et al. 2000). Studies investigating 
haplotypic variation of the MHC region (Walsh et al. 2003) and more specifically the 
MHC Class III region (Ackerman et al. 2003a; Ackerman et al. 2003b) have been 
reported. Ackerman et al (Ackerman et al. 2003b) investigated the haplotypic structure of 
the TNF region, within MHC Class III, in a population of West Africans. Genotyping a 
small number of SNP markers (N=25) over an 80kb region, they found that linkage 
disequilibrium (LD) was remarkably heterogenous and concluded that more detailed 
marker maps of the TNF region were needed when attempting to identify the causal basis 
of a genetic association with disease (Ackerman et al. 2003b). Haplotypic structures of 
the TNF gene region have also been constructed using 12 SNPs for both the Gambian and 
Malawian populations. There were a number of interesting features that distinguish these 
two populations at the haplotypic level, with some of these haplotypes being unique to 
each ethnicity (Ackerman et al. 2003a).
To understand how a potential association between, for instance, a TNF promoter 
polymorphism and disease may arise in a Vietnamese population, it is necessary to 
understand the haplotypic structure in the region of this locus. A haplotypic approach to
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genetics also allows us to prioritise the further investigation of SNPs by selecting only the 
informative SNPs (or SNPs that “tag’ a haplotype namely tag-SNPs) for future case- 
control studies. Tag-SNPs offer an efficient and cost-effective way of genotyping SNPs 
across a large genomic region. From the tag-SNP data obtained the regional full 
haplotypes can be extrapolated and reconstructed.
The aims of this chapter are to establish the haplotype structure of the TNF region in the 
Vietnamese population and to identify the tag-SNPs for future disease association studies 
by understanding; firstly, how the TNF SNPs relate to each other in the TNF region; and 
secondly, which SNPs are the best representative markers of the TNF region.
4.2. Results
4.2.1. Selection of SNPs
The region of interest for this study was a 150kb segment of the MHC Class III region 
encompassing TNF A on chromosome 6, spanning 12 genes around TNFA; MICB, BAT1 
(UAP56), ATP6V1G2, NFKBIL1, LTA, TNF, LTB, LST1 (1C7), NCR3, AIF-1, BAT2, 
and BAT8 (figure 4.1). Through genomic sequencing and public database interrogation 
approximately 200 SNPs were identified in this region (Kwiatkowski et al personal 
communication). Information about the frequency of heterozygosity and typing success 
rate of these SNPs was considered. One hundred and sixty SNPs with a high frequency of 
heterozygosity, a high success rate in genotyping, and a minor allele frequency of higher 
than 5% were selected for Sequenom typing in Caucasian and Gambian populations 
(Kwiatkowski et al personal communication). Eighty (80) SNPs with a minor allele 
frequency of at least 5% in Gambians and Caucasians, and an 80% success rate by 
Sequenom-MassExtend/ MassArray system (hereafter referred to as Sequenom) 
genotyping were selected for typing in 95 Vietnamese individuals, consisting of 31 family 
trios (typhoid case, mother and father) and one pair o f parents.
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4.2.2. Multiplexes set up for genotyping
The Spectro Designer Software was used for setting up multiplexes for Sequenom 
genotyping. This software automatically checks the products in the multiplex reaction to 
ensure that the size of all allele-specific products and primers are not closer than 50 Da to 
each other. For this study, multiplexes were designed using a manual cutoff where peaks 
of alleles are not closer than 15 Da. The 80 selected SNPs were set up in 24 multiplexes 
(table 4.1). The sequenom results obtained from these multiplexes were clear enough for 
the automatic reader to distinguish between the specific alleles. From two to four SNPs 
were set up in a multiplex with each SNP in the one multiplex containing the same 
terminate nucleotide.
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4.2.3. SNP genotyping
Ninety-five Vietnamese individuals; 31 case/mother/father trios (93) plus one additional 
mother/father pair (2) were genotyped for 80 selected SNPs by Sequenom. Of the 80 
SNPs genotyped by Sequenom, 7 SNPs failed completely, 8 SNPs had a failure rate 
>20%, 21 SNPs were monomorphic and 9 SNPs had a minor allele frequency of <4.3%. 
Table 4.2 shows the SNP name, position, failure rate and minor allele frequency of the 80 
SNPs in 64 unrelated Vietnamese individuals (32 mother/father pairs). According to 
Forton (Forton Julian, personal communication) the power required to identify a genetic 
effect for a marker with a frequency of >5% increases dramatically compared to power for 
markers with lower frequencies. Therefore, in this study we aimed to select SNPs with a 
minor allele frequency in the population higher than 5%, combined with a failure rate 
lower than 20%, to establish the haplotype structure. However, some SNPs with a minor 
allele frequency lower than 5%, but higher than 4.3%, were also selected to avoid missing 
interesting SNPs. In total, 35 SNPs which had a genotyping failure rate of <20% and a 
minor allele frequency of >4.3% were selected for the next analysis (SNPs marked as * in 
table 4.2). Data from two of these SNPs, UAP56*7126 and NFKBIL1*15811, were not 
analysed further as their chromosomal location was not confirmed. Within the remaining 
selected SNP data, HWE was tested using the STATA statistical package. Table 4.3 
shows that 33 SNPs are valid for further analysis, as 30 SNPs display HWE with a P 
value > 0.05, and 3 SNPs have a P value of 0.01 -0.05.
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Table 4.2: SNP allele frequencies and genotyping failure rates.
SNPs nam e rs num ber SNP code position function
allele
frequency
Failure rate
Selected
SNPs
TNF*707887 707887 R 24758650 UTR 0 0.563
M ICB*25164I2 2516412 M 31570300 locus 0.139 0.438
BAT1*3219190 3219190 R 31605954 intron 0 0.266
BAT1*1 1796 11796 W 31609191 intron 0.367 0 *
UAP56*7126 11796 W 31609191 intron 0.405 0.094
BAT1*929138 929138 R 31611677 intron 0.107 0.125 *
U A P 56*1595 2516393 M 31614723 locus 0.095 0.016 *
BAT1*2071595 2071595 S 31615041 intron 0.189 0.172 *
BAT 1 *2239709 2239709 Y 31615426 intron 0.191 0.141 *
BAT1 *2239527 2239527 S 31617758 UTR 0.5 0.141 ♦
BAT1 *2523506 2523506 M 31617946 UTR 0.232 0.125 *
BAT 1 *2239528 2239528 R 31618084 promoter 0.135 0.016 *
A T P6V 1 G2*2071 593 2071593 Y 31620778 UTR 0 1,000
ATP6V 102*2239705 2239705 Y 31621381 coding 0.079 0.406
NFKBIL I-1068ATG novel R 31622382 intron 0 0
NFKBIL1-685ATG novel S 31622765 locus 0 0.078
NFKB-616 novel S 31622765 locus 0 0.016
NFKBIL 1 *3219184 3219184 Y 31623119 promoter 0.047 0 *
NFKB-63 2071592 W 31623319 promoter 0.492 0.078 *
NFKBIL 1 *2230365 2230365 Y 31633427 synonymous 0.19 0.016 *
TNF*928815 928815 M 31639194 locus 0.21 0.031 *
LTA*2009658 2009658 S 31646223 locus 0.222 0.016 *
LTA *2516312 2516312 Y 31647414 locus 0.008 0.016
LTA*2071590 2071590 Y 31647747 locus 0.125 0.063 *
LTA* 1800683 1800683 R 31648049 locus 0.314 0.328
LTA*2239704 2239704 K 31648119 UTR 0.054 0.281
LTA*3093546 3093546 R 31648121 UTR 0 0.25
hLT-alpha_NcoI_B 909253 Y 31648292 UTR 0.484 0.047 *
LTA*746868 746868 S 31648408 UTR 0.19 0.016 *
LTA + 492 2857713 R 31648535 non synomynous 0 1,000
LTA*3093542 3093542 S 31648672 intron 0 0.297
LTA*3093543 3093543 M 31648736 non synomynous 0 0
LTA* 1041981 1041981 M 31648763 non synomynous 0.47 0.203
LTA*4647195 4647195 Y 31648936 intron 0 1,000
LTA*3093544 3093544 R 31649758 UTR 0 0.203
hTNF* 1799964 1799964 Y 31650287 locus 0.27 0.609 *
hTNF* 1799724 1799724 Y 31650461 locus 0.059 0.219 *
LTA*4248158 4248158 Y 31650513 locus 0.016 0.047
T N F*4248160 4248160 R 31650672 locus 0.016 0.047
TNF*4248161 4248161 M 31650746 locus 0 0
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Table 4.2: SNP allele frequencies and genotyping failure rates. (Continued)
SNPs name rs num ber SNP code position function
allele
frequency
Failure rate
Selected
SNPs
hTNF* 1800629 1800629 R 31651010 locus 0.063 0 *
hTNF*361525 361525 R 31651080 locus 0.012 0.344
TNF* 1800610 1800610 Y 31651806 utr/intronic 0.047 0 *
TNF*3093662 3093662 R 31652168 intron 0.035 0.109
TNF*3093664 3093664 R 31652621 intron 0.075 0.063 *
TNF*3093665 3093665 M 31653370 UTR 0 0
TNF*3093667 3093667 K 31653746 UTR 0 0.906
TNF*3093668 3093668 S 31654474 intergenic 0.047 0 *
TNF*3093726 3093726 Y 31654768 intergenic 0 0.031
TNF*3093671 3093671 R 31654959 intergenic 0 1,000
TNF*3093727 3093727 R 31655094 intergenic 0 0.625
TNF*3091258 3091258 Y 31655439 intergenic 0 0.813
LTB*769178 769178 M 31655493 5' upstream 0 0.969
LT13+2591 769177 R 31655590 5' upstream 0.018 0.125
LTB*3093559 3093559 R 31655771 locus 0 0.953
LTB*3093557 3093557 Y 31656175 locus 0 0.891
LTB*4645846 4645846 S 31656245 locus 0 0
LTB*3093556 3093556 Y 31656430 UTR 0 0.297
LTB*3093555 3093555 S 31656869 UTR 0 1,000
LTB*3093553 3093553 M 31657535 coding 0 1,000
LTB*4647175 4647175 Y 31659632 locus 0.2 0.688
LST 1*2256974 2256974 K 31663371 intron 0.397 0.547
L ST 1*1052248 1052248 W 31664560 coding 0.313 0 *
1C7*986475 986475 Y 31664688 UTR 0.043 0.094 *
1C7*3179003 3179003 M 31664907 non synomynous 0.024 0.359
1C7*2708 2708 R 31665770 coding 0.054 0.125 *
1C7-172ATG 11575837 S 31668649 Locus 0 0.016
1C7-412ATG 2736191 S 31668889 Locus 0.46 0.016 *
A1F1*2259571 2259571 M 31691806 intron 0.492 0 *
A1F1*2269475 2269475 R 31691910 coding 0.08 0.125 *
BAT2*2736158 2736158 S 31708283 non synomynous 0.25 0 *
BAT2*2272593 2272593 R 31709323 non synomynous 0.023 0
BAT2*2242657 2242657 Y 31710468 intron 0 4 0 2 0 *
BAT2* 1046089 1046089 R 31710946 non synomynous 0.433 0.188 *
BAT2*2261033 2261033 Y 31711570 intron 0.331 0.031 *
BAT2+13510 17354367 S 31711749 0 1,000
BAT2* 13716 13716 S 31711989 synomymous 0.486 0.406
BAT2* 10885 10885 Y 31712570 non synomynous 0.065 0.156 *
BAT8+10309 B 555007 R 31958311 0.016 0
NFKBIL1 *15811 not in chr6 R 158324741 0.293 0.094
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Table 4.3: HWE test for selected SNPs. SNP names are listed in the order of chromosome 
position.
SNPs
order
SNPs name rs number Genotyping 
failure rate
32 mother/father pairs
HWE 
P value
Genotypyes Allele 1 Allele 2
11 12 22 count frequcncj count frequcncj
1 BAT1* 11796 11796 0 26 29 9 81 0.633 47 0.367 0.842
2 BATP929138 929138 0.125 51 12 0 100 0.893 12 0.107 0.618
3 UAP56*1595 2516393 0.016 45 10 1 114 0.905 12 0.095 0.403
4 BAT1 *2071595 2071595 0.172 33 20 0 86 0.811 20 0.1890 .09
5 BAT1 *2239709 2239709 0.141 34 21 0 89 0.809 21 0.1910 .08
6 BAT1 *2239527 2239527 0.141 17 21 17 55 0.5 55 0.5 0.079
7 BAT1 *2523506 2523506 0.125 36 14 6 86 0.768 26 0.232 0.025
8 BAT1 *2239528 2239528 0.016 47 15 1 109 0.865 17 0.135 0.874
9 NFKBIL1*3219184 3219184 0 58 6 0 122 0.953 6 0.047 0.694
10 NFKB-63 2071592 0.078 20 20 19 60 0.508 58 0.492 0.013
11 NFKBIL1 *2230365 2230365 0.016 41 20 2 102 0.81 24 0.19 0.815
12 TNP928815 928815 0.031 40 18 4 98 0.79 26 0.21 0.328
13 LTA*2009658 2009658 0.016 41 16 6 98 0.778 28 0.222 0.035
14 LTA*2071590 2071590 0.063 46 13 1 105 0.875 15 0.125 0.941
15 hLT-alpha_NcoI_B 909253 0.047 20 23 18 63 0.516 59 0.484 0.056
16 LTA*746868 746868 0.016 43 16 4 102 0.81 24 0.19 0.161
17 hTNF* 1799964 1799964 0.609 36 20 7 92 0.73 34 0.27 0.123
18 hTNP 1799724 1799724 0.219 45 6 0 96 0.941 6 0.059 0.655
19 hTNP 1800629 1800629 0 57 6 1 120 0.937 8 0.063 0.109
20 T N P 1800610 1800610 0 58 6 0 122 0.953 6 0.047 0.694
21 TNP3093664 3093664 0.063 1 7 52 9 0.075 111 0.925 0.217
22 TNP3093668 3093668 0 58 6 0 122 0.953 6 0.047 0.694
23 LST1*1052248 1052248 0 31 26 7 88 0.687 40 0.313 0.663
24 1(27*986475 986475 0.094 53 5 0 111 0.957 5 0.043 0.732
25 1C7*2708 2708 0.125 50 6 0 106 0.946 6 0.054 0.672
26 1C7-412ATG 2736191 0.016 20 28 20 68 0.54 58 0.46 0.403
27 AIF1*2259571 2259571 0 17 29 18 63 0.492 65 0.508 0.454
28 AIF1*2269475 2269475 0.125 48 7 1 103 0.92 9 0.08 0.248
29 BAT2*2736158 2736158 0 37 22 5 96 0.75 32 0.25 0.505
30 BAT2*2242657 2242657 0 52 11 1 115 0.898 13 0.102 0.642
31 BAT2* 1046089 1046089 0.188 18 23 11 59 0.567 45 0.433 0.475
32 BAT2*2261033 2261033 0.031 29 25 8 83 0.669 41 0.331 0.483
33 BAT2* 10885 10885 0.156 47 7 0 101 0.935 7 0.065 0.611
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4.2.4. Haplotype construction
The genotyping data was saved in a Data Manager Progamme at The Wellcome Trust 
Centre for Human Genetics, Oxford. Only principal investigators of the study are allowed 
to access data from the Data Manager. The raw data was then cleaned and stored in Portal 
in gMap (www.gmap.net). The data exported from Portal is ready for analysis as it is set 
up in a pedigree format with the marker genotypes in order of chromosome position.
Haplotypes were constructed using a combination of the programs PHASE (Stephens et 
al 2001) and PHAMILY (Dr Hans Ackerman, Dphil thesis, Oxford University, 2001). 
PHASE has been developed to statistically infer haplotypes from unrelated individuals. 
Using coalescent theory and theory from population genetics it also takes into account that 
chromosomes share common ancestry. It captures the idea that the next haplotype is 
likely to look exactly like, or similar to, an already observed haplotype. PHASE also has 
the novel feature of providing a level of certainty for each haplotype assignment to 
prevent over confidence in these statistically reconstructed haplotypes. PHAMILY is also 
a program used to construct haplotypes, which has been developed to use data from 
family trios (case, mother father trios). PHAMILY allows known phase data to be entered 
into the PHASE program.
The pedigree format of genotyping data from 95 individuals, consisting of 31 families 
(93) and 2 parents, was uploaded into the QUICKSTART program 
(http://archimedes.well.ox.ac.uk/pise/quickstart.html). This program checks the pedigree 
format of the data. This program then transfers the data to the PHAMILY program, and 
the pedigree is then checked again by PHAMILY. Only the parents’ genotyping data in 
the pedigree were used for haplotype construction representing unrelated individuals in 
the population. Therefore, the database of only 62/95 individuals was used for the
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haplotype construction. Only trios with complete data were included in the analysis as 
the QUICKSTART program filters data from incomplete trios. Therefore the 2 parents 
without the affected child were excluded from the analysis.
To further our understanding of how changes in the dataset effect haplotype construction, 
the haplotype construction was performed on two different datasets; namely, the 
incomplete-genotype dataset, and the complete-genotype dataset. The incomplete dataset 
included genotyping data of 62 parents, from 31 complete trios. This dataset includes 
parents with missing genotypes, where missing genotypes were replaced by predicted 
genotypes based on their child’s genotypes. The complete genotype dataset contained 
only data on 21 individuals, including only those individuals with complete genotypes for 
all 33 SNPs.
4.2.4.I. Haplotype construction based on the incomplete-genotype dataset.
Genotypes of 33 SNPs from 62 individuals, or from 124 unrelated parental chromosomes, 
were used for the haplotype construction. Forty-two haplotypes (A1-A42) with a 
frequency of 1% or greater were constructed (table 4.4). The SNP genotypes within the 
haplotypes in table 4.4 are in the chromosome position order as listed in table 4.3. 
Haplotypes A2, A5, A8 and A10 are common in the population with frequencies greater 
than 5%. The haplotype A5 is the most common with a frequency of 17%. Twenty 
haplotypes are at frequency of 1%, 13 are at frequency of 2%, 5 are at frequency of 3%, 
and 3 haplotypes are at frequency of 5-10% (figure 4.2).
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Table 4.4: The founder haplotypes and frequency o f each haplotype in the population using the 
incomplete genotype dataset to construct haplotype.
Hap name 
Al 
A 2 
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A 4 
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Figure 4.2: Frequency o f 42 haplotypes in 124 chromosomes.
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4.2.4.2. Haplotype construction based on the complete-genotype dataset
Genotypes of 33 SNPs from 21 individuals, or from 42 unrelated parental chromosomes,
were used for the haplotype construction. Twenty-three haplotypes (B1-B23), 33 SNPs in
length, were constructed with a frequency of 1% or greater (table 4.5). Frequencies of
haplotypes B1 and B5 were greater than 5%. Haplotype B1 was the most common, at a
frequency of 19%. Eight haplotypes were at a frequency of 5% while 13 were at a
frequency of 2% (figure 4.3).
Table 4.5: The founder haplotypes and frequencies of each haplotype in the population using the 
complete genotype dataset to construct haplotypes.
Hap name Haplotypes of 33 SNPs in new chromosome position order observed frequency
B1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 8 0.19
B2 1 2 1 1 1 2 1 1 1 2 1 1 1 1 2 1 2 1 1 1 2 2 1 1 1 2 2 1 1 1 1 2 1 1 0.02
B3 2 1 1 1 1 1 1 1 1 2  1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 2 0.05
B4 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 1 1 1 1 2 1 1 0.02
B5 1 1 1 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 2 1 2 1 1 5 0.12
B6 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2  1 1 1 1 1 1 1 1 1 1 1 2  1 2 2 0.05
B7 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2  1 1 1 1 1 1 1 1 1 2  1 2  11 2 0.05
B8 1 1 1 1 1 2 2 1 1 2 2 1 2 1 2 1 2 1 1 1 1 1 2 1 1 1 1 1 2 1 2 1 1 2 0.05
B9 1 1 1 1 1 2 2 1 1 2 2 1 2 1 2 1 2 1 1 1 1 1 2 1 1 1 2 1 1 1 1 2 1 2 0.05
BIO 2 1 1 1 1 2  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2  1 1 1 1 1 1 1 1 1 1 1 0.02
B it 1 1 2 1 1 2 1 2 1 2 1 2 1 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.02
B12 1 1 1 1 1 2 2 1 1 2 1 1 2 1 2 1 2 1 1 1 1 1 2 1 2 1 2 1 1 1 1 2 1 1 0.02
B 13 1 1 1 2 2 2  1 2 2 2 2 2  1 1 2 1 1 1 1 1 1 1 2 1 1 1 2 1 1 1 1 2 1 1 0.02
B14 1 1 1 1 1 2 2 1 1 2 1 1 2 1 2 1 2 1 1 1 1 1 2 1 2 1 1 1 1 1 2 1 2 2 0.05
B15 1 2 1 1 1 2 1 1 1 2 1 2 1 2 2 2  1 2 1 2 1 1 1 2 1 1 2 1 1 1 1 2 1 1 0.02
B16 1 1 1 2 2 2  1 2 2 2 2 2  1 1 2 2  1 1 1 1 1 1 2 1 1 1 2 1 1 1 1 2 1 2 0.05
B17 1 2 1 1 1 2 1 1 1 2 1 2 1 2 2 2 1 2 1 2 1 1 1 2  1 1 2  1 1 1 1 1 1 1 0.02
B18 1 2 1 1 1 2 1 1 1 2 1 2  1 2 2 2  1 1 1 1 1 1 1 1 1 1 2  1 1 1 1 2  1 1 0.02
B19 1 1 1 1 1 2 2 1 1 2 2 1 2 1 2 1 2 1 1 1 1 1 2  1 1 1 2  1 1 1 1 1 1 1 0.02
B20 1 1 2 1 1 2 1 2 1 2 1 2 1 2 2 2 1 1 1 1 1 1 1 1 1 1 2  1 1 1 1 1 1 1 0.02
B21 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2  1 1 1 1 2  11 1 0.02
B22 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 2 1 2 2 2  1 2 0.05
B23 1 1 1 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 2 1 2 2 2  1 1 0.02
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Figure 4.3: Frequency of haplotypes identified in 42 chromosomes.
Comparing the 42-haplotype set (A 1-A 42) and the 23- haplotype set (B 1 -B 2 3 ), w hich  
were constructed for the 150kb TNF region in the V ietnam ese population, w e found that 
the 42-haplotype set included the 23-haplotype set (table 4 .6). This m eans that when w e  
used the com plete genotype dataset to construct haplotypes w e m issed  19 haplotypes 
which may exist in the population. N otably, the high frequency haplotypes in the 42- 
haplotype set appeared at high frequencies in the 23-haplotype set. The construction o f  
haplotypes for the 150kb TNF region in the V ietnam ese population using tw o different 
datasets was reproducible how ever the smaller sam ple set m issed a number o f  haplotypes. 
The 19 extra haplotypes were constructed in the incom plete genotype datasets based on 
the predicted genotypes given to the 41 parents with m issing genotypes. Thus, the 
haplotype structure for the V ietnam ese population was based on the 42-haplotypes set, as 
this set generates a more com plete haplotype structure than the 23-haplotypes set.
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Table 4.6: Comparison o f  haplotypes constructed using two different datasets (the incomplete 
and complete genotype datasets)
Happlotype's name
42-haps 23-haps
Haplotypes of 33 SNPs
frequency (%)
42-haps 23-haps
A l 12 1 1 1 2  11
A2 B9 1 1 1 1 1 2  2 1
A3 1 1 1 1 1 2  2 1
A4 B ll 112 1 1 2  1 2
A5 B1 2 1 1 1 1 1 1 1
A6 B14 1 1 1 1 1 2  2 1
A7 1 1 1 1 1 2  2 1
A8 B5 1112  2 1 1 1
A9 12 1 1 1 2  11
A10 B22 2 1 1 1 1 1 1 1
A ll 1112  2 1 1 1
A12 B16 1 1 1 2  2 2 1 2
A 13 B17 12 1 1 1 2  11
A14 112 1 1 2  1 2
A15 B3 2 1 1 1 1 1 1 1
A16 B2 12 1 1 1 2  11
A 17 B4 2 1 1 1 1 1 1 1
A18 1 1 1 1 1 2  2 1
A19 B6 2 1 1 1 1 1 1 1
A20 1112  2 2 1 2
A21 2 1 1 1 1 1 1 1
A22 B7 2 1 1 1 1 1 1 1
A23 B8 1 1 1 1 1 2  2 1
A24 1112  2 1 1 1
A25 112 1 1 2  1 2
A26 B10 2 1 1 1 1 2  11
A27 12 1 1 1 1 1 1
A28 12 1 1 1 2  11
A29 112 1 1 2  1 2
A30 112 1 1 2  1 2
A31 B12 1 1 1112  2 1
A32 1 1 1 1 1 2  2 1
A33 1112  2 1 1 1
A34 B13 111 2 2 2 1 2
A35 B15 12 1 1 1 2  11
A36 B18 12 1 1 1 2  11
A37 12 1 1 1 2  11
A38 1 1 1 1 1 2  2 1
A39 B19 1 1 1 1 1 2  2 1
A40 B20 112 1 1 2  1 2
A41 B21 2 1 1 1 1 1 1 1
A42 B23 1112  2 1 1 1
12 12 
1 2  2 1 
1 2  2 1 
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12 11 
12 2 1 
1 1 1 1  
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0.08
0.01
0.02
0.17
0.03
0.02
0.10
0.02
0.06
0.01
0.03
0.02
0.03
0.02
0.02
0.02
0.02
0.03
0.01
0.02
0.03
0.02
0.02
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.01
0.01
0.01
0.05
0.02
0.19
0.05
0.12
0.05
0.05
0.02
0.05
0.02
0.02
0.05
0.05
0.05
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
4.2.5. LD structure of the TNF genomic region.
• • •In principle, 33 SNPs could give rise to 2 different haplotypes (according to (Altshuler
2005)). In our study, the haplotype construction above showed that 42 haplotypes of 33 
SNPs in length existed in the population. This means that low haplotypic diversity is 
present in the TNF region. This suggests that high LD and few recombination hotspots are 
present across the TNF genomic region. To understand the cause of simple haplotypic 
structure in this region, it is necessary to understand the LD structure or the haplotype
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block of this region. LD structure in a genomic region offers insight into the causes of 
haplotypic diversity, and enables understanding of the interaction between SNPs within a 
genomic region in disease associations. We performed LD calculations between pairs of 
SNPs based on the haplotype data of the TNF region in the Vietnamese population, and 
then mapped the haplotype blocks or LD structure of this region.
The HaploXT program was used for considering the levels of LD among 33 SNPs in the 
TNF region. Haplotype data, generated from the PHAMILY-PHASE programs, was used 
for the HaploXT program. This program provides the following measures for each 
pairwise comparison: delta squared, standardised disequilibrium coefficient (D'), Chi 
squared value and the Chi squared probability (P value). In this study, Lewontin's 
standardised disequilibrium coefficient, D ' (Lewontin R C 1960), was used to evaluate the 
linkage Disequilibrium (LD) between the SNPs within a region of over 150kb. A D ' = 0  
indicates linkage equilibrium, and D '=  1 indicates maximum linkage disequilibrium or no 
evidence of recombination. To visualize the LD patterns in a graphical format, the 
MARKER beta program (http://www.gmap.net/perl/marker/marker_entry) was used to 
display the D ' values for each pairwise comparison. The MARKER beta program used 
the LD data to draw the association map.
Pairwise correlations among 33 SNPs in the 150kb TNF region were performed by D ’in
table 4.7 and figure 4.4. The results of the analyses showed that the level o f LD among
33SNPs in 150kb TNF region is high (black boxes in table 4.7). The graphical display
program Marker beta clearly shows the high level of LD (red dot) among 33 SNPs within
the 150kb TNF region (figure 4.4). There were a small number of SNPs that have little or
no levels of LD with adjacent SNPs but have high levels of LD with distant SNPs. For
example; BAT1 *2239527 and BAT1 *2239528 have low LD with two adjacent SNPs
BAT1 *2071595 and BAT1 *2239709 (D’=0.5 and D ’=0.2, respectively). Analysis of the
148
, f ' < f i ^ <,  "m  m  V ietnam ese p o p u la tio n  
haplotype data using HaploXT program showed the LD pattern of this genomic region is
simple; there were only two clusters of association between markers in the 150kb TNF
region. The first cluster encompasses BAT1, NFKB, LTA, TNF, LST and 1C7, which
contains the first 25 markers as listed in table 4.3 (the block from BAT1* 11796 to
1C7*2708). The second cluster includes AIF and BAT2, which contains 8 markers (the
block from 1C7-412ATG to BAT2* 10885) (see in table 4.7 and figure 4.4). There are
clearly high levels of LD in each cluster. This data suggests that only one hotspot (1C7-
412ATG) is present in the 150kb TNF region. At a hotspot the recombination rate is high
(Altshuler 2005). Thus, the cause of simple haplotype structure and low haplotypic
diversity of the TNF region was clarified. It is caused by few recombinations occurring in
the genomic region.
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Chapter 4: Haplotype construction for TNF region in Vietnamese population
1 B ATI *11796
2 BAT1*929138
3 UAP56*1595
4 B ATI *2071595
5 B ATI *2239709
6 B ATI *2239527
7 B ATI *2523506
8 B ATI *2239528
9 NFKBIL 1*3219184
10 NFKB-63
11 NFKBIL 1*2230365
12 TNF*928815
13 LTA *2009658
14 LTA *2071590
15 hLT-ilplia_N coI_B
16 LTA*746868
17 hTNF*l 799964
18 hTNF*l 799724
19 KINF*1800629
20 TNF*1800610
21 TNF*3093664
22 TNF*3093668
23 LST1 *1052248
24 1C7*986475
25 1C7*2708
26 1C7-412ATG
27 AIF1*2259571
28 AIF1*2269475
29 BAT2*2736158
30 BAT2*2242657
31 BAT2*1046089
32 BAT2*2251CG3
33 B AT2*10885
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Figure 4.4: The correlations between 33 SNPs across the TNF region were displayed by the 
MARKER program. LD parameters are displayed by D ’values. The red spots represents high 
LD with D ’ of 0.9 or over, green spots represent D ’ of 0.7 - 0.9, gray spots represent D ’ of 0.5 - 
0.7, and the no spot represents low LD with D ’<0.5.
HaploBlockFinder (http://cgi.uc.edu/cgi-bin/kzhang/haploBlockFinder.cgi) is another 
computer program to analyse the haplotype block or block-like LD structure. The LD 
structure of the TNF region in Vietnamese population was visualized in a different way. 
Using the HaploBlockFinder program the markers were parsed into haplotype blocks by a 
greedy algorithm based on the haplotype data. Two separate utilities are also provided to 
assist visual inspection of haplotype block structure and pattern of LD.
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Eleven putative haplotype blocks were identified, including 3 potential recombination 
hotspots, each of which identified >90% of chromosomes within the corresponding region 
(figure 4.5). Comparing this putative haplotype block structure to the two major clusters 
of marker association shown in figure 4.4, the first association cluster contains 7 blocks 
(BAT1, BAT1/NFKB, NFKB, LTA, TNF, TNF , LST /1C7, and 1C7 ), while the second 
association cluster contains 3 haplotype blocks (AIF / BAT2, BAT2 and BAT2). When 
the blocks were analysed by HaploXT there was only one recombination hotspot, which 
was located at 1C7-412ATG and broke down the whole region into 2 clusters. Three 
recombination hotspots were identified by HaploBlockFinder which are located at 1C7- 
412ATG, hTNF* 1799964, and BAT2* 1046089. Notably, although haplotype blocks 
included up to 5 SNP markers, they comprised no more than 4 different haplotypes. Thus, 
the low haplotypic diversity in TNF region was consistent between the two different 
methods of analysis (HaploXT and HaploBlockFinder). However, the haplotype blocks 
constructed by HaploXT may be more reliable than those constructed by 
HaploBlockFinder as HaploBlockFinder has some limitations. HaploBlockFinder does 
not guarantee that the haplotype blocks are globally optimal, and it can not recognize and 
correct genotyping error which may lead to artifacts in some strict block definitions.
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Figure 4.5: Haplotype and haploblock structure across the TNF region constructed by 
HaploBlockFinder. Within blocks LD (by D’) was 0.8 or greater. The frequencies of each 
haplotype are shown in color with the color ladder on the left.
4.2.6. Identification o f tag-SNPs by the ENTROPY program.
The selection of tag-SNPs is necessary for the efficiency of a human genetics study, in 
that it reduces the time and financial costs associated with genotyping all SNPs within a 
region. Haplotypic information of the whole region can be extrapolated from the 
genotyping data of only a small number of tag-SNPs.
ENTROPY is a program which was developed to identify a subset of SNPs (the tag-
SNPs) that most efficiently distinguish the haplotypes in a population based on entropy,
a measurement of haplotypic diversity (Ackerman et al. 2003a; Johnson et al. 2001;
Zhang et al. 2002b). ENTROPY allows us to pick out a subset of SNPs, the tag-SNPs,
which capture the greatest amount of haplotypic diversity. The ENTROPY program was
used to select tag-SNPs for the 42 haplotypes constructed from genotyping 33 SNPs in
124 chromosomes. A minimum subset of 15 tag-SNPs was selected. These 15 tag-
SNPs capture the diversity of the 42 haplotypes and give a maximum entropy value of
4.79 (figure 4.6A). Figure 4.6B shows the percentage of the full 33-SNP haplotypic
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diversity that is accounted for by the optimal subset of tag-SNPs when the number of 
tag-SNPs in the subset increases from 1 to 15. The single tag-SNP that explains the 
greatest proportion of the haplotypic diversity is hLT-alpha_NcoI_B. When additional 
SNPs (indicated on the curve in figure 4.6B) are added into the subset of tag-SNPs, the 
percentage of haplotypic diversity captured is increased. When the last additional SNP is 
added, the 15 tag-SNPs capture 100% of the 33-SNP haplotypic diversity. The first tag- 
SNP selected was hLT-alpha_NcoI_B with an entropy value of 1 (the highest entropy 
value), and it accounted for 20.88% of the full 33-SNP haplotypic diversity (table 4.8). 
The last tag-SNP selected was BAT1 *2239527 with an entropy value of 0.02 making the 
maximum entropy of all tag-SNPs up to 4.79. Thus the complete 15 tag-SNP set 
accounted for 100% of the 33-SNP haplotypic diversity (table 4.8).
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Figure 4.6: (A) Entropy o f selected tag-SNP markers. The red line shows partial entropy 
corresponding to the number o f markers selected. The green line shows the maximum entropy. 
(B) Percentage o f the 33-SNP haplotype diversity which was accounted for by the subset o f 
SNPs from 1 to 15.
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Table 4.9: The 15 tag-SNPs selected using the Entropy program (capturing the diversity of 42 
haplotypes that are 33 SNPs in length).
SNP SNPs name rs number code* function 15-tag SNP
1 BAT1* 11796 11796 W intron
2 BAT1 *929138 929138 R intron
3 UAP56*1595 2516393 M locus T1
4 BAT1 *2071595 2071595 S intron T2
5 BAT1 *2239709 2239709 Y intron
6 BAT1 *2239527 2239527 S UTR T3
7 BAT1 *2523506 2523506 M UTR
8 BAT1 *2239528 2239528 R promoter
9 NFKBIL1*3219184 3219184 Y promoter
10 NFKB-63 2071592 W promoter
11 NFKBIL1 *2230365 2230365 Y synonymous T4
12 TNF*928815 928815 M locus
13 LTA*2009658 2009658 S locus
14 LTA*2071590 2071590 Y locus
15 hLT-alpha_NcoI_B 909253 Y UTR T5
16 LTA*746868 746868 S UTR T6
17 hTNF* 1799964 1799964 Y locus
18 TNF*1799724 1799724 Y locus
19 hTNF* 1800629 1800629 R locus
20 TNF*1800610 1800610 Y utr/intronic T7
21 TNF*3093664 3093664 R intron
22 TNF*3093668 3093668 S intergenic T8
23 LST1*1052248 1052248 w coding T9
24 1C7*986475 986475 Y UTR
25 1C7*2708 2708 R coding T10
26 1C7-412ATG 2736191 S Locus T il
27 AIF1*2259571 2259571 M intron T12
28 AIF1*2269475 2269475 R coding
29 BAT2*2736158 2736158 S non synon T13
30 BAT2*2242657 2242657 Y intron
31 BAT2* 1046089 1046089 R non synon T14
32 BAT2*2261033 2261033 Y intron T15
33 BAT2* 10885 10885 Y non synon
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Table 4.9 lists the 33 SNPs which were used for haplotype construction and the 15 tag- 
SNPs. These 15 tag-SNPs were selected by the ENTROPY program based on the 
chromosome position order of the 33 SNPs that was available on dbSNP 
(http://www.ncbi.nlm.nih.gov/SNP/) (August, 2003). As the chromosome positions of 
SNPs can be updated every 3 months, we updated the positions at a later date (May, 2006) 
and a different set of tag-SNPs for this genomic region was selected. However, only one 
SNP was changed in the tag-SNP set. With the new SNP positions, the first tag-SNP (T l, 
UAP56*1595) in the tag-SNP set in table 4.9 was replaced by the chromosomally 
adjacent SNP BAT1*929138 (see in table 4.9). This replacement did not alter the entropy 
value. This means that the entropy value is still maximum if UAP56*1595 is replaced by 
BAT1*929138. Whether we use UAP56*1595 or BAT1*929138 as a tag-SNP in further 
studies, the tag-SNP set still captures the 33-SNPs haplotype diversity. This is because 
UAP56*1595 and BAT1*929138 are in complete LD (D’=l).
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4.2.7. Error rate estimation for using the tag-SNP in genotyping for association 
studies.
Using tag-SNPs as a way of screening regions of the genome for association with disease 
is a common approach. The objective of this approach is to genotype the tag-SNPs in a 
study population, and to use this information to draw inferences about each individual's 
haplotypic makeup, including SNPs that were not directly genotyped. The ENTROPY 
program has the cost effective advantage of selecting a smaller tag-SNP set. Although 
these sets may be more cost effective, they carry little if any redundancy of information 
and are therefore more susceptible to error when used to reconstruct haplotypes from 
genotype data. To evaluate the tag-SNP set for further genotyping, an error rate 
calculation was performed to estimate the error level when we use the 15 tag-SNPs for 
reconstructing the 33-SNP haplotypes.
When we use UAP56*1595 or BAT1*929138 as T1 in the 15 tag-SNP set the error rates 
for reconstructing genotyping data for the full 33-SNP haplotype were slightly different. 
For the 15 tag-SNP set containing UAP56*1595 as T l, the error rate was estimated to be 
0.2 +/- 0.07 % novel haplotypes constructed if there was no missing data and 0.4 +/- 
0.18% novel haplotypes constructed if there was missing data following genotyping of the 
15 tag-SNPs (figure 4.7A). For the 15 tag-SNP set containing BAT1 *929138 as T l, the 
error rate was 0.38 +/- 0.23% novel haplotypes if there was no missing data and 0.57 +/- 
0.28% novel haplotypes if there was missing data following genotyping of the 15 tag- 
SNPs (figure 4.7B). Table 4.10 summarises the error rate when we use the tag-SNPs for 
genotyping and for reconstruction of the full 33-SNP haplotypes.
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Table 4.10: The error rate when the tag-SNPs were used for genotyping and for reconstruction 
of the full 33-SNP haplotypes. Either UAP56*1595 or BAT1*929138 was used as Tl in the 15 
tag-SNP set.
Error rate when the 15 tag-SNP set was used for reconstructing 33-SNP haplotypes (%)
UAP56*1595 as Tl BAT1 *929138 as T l
no missing data with missing data no missing data with missing data
0.2 ± 0.07 0.4 ± 0.18 0.38 ± 0.23 0.57 ± 0.28
4.3. Discussion
In human genetics the development of efficient and powerful methods for studying the 
genetic susceptibility to complex disease is necessary. This is perhaps in contrast to 
studying Mendelian disorders in which single gene variants are sufficient to cause disease. 
Susceptibility to complex diseases, such as infectious diseases, is multigenic and may be 
due to the combined effect of many gene variants interacting with environmental factors. 
Genetic studies of complex diseases have been based on family-based linkage studies 
across the entire genome and population-based association studies of individual candidate 
genes. Although there have been notable successes, progress has been slow due to the 
inherent limitations of the methods. For example, linkage analysis has low power except 
when a single locus explains a substantial fraction of disease, and association studies of a 
small number of candidate genes examine only a tiny fraction of the ‘universe’ of 
sequence variation in each genome. Ideally a comprehensive search for genetic influences 
on disease must involve examining all genetic differences in a very large number of 
disease affected individuals and suitably chosen control individuals. Technically and 
financially this is not a possible approach at present. Recently, new approaches have been 
developed to reduce the cost and increase the power for complex disease association 
studies. The development of efficient and powerful approaches for genetic studies
includes the development of high throughput technologies, the availability of
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comprehensive databases of genetic variation (SNP and haplotypic databases) and new 
methods of genetic analysis.
The objective of the International HapMap project is to create a public, genome-wide 
database of common sequence variations that can be used as a comprehensive source of 
information to design efficient disease genetic association studies. Insight into the 
correlations (LD) among nearby genetic variants across a genomic region can be used to 
improve the cost effectiveness of association studies. There is evidence that tag-SNP 
selection based on the LD information from HapMap can reduce the cost of an association 
study (Altshuler 2005; de Bakker et al. 2005). The cost is reduced further if the selected 
tag-SNPs are members of a specific haplotype. Haplotype tag-SNPs have been 
demonstrated to give more efficiency and power in a genetic study of ten 500kb genomic 
regions (de Bakker et al. 2005).
The major impetus for developing the HapMap was to guide the design and prioritization 
of SNP genotyping assays for disease association studies. However, the HapMap 
database can be used to inform association testing, regardless of how tags are selected 
(Altshuler 2005). How tag-SNPs are selected is an important step in disease association 
studies. Tag-SNPs are a given set of SNPs which can be analysed for association with a 
phenotype using a variety of statistical methods which are based either on the genotypes 
of single SNPs or combinations of multiple SNPs. The principal of all tag selection 
methods is to exploit redundancy among SNPs, maximizing efficiency in the laboratory 
while minimizing loss of information (Daly et al. 2001; Johnson et al. 2001; Nickerson et 
al. 1998; Zhu et al. 2000).
There are a number of different methods to select tag-SNPs but they are based on two 
main approaches; (1) using the LD structure of a genomic region (Altshuler 2005) and (2)
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using the haplotype structure of a genomic region. The observation that many SNPs are 
redundant markers of each other based on the LD structure of a genomic region can help 
us to select tag-SNPs using the LD approach. The tag-SNPs can be selected either based 
on the levels of correlation between SNPs (LD value) in the genomic region (using a cut 
off r2 > 0.8 or D ’>0.75 for example) or based on the priority order o f the number of other 
SNPs in the region which the selected SNP can capture (prioritization tag) (de Bakker et 
al. 2005). As these selected SNPs may not be set in a haplotype, they may have to be 
tested as single SNPs in statistical analysis. This method therefore can lead to a loss of 
power to detect an association because the overall degree of freedom for the study is high 
when we test many single SNPs. The single test for tag-SNPs which showed a loss of 
power was demonstrated by de Bakker et al (de Bakker et al. 2005). However the main 
advantage of using an LD approach to select tag-SNPs is that it is simple and fast to select 
SNPs from any genomic region, large or small, from the readily available HapMap 
database. With this approach it is not necessary to perform in depth haplotypic analysis of 
your genomic region.
Using a haplotypic approach to select tag-SNPs may be more informative when 
investigating a relatively small genomic region in disease association studies, such as the 
TNF region (~150kb). The advantages of a haplotype-based approach in genetic 
association analysis is that this approach can (1) directly identify unique chromosomal 
segments that contain disease susceptibility genes by assessing the haplotype-specific risk 
for disease, (2) overcome the limitation of historical association studies which were 
limited to single makers and (3) overcome the limitation of performing multiple tests on 
single SNP markers leading to a loss of power to detect a “real” association. Haplotypic 
information is an essential ingredient in many analyses of fme-scale molecular-genetics, 
for example, in disease mapping (Hodge et al. 1999; Rieder et al. 1999; Risch and 
Merikangas 1996). A population-based case-control study design using a haplotypic
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approach to genetic analysis has become popular due to cost-efficiency. For example, 
genotyping of SNPs across a 135 Kb segment of DNA was significantly reduced from 122 
to 34 SNPs in a study of 384 European individuals to identify common disease genes 
(Johnson et al. 2001). Usually the haplotype structure of a genomic region for a specific 
population is constructed and then the tag-SNPs are selected based on this haplotypic 
structure. This results in a small number of haplotype tag-SNPs and an increased power 
to detect associations with disease using a case control study design. In fact, the number 
of tag-SNPs selected based on the haplotype structure is smaller than the number selected 
based on the LD approach (de Bakker et al. 2005). Therefore the analysis of haplotype 
tag-SNPs to look for associations with clinical phenotypes has more power as the overall 
degree of freedom of the study is lower than a single SNP analysis (de Bakker et al. 
2005).
Understanding the efficiency of a haplotype-based approach encouraged us to apply it to 
our genetic study of typhoid fever investigating a 150 Kb segment of the central MHC 
flanking the TNFA locus. As this is a relatively small genomic region the haplotype 
approach was efficient as only a small number of tag-SNPs were necessary for this study. 
Forty two haplotypes were constructed for the 150 Kb TNF region in the Vietnamese 
population, and a minimum set of 15 tag-SNPs, which captured 100% of the haplotypic 
structure o f the TNF region, were selected for further association studies. Beginning with 
nearly 200 SNPs in the TNF region, 33 common SNPs were identified for the Vietnamese 
population, and then 15 tag-SNPs were selected. The selection of haplotype tag-SNPs in 
this study reduced the number of common SNPs needed for genotyping by at least 54.5% 
(15/33). Moreover, as the 15 SNPs are haplotype tag-SNPs, which are representative for 
the haplotypes of the whole 150 Kb TNF region, the number of SNPs needed for 
genotyping was reduced by 92.5% (15/200).
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Haplotype construction based on genotyping data from case/mother/father family trios 
using the combination of two programs, PHASE and PHAMILY, is the most accurate 
approach for haplotype-based analysis. Using PHASE and PHAMILY together in 
haplotype inference shows an advantage over using PHASE only, as PHASE uses 
genotypic data from unrelated individuals to infer haplotypes. When there is missing data 
in a dataset, PHASE may infer haplotypes based on ambiguous data which may result in 
inaccurate haplotypes. The PHAMILY program was designed to overcome these 
problems. Once additional family members have been genotyped, their genotypes can be 
used to infer the “real” known haplotypes before running phase. This provides phase with 
more information enabling increased reliability of results and faster execution. For 
PHASE the population of parents can be considered as a sample of unrelated individuals. 
However the knowledge of the childrens' genotypes enables PHAMILY to logically infer 
some of the parental haplotypes which would not be possible without this additional data.
Using HapMap data, de Bakker et al (de Bakker et al. 2005) showed that a haplotypic 
approach remains efficient for genetic association analysis even in the presence of missing 
data. In this study, we examined this by comparing haplotypes constructed using the 
incomplete dataset (dataset which includes parents with missing genotypes, but missing 
genotypes are replaced by predicted genotypes based on their child’s genotypes) and the 
complete dataset (dataset including only those parents with complete genotypes for all 33 
SNPs). Although the haplotypes constructed based on the complete dataset are “real” 
haplotypes that exist in the population, they may not be representative of the population 
haplotype structure as they were constructed from a small number o f individuals. The 
haplotypes constructed from the incomplete dataset may be less accurate as we are relying 
on predicted genotypes whenever there is missing genotype data. However, we showed 
that all haplotypes constructed based on the complete data (23 haplotypes) are a subset of 
haplotypes constructed using the incomplete data (42 haplotypes). Using the incomplete
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sample set therefore increases the amount of genotype information used to construct 
haplotypes (incomplete dataset from 124 chromosomes; complete dataset from 42 
chromosomes) while retaining the “real” haplotypes obtained through using the complete 
dataset. This exercise confirmed that using a combination of PHAMILY and PHASE, 
and being able to predict genotypes for missing data, is the most efficient approach to 
capture more of the haplotypic diversity of a genomic region.
It is possible to select haplotype tag-SNPs using either an unstructured or a block- 
structure approach. HaploBlockFinder is one program that can construct haplotype blocks 
of a genomic region. The TNF genomic region was divided into contiguous haplotype 
blocks with the chromosomal coverage algorithm at 90% (Zhang and Jin 2003). 
Consequent haplotype blocks were small and the tag-SNPs were then selected by eye. 
The block-structure tag-SNPs were selected based on the combination of multiple SNPs in 
each haplotype block (in this study each block contains up to 5 SNPs). The haplotype 
tag-SNPs in this case did not provide more power as they lie on small fraction sites. As 
noted by other authors (Forton et al. 2005; Halldorsson et al. 2004), the unstructured 
approach discussed below consistently generates a smaller set of tag-SNPs than the block 
approach.
In this study we used the ENTROPY program to select 15 tag-SNPs that represent the 
greatest proportion of the full 33-SNP haplotypic diversity (entropy = 4.79). The 
ENTROPY program selects haplotype tag-SNPs based on an unstructured approach using 
a greedy algorithm approximation on the whole region as one block. This method 
determines the information content of each SNP without consideration of block structure 
and can provide optimal tag-SNP selection even in the absence of a clear haplotype block 
structure ((Ackerman et al. 2003a); R.Mott’s Web site, 
http://www.well.ox.ac.uk/~rmott/SNPs/ for Entropy algorithm). It selects tag-SNPs based
166
i'inxpter V ila i en/yvr <umemos n-n far TNI'' region in Vietnamese population.
on haplotype data and all tag-SNPs selected are within the haplotypes. The input for 
ENTROPY requires the haplotype structure and frequency of each haplotype in the 
population. ENTROPY measures the haplotypic diversity and determines the subset of 
SNPs which account for the maximum haplotypic diversity (entropy). This method is 
based on an algorithm that first individually chooses SNPs, then multi-SNP haplotypes, 
that maximize entropy (Ackerman et al. 2003a). Because all tag-SNPs are in the 
haplotype, tests comparing haplotypes (not individual SNPs) can be performed which 
therefore increases the power and efficiency of the association study (de Bakker et al. 
2005). Constructing haplotypes of tag-SNPs (tag-SNP haplotypes) can be used to 
extrapolate information of the original or full haplotypes.
The LD pattern of a genomic region provides information regarding the nature of the 
haplotypic structure for a population. Low haplotypic diversity in the TNF region in the 
Vietnamese (42 haplotypes that are 33 SNPs in length) is related to the high level of LD 
and the existence of few recombination hotspots within this region. Therefore high LD 
and few recombination hotspots results in a high correlation between SNPs. The LD 
pattern of the TNF genomic region in the Vietnamese population is in contrast to that in 
the West African population (Ackerman et al. 2003b). Low haplotypic diversity or high 
LD is often observed in non-African populations (Gabriel et al. 2002; Hull et al. 2004) 
while complex haplotypic structure is normally observed in African populations 
(Ackerman et al. 2003b). The high LD across the TNF region in the Vietnamese 
population suggests a high correlation between the SNPs that are associated with typhoid 
fever in this study. However, the LD pattern, haplotype structures and typhoid associated 
tag-SNPs may only apply to the Vietnamese population. Therefore the most optimal tag- 
SNPs for a certain genomic region are different in varying populations. The selection of 
tag-SNPs in the International HapMap project is restricted to four populations; Yoruba, 
Japanese, Han Chinese and Caucasian. The advantage of public access to HapMap data
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allows researchers to quickly and easily select tag-SNPs across the whole genome and 
perform studies in very large genomic regions or between regions. When studying a small 
genomic region, detailed studies into LD patterns, haplotype structure and haplotype tag- 
SNPs, specific for an ethnic population, are required to accurately determine the 
contribution of a genomic region to disease susceptibility.
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Chapter five
5. TNF region Polymorphisms are associated with
Typhoid Fever in Vietnam
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5.1. Introduction
The major histocompatibility complex (MHC) has been classically studied as molecules
central to the pathogenesis of infectious, inflammatory and autoimmune diseases. A
number of genes from the MHC region have been associated with a variety of diseases,
including malaria, leishmaniasis, meningococcal sepsis, trachoma, asthma, multiple
sclerosis, typhoid, and inflammatory bowel disease (Cabrera et al. 1995; Conway et al.
1997; Dunstan et al. 2001; Fernandez-Arquero et al. 1999; Knight et al. 1999; McGuire et
al. 1994; McGuire et al. 1999; Moffatt and Cookson 1997; Nadel et al. 1996; Negoro et al.
1999). One such study by Dunstan et al (Dunstan et al. 2001) reported an association
between HLA-DR and TNFA alleles with typhoid fever. The TNF region containing
TNFA lies in the central part of the MHC, or the MHC class III region. In this region
there are many candidate genes that could potentially be responsible for an association
with an infectious disease such as typhoid fever. TNFA is a strong candidate gene itself,
as it encodes the potent pro-inflammatory cytokine TNF-a. Bhutta et al (Bhutta et al.
1997) have reported an association between circulating TNF levels and typhoid fever
severity, and more recently House et al (House et al. 2002) showed that low ex vivo
production of TNF-a was associated with a delayed recovery. Additionally it has been
shown that the degree of down-regulation of TNF-a production capacity in the acute
phase of typhoid fever correlates with severity of the disease (Keuter et al. 1994). There
is a significant body of clinical and experimental data suggesting a causal role for TNF-a
in the pathogenesis of many diseases. The recent generation of deficient mice in TNF-a,
LT-a or their receptors has provided exciting new insights into the physiological role of
these molecules in the development of the secondary lymphoid tissues and in the
organization of the humoral immune response. Acute infections and active inflammatory
diseases are usually associated with increased production of TNF-a (Butler et al. 1993).
Several studies demonstrated the beneficial effects of TNF-a in resistance to intracellular
bacterial infections (Liew et al. 1990b; Nakano et al. 1990; Silva and Foss 1989). The
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plasma levels of TNF-a are positively correlated with severity and mortality in malaria
and leishmaniasis (Cabrera et al. 1995; McGuire et al. 1994). Additionally the direct
suppression of TNF-a activity is the best treatment available at present for rheumatoid
arthritis; in patients with persistently active rheumatoid arthritis, the combination of
soluble tumor necrosis factor receptor (P75):Fc fusion protein (TNFR:Fc) and
methotrexate was safe and well tolerated and provided significantly greater clinical
benefit than methotrexate alone (Weinblatt et al. 1999).
Cytokine imbalance is responsible for the pathogenesis of diverse inflammatory, 
autoimmune and infectious diseases, and TNF-a, among other cytokines, plays a central 
role. TNF-a production can be regulated at the transcriptional, post-transcriptional and 
translational level. Variability in the promoter and coding regions of the TNFA gene may 
modulate the magnitude of its secretory response. Cellular studies of gene regulation in 
vitro suggested that the molecular basis of the disease association may be, at least in some 
cases, a direct effect of the polymorphism on levels of gene expression (Knight et al. 
1999; Udalova et al. 2000). Furthermore, most of the reported associations are with 
polymorphisms, which are located in the TNFA promoter region. With typhoid, TNFA*2 
(-308) was associated with susceptibility to disease whereas TNFA*1 (-308) was 
associated with disease resistance (Dunstan et al. 2001). These factors raise the 
possibility that polymorphism of the TNFA gene might affect disease susceptibility.
To further understand the association of TNFA and the adjacent genes with susceptibility 
to typhoid fever, family and case-control studies were performed. Tag-SNPs, which were 
selected for the 150 Kb TNF region in the previous chapter, were genotyped in a 
case/control sample set and analysed to identify associations between SNPs and tag-SNP 
haplotypes, and typhoid fever.
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5.2. Results
5.2.1. Selection of SNPs for association analysis
Fifteen tag-SNPs were selected from the TNF region as stated in the previous chapter. 
These 15 SNPs were genotyped from 380 cases and 380 control samples. Sequenom- 
Mass spectrometry, a high throughput genotyping method was used, and then the 
genotype data was used in association analysis. Prior to analysis, the genotype data must 
go through a necessary “cleaning” process, to avoid inaccuracies in the dataset. SNPs 
with a minor allele frequency lower than 5%, and a genotyping success rate of lower than 
80% should be excluded from the database. The success rates of each SNP were 
calculated and are displayed in table 5.1. The genotyping success rate for all SNPs was 
high, greater than 90% in both typhoid fever cases and controls. The genotyping data is 
also displayed in table 5.1 and alleles were recoded based on the allele frequency of each 
SNP in the case group. Number 1 denotes the major allele and number 2 denotes the 
minor allele in the population. Three SNPs (TNF* 1800610, TNF*3093668 and 
1C7*2708) have minor allele frequencies lower than 10% in the whole population 
(combining typhoid fever cases and controls), while the remaining SNPs have minor allele 
frequencies higher than 10%. All 15 SNPs had a frequency of 5% or greater in the whole 
population. Therefore no SNPs were excluded from further analysis based on allele 
frequency and genotyping success.
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The Hardy Weinberg Equilibrium (HWE) calculation is performed as a further step taken 
to avoid inaccuracies in the dataset. HWE was calculated for each SNP using the 
genotype data of the controls. SNPs with P>0.05 display HWE. SNPs with P O .05  do 
not display HWE, and this could be due to genotyping error. HWE calculations are 
displayed in table 5.2. All 15 SNPs displayed HWE (P>0.05), and therefore no SNPs 
were excluded from further analysis.
Table 5.2: HWE calculation for the genotyping data of the 15 tag-SNPs.
SNP name Tag SNP
Control genotypes HWE 
P value11 12 22
UAP56*1595 T l 260 88 15 0.055
BAT1*2071595 T2 261 100 12 0.634
BAT1 *2239527 T3 84 160 117 0.053
NFKBIL1 *2230365 T4 257 100 14 0.349
hLT-alpha_NcoIJB T5 81 174 120 0.266
LTA*746868 T6 184 140 40 0.111
TNF* 1800610 T7 296 63 3 0.911
TNF*3093668 T8 345 27 0 0.922
LST1 *1052248 T9 200 141 32 0.377
1C7*2708 T10 326 45 3 0.492
1C7-412ATG T i l 141 175 59 0.757
AIF1*2259571 T12 104 178 94 0.350
BAT2*2736158 T13 234 116 18 0.549
BAT2* 1046089 T14 119 166 88 0.054
BAT2*2261033 T15 161 152 39 0.805
To estimate the ability to detect an association between each SNP and disease a power 
calculation was performed. The power to detect an association between the 15 tag-SNPs 
and typhoid fever is displayed in table 5.3. With a sample size of 380 cases and 380 
controls the power to detect an association between the tag-SNPs and disease is almost 
100% if the effect size is very large (OR=3). The power still remains high if the effect
174
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size is 0R=2. When detecting small effects (0R=1.5), the power to detect an 
association is reduced for all 15 tag-SNPs. For SNPs with low allele frequencies for 
example, TNF*3093668, the power to detect an association is low (40% for P=0.05, 20% 
for P=0.01) (table 5.3). However, as the majority of tag SNPs have allele frequencies 
greater than 10%, there is sufflcent power in this sample set to detect associations with a 
moderate effect.
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5.2.2. Case/control analysis of disease association in a single SNP manner.
Associations between SNPs in the TNF region and typhoid fever were identified using 
the case/control dataset. All of analyses were implemented within the GenAssoc package 
(http://www.stata.com) in STATA version 8.0. The Bonferroni correction for multiple 
testing was also applied for each single point test.
5.2.2.I. Single point logistic regression analysis
Allelic and genotypic logistic regression analysis for each SNP using the case/control 
dataset was performed in a single-point manner. The possible allelic and genotypic 
associations between the selected SNPs and typhoid fever were investigated. The allele- 
and genotype-wise logistic analysis results are displayed in table 5.4. Allelic frequencies 
of seven SNPs UAP56*1595 (Tl), BAT1*2071595 (T2), BAT1*2239527 (T3), hLT- 
alpha_NcoI_B (T5), LTA*746868 (T6), TNF*1800610 (T7) and TNF*3093668 (T8) 
were significantly different between typhoid cases and controls. Genotypic frequencies 
of 6 SNPs UAP56*1595 (Tl), BAT1*2239527 (T3), hLT-alpha_NcoI_B (T5), 
LTA*746868 (T6), TNF* 1800610 (T7) and TNF*3093668 (T8) were significantly 
different between typhoid cases and controls. Five SNPs (T l, T3, T5, T6 and T7) were 
shown to be disease-protective, with odd ratios and 95%CIs <1. Two SNPs (T2 and T8) 
were shown to increase disease susceptibility, with odd ratios and 95%CIs >1.
The comparison of the genotype-wise (2df test) and the allele-wise ( ld f  test) associations 
allow the identification of any dominant effects or deviation from the assumed 
multiplicative model at the candidate loci. The results of the Likelihood Ratio Test (LRT) 
support the hypothesis that the allele-wise analysis describes the best model for this 
dataset (LRT P>0.05 for all associated SNPs; see table 5.4).
177
Ta
bl
e 
5.
4:
 
Si
ng
le 
po
in
t 
lo
gi
st
ic
 
re
gr
es
sio
n 
an
al
ys
is 
us
in
g 
the
 
ca
se
/c
on
tr
ol
 d
at
as
et
oo
L
ik
el
ih
oo
d 
ra
ti
o 
te
st
ft,
0.
92
2
0.
54
4 ZIV
O
0.
39
8
0.
39
2
0.
82
4
0.
92
2
*
0.
22
5
0.
36
6
0.
86
9
0.
19
5
0.
08
0
0.
05
7
0.
28
5
<s
0.
01
0.
37
2.
52
0.
71
0.
73
0.
05 p
d
*
1.
47
0.
82
0.
03
1.
71
3.
05
3.
62
1.
14
ge
no
ty
pi
c 
co
m
pa
ri
so
n 
by 
lo
gi
st
ic
 
re
gr
es
si
on
£ 0.
27
i
6
6
0
0.
51
10
.2
9
0.
58
5
0.
28
5
0.
45
0.
54
6.
96
00oo
oo 10
.3
5
3.
07
5 OOOS
1.
23
VSNfr
OO
ft,
0.
01
8
0.
06
6
0.
03
4 98
9
0
0.
03
9
0.
01
9
0.
03
0
0.
03
6
0.
46
4
0.
59
2
0.
69
0
0.
20
5
0.
13
2
0.
08
2
0.
12
3
fS
7.
97
5.
44
6.
75
0.
75
6.
44
7.
90
oo
4.
39
1.
53
1.
05
0.
74
3.
16
1.
04
4.
98
4.
19
al
le
lic
 
co
m
pa
ri
so
n 
by
 
lo
gi
st
ic
 
re
gr
es
io
n
Cj
ft. 0.
07
5
0.
36
0.
58
5
12
.4
5
0.
24
0.
07
5 ZV
O
0.
34
5
11
.9
4
9.
46
5
5.
97
3.
42
4.
77
3.
66 (N
ft.
«/0O
©
© 0
.0
24
0.
03
9
0.
83
0
0.
01
6
0.
00
5 00o
p
o 0.
02
3
0.
79
6
0.
63
1
0.
39
8
0.
22
8
0.
31
8
0.
24
4
0.
08
0
7.
97
1
5.
07
4.
24 ©
o 5.
71
7.
86
6.
99
5.
16
r-
p
d 0.
23
0.
71
1.
45
0.
99
1.
36
3.
05
95%
 
C
l OOOO
o
ck
© 1
.0
3-
1.
75
0.
66
-0
.9
9
0.
74
-1
.2
7
0.
64
-0
.9
5
0.
57
-0
.9
1
0.
39
-0
.8
7
1.
07
-2
.8
7
0.
82
-1
.2
9
0.
6-
1.
36
0.
89
-1
.3
4
0.
72
-1
.0
8
0.
88
-1
.4
6
0.
92
-1
.3
7
0.
65
-1
.0
2
O
R
0.
65
1.
34
0.
81
0.
97
0.
78
0.
72
0.
58
1.
75
1.
03
0.
90
1.
09
8
8
0 1.
14
z
n
0.
82
Ta
g 
S
N
P
H
ID
H
VO
H
00
H
as
H T
10
T
il
T
12
T
13
T
14
T
15
SN
P 
n
am
e
U
A
P
56
*1
59
5
B
A
T
1 
*2
07
15
95
B
A
T
1 
*2
23
95
27
N
F
K
B
IL
l 
*2
23
03
65
hL
T
-a
lp
ha
_N
co
I 
B
L
T
A
*7
46
86
8
T
N
F
*1
80
06
10
T
N
F
*3
09
36
68
LS
T
1*
 
10
52
24
8
1C
7*
27
08
1C
7-
41
2A
T
G
A
IF
1*
22
59
57
1
B
A
T
2*
27
36
15
8
B
A
T
2*
 
10
46
08
9
B
A
T
2*
22
61
03
3
X
Oh
C/0<D
Od<uTD
* 
Li
ke
lih
oo
d 
Ra
tio
s 
Te
st 
ca
nn
ot
 b
e 
pe
rfo
rm
ed
 
as 
on
e 
va
ria
bl
e 
do
es
 n
ot 
ex
is
t..
C hapter 5: TMF reg io n  po lym orph ism s are a ssoc ia ted  with T ypho id  fe v e r  in V ietnam ese
Disease associations were detected with SNPs in three different genes within this genomic
region, BAT1, LTA and TNF (table 5.4, figure 5.1). Logistic regression analysis showed
significant associations between typhoid fever and the SNPs UAP56*1595 (Tl),
BAT1*2071595 (T2) and BAT1*2239527 (T3) at the BAT1 gene (table 5.4, figure 5.1).
The allele-wise risk associated with the minor allele of UAP56*1595 (T l) was 0.65 (95%
Cl 0.49-0.88, P=0,005), of BAT1 *2071595 (T2) was 1.34 (95% Cl 1.03-1.75, P=0.024),
and of BAT1 *2239527 (T3) was 0.81 (95% Cl 0.66-0.99, 7M).039). The variant allele of
UAP56*1595 (T l) and BAT1 *2239527 (T3) were disease-protective, whereas the variant
allele at BAT1 *2071595 (T2) was a disease susceptibility allele.
Logistic regression analysis identified significant associations between typhoid fever and 
the SNPs hLT-alpha_NcoI_B (T5) and LTA*746868 (T6) at the LTA gene (table 5.4, 
figure 5.1). The allele-wise risk associated with the minor allele of hLT-alpha_NcoI_B 
(T5) was 0.78 (95% Cl 0.64-0.95, P=0.016), and of LTA*746868 (T6) was 0.72 (95% Cl 
0.57-0.91, /M1.005). The variant alleles of these two SNPs were disease-protective.
Logistic regression analysis also identified significant associations between typhoid fever 
and the SNPs TNF*1800610 (T7) and TNF*3093668 (T8) at the TNF gene (table 5.5, 
figure 5.1). The allele-wise risk associated with the minor allele of TNF* 1800610 (T7) 
was 0.58 (95% Cl 0.39-0.87, P=0.008), and of TNF*3093668 (T8) was 1.75 (95% Cl 
1.07-2.87, P=0.023). The variant allele at TNF* 1800610 (T7) was disease protective, and 
the variant allele at TNF*3093668 (T8) was a disease susceptibility allele (table 5.4, 
figure 5.1).
After application of a strict Bonferroni correction (multiplication by 15 informative SNP 
types) only two SNPs remained mildly associated with typhoid fever: UAP56*1595 (T l) 
and LTA*746868 (T6) (P=0.075) (see in table 5.4).
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Figure 5.1 shows a summary of the SNP selection and analysis. All seven SNPs showing 
an association with typhoid fever are located in three genes BAT1, LTA and TNF (green 
spots in figure 5.1). Two SNPs that show the strongest association with typhoid fever 
UAP56*1595 (T l) and LTA*746868 (T6) are located within the BAT1 and LTA loci 
(purple spots in figure 5.1), respectively.
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5 .2 2 .2 . Dom inant and recessive effect of m inor allele on the disease.
The dominant and recessive analysis allows us to see whether minor alleles (which are
considered as the affected allele) have dominant or recessive effects on the disease. The
dominant / recessive analyses were performed in a single point manner in the same case /
control dataset above. Doing these tests adds a greater understanding of the effective
degree of the minor alleles on disease. A dominant effect is considered if either 1 or 2
minor alleles have a significant effect on the disease. A recessive effect is considered if
only 2 minor alleles have a significant effect on the disease.
The dominant analysis was performed by comparing the combined number of individuals 
who have one and two minor alleles (affected allele) with the number of individuals who 
have two major alleles (unaffected allele) in the population. Seven SNPs, uap56*1595 
(Tl), BAT1 *2071595 (T2), LTA*746868 (T6), TNF*1800610 (T7), TNF*3093668 (T8), 
BAT2* 1046089 (T14) and BAT2*2261033 (T15) were shown to have a dominant effect 
on the disease (see table 5.5). Five of these seven SNPs were shown to be associated with 
the disease in allelic logistic regression analysis UAP56*1595 (Tl), BAT1 *2071595 (T2), 
BAT1 *2239527 (T3), LTA*746868 (T6), TNF*1800610 (T7), and TNF*3093668 (T8). 
Two other SNPs, BAT2* 1046089 (T14) and BAT2*2261033 (T15), were not associated 
with the disease in the allelic logistic regression analysis. Individuals with 1 or 2 copies 
of minor alleles of SNP T l, T6, T7 or T15 have low risk of getting typhoid fever (OR<l) 
while individuals with 1 or 2 copies of minor alleles of SNP T2, T8 or T14 have high risk 
of getting typhoid fever (OR>l).
The recessive analysis is the comparison between the number of individuals who have two 
minor alleles and the combined number of individuals who have one or two major alleles. 
Two SNPs, BAT1 *2239527 (T3) and hLT-alpha_NcoI_B (T5), were shown to have a 
recessive effect on the disease.
182
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By doing dominant and recessive analysis five of seven SNPs, which showed associations
with the disease in allelic logistic regression analysis, also showed a dominant effect of
minor allele on the disease, while two others showed a recessive effect o f minor allele on
the disease. In addition, two other SNPs showed a dominant effect of the minor allele on
the disease, although they were not associated with the disease in logistic regression
analysis (table 5.5).
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5.2.3. Stepwise logistic regression analyses of multiple m arkers
To determine whether each associated SNP behaved in an independent or a dependent 
manner, we carried out tests to determine the main association effect at each locus using a 
forward stepwise logistic regression procedure (Cordell and Clayton 2002). From this 
point on the original name of each SNP is replaced by the tag-SNP name for convenience 
(see table 5.1-5.5 for key).
Stepwise logistic regression was performed within associated SNPs to see whether the 
effects of these associated SNPs were independent effects or not. Two tests can be 
performed within stepwise logistic regression, an intralocus test is performed for the 
associated SNPs within each gene, and an interlocus test is performed between the most 
associated SNPs for each gene. Within intralocus and interlocus tests, 2 tests can be 
performed of which the results complement each other, (1) adding another SNP to the 
logistic regression model containing the SNP of interest and (2) adding the SNP of 
interest to the logistic regression model containing another SNP or a combination of other 
SNPs. When performing these tests, the null hypothesis is that the SNP of interest is 
associated with the disease, and the alternative hypothesis is that all SNPs are associated 
with the disease. The null model in these tests could be one SNP or the combination of 
two or more SNPs.
A P value of <0.05 in these tests indicates a significant difference between the level of 
association of the alternative model with the disease and the level of association of the 
null model with the disease. P<0.05 indicates that the SNP which is added into the 
alternative model (the added SNP) increases the significance level of the disease 
association compared to the level of association of the SNP or the combined SNPs in the 
null model.
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In terms of the association between SNPs and disease, there are three possible correlations
that can be observed between SNPs in the stepwise logistic regression analysis, (a) if a
significance of P>0.05 is observed in the two comparison tests, (1) and (2), the SNPs in
the null as well as alternative models are markers of the one disease loci, (b) if a
significance of P<0.05 is observed in only one of the two comparison tests, (1) or (2),
that means the added SNP and the SNPs in the null model are associated with the one
disease loci, in which the added SNP in the test with P<0.05 plays a role by significantly
increasing the level of association with the disease compared to SNPs in the null model,
and (c) if a significance of P<0.05 is observed in the two comparison tests, (1) and (2), the
added SNP and the SNP(s) in the null model may be either associated with two separated
disease loci, or independently associated with one disease loci.
5.2.3.1. Intralocus forward stepwise logistic regression analyses
Intralocus forward stepwise logistic regression analysis was carried out for multiple SNPs 
within each candidate gene locus to determine whether they are dependently associated 
with the same disease loci or if they are independently associated with one disease loci or 
more than one disease loci. The variables (associated SNPs) with a significance of 
P<0.05 were added into the regression model in a forward step-wise manner with the 
most significant variable first. SNPs from 3 genes, BAT1, LTA, and TNFA, (T l, T2, T3, 
T5, T6, T7 and T8) that were associated with the disease in allelic logistic regression 
analysis were included in the intralocus test.
Within the BAT1 gene, three markers T l, T2 and T3 were analysed. The results in table 
5.6 show that for T2 and T3 a significance of P>0.05 was observed in the two comparison 
tests (1) and (2) therefore T2 and T3 are markers of the one disease loci. For T2 and T l, 
when comparing the alternative model (adding T2 to the logistic regression model 
containing T l) to the null model (Tl) /*=(). 12, and when comparing the alternative model
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(adding Tl to the logistic regression model containing T2) to the null model (T2)
.P=0.016, therefore T l and T2 are markers of one disease loci, and T l increases the level
of association with the disease. T3 and Tl displayed this same pattern of correlation and
therefore are also markers of one disease loci, with T l increasing the level of association
with the disease. In terms of the correlation among three SNPs, T l, T2 and T3, the
comparisons made between the different combinations of alternative and null models
(table 5.6) suggest that the 3 SNPs are all markers of the one disease loci. T l plays a
main role in the association between the BAT1 gene with the disease as it increases the
level of association compared with the association seen with the other SNPs and disease.
Within the LTA gene, two markers T5 and T6 were significantly associated with the 
disease and were used in stepwise logistic regression analysis. The results show that 
when adding T6 to the logisitic regression model containing T5 and comparing to the null 
model containing only T6, P=0.057, and when adding T5 to the model containing T6 and 
comparing to the null model containing only T5, 7M1.601. Thus, T5 and T6 are markers 
of one disease loci. However, it is likely that T6 is more important than T5 in the 
association of LTA with disease, as the association with the disease is increased when T5 
+T6 are combined compared with T5 alone (/M).057 compared to /*=0.601).
Within the TNFA gene, two SNPs T7 and T8 were significantly associated with the 
disease. The results of intralocus step-wise logisitic regression show that P= 0.078 when a 
comparison was made between the alternative model (T7+T8) and the null model (T7), 
but P=0.004 when a comparison was made between the alternative model (T8+T7) and 
the null model (T8). Thus, T7 and T8 are makers of the one disease loci, and T7 plays a 
main role in the association between the TNF gene and disease.
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From the intralocus step-wise logisitic regression we can conclude that SNPs T l, T6 and 
T7 of the BAT1, LTA and TNF genes are the main contributors to the disease association.
Table 5.6: Intralocus forward stepwise regression analysis within 3 candidate genes.
Gene Null model Alternative model
Test statistic
d f P
Tl Tl +T2 2.42 1 0.120
Tl Tl +T3 0.67 1 0.414
T2 T2 + T1 5.81 1 0.016
T2 T2 + T3 2.19 1 0.139
BAT 1 T3 T3+T1 4.97 1 0.026
T3 T3+T 2 2.49 1 0.115
T1+T2 Tl +T2 + T3 0.34 1 0.560
T1+T3 Tl +T3 + T2 1.83 1 0.177
T2+T3 T2 + T3 + T l 4.3 1 0.038
LTA
T5 T 5+T 6 3.63 1 0.057
T6 T6 + T5 0.27 1 0.601
TNF
T7 T7 + T8 3.1 1 0.078
T8 T8 + T7 8.17 1 0.004
5.2.3.2. Interlocus forward stepwise logistic regression analysis.
Interlocus forward stepwise logistic regression analysis was performed to determine 
whether SNPs at the three candidate gene loci (BAT1, LTA, TNF) are associated with one 
functional disease polymorphism or if they are independently associated with different 
functional disease polymorphisms (table 5.7). The test was performed using three SNPs 
(T l, T6 and T7), which were identified by intralocus forward stepwise logistic regression 
analysis (table 5.6).
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The results in table 5.7 show that when comparing the alternative model containing
T1+T7 (adding Tl to the logistic regression model containing T7) to the null model
containing T l, /M1.005. When making the reverse comparison (T7+T1 vs T7) /M).008.
Thus, Tl and T7 may be associated with two separate disease loci or independently
associated with one disease loci. In contrast, T6 and Tl are associated with one disease
loci as P>0.05 in the two tests (1) and (2). The same pattern of correlation occurred with
T6 and T7 so they are also associated with the one disease loci.
In terms of testing correlation between the 3 SNPs, T l was added to the combination of 
T6 + T7, T6 was added to T1+ T7, and T7 was added to T l + T6 and these were 
compared to the respective null models (table 5.7). The results show that T6 did not 
increase the level association of the combined Tl + T7 with the disease (P=Q2Q6). Thus 
they are all markers of the one disease loci. In addition, both T l and T7 increased the 
level of association of the combined (T6 + T7) and (T6 + T l) models, with P=0.005 and 
/*=0.003, respectively.
To summarise, T l and T7 may be associated with two different disease loci or 
independently associated with one disease loci. However T l and T7 both share the same 
disease loci with which T6 is associated. Therefore, T l and T7 must be independently 
associated with the one disease loci. In conclusion, T l, T6 and T7 are all markers of the 
one disease loci, in which Tl and T7 play independent roles.
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Table 5.7: Interlocus forward stepwise regression analysis between T l, T6 and T7
Null model Alternative model
Test statistic
%2 d f P
Tl Tl + T6 1.29 1 0.256
T6 T6 + T1 1.76 1 0.185
Tl Tl +T 7 8.04 1 0.005
T7 T7 + T1 7 1 0.008
T6 T6 + T7 2.99 1 0.084
T7 T7 + T6 2.83 1 0.093
Tl +T 6 Tl + T6 + T7 9.13 1 0.003
Tl +T 7 Tl + T7 + T6 1.6 1 0.206
T6 + T7 T6 + T7 + T l 7.83 1 0.005
The interlocus forward stepwise logistic regression results support the hypothesis that 
three SNPs T l, T6 and T7 share the correlation of a disease signal. A model of this 
hypothesis is graphically represented in figure 5.2. The association effects of T l (yellow 
box) and T7 (blue box) are independent of each other but do not account for two separate 
association signals. T6 (red box) shares some of the correlation with disease that exists for 
T l and some of the correlation with the disease that exists for T7
T6
Figure 5.2: Model generated from logistic regression analysis suggesting there is one signal 
associated with the disease at this locus. The central gray circle represents the protective disease 
signal. The association effects of T l (yellow box) and T7 (blue box) are independent of each 
other but do not account for two separate association signals. T6 (red box) shares some of the 
correlation with disease that exists for T l and some of the correlation with the disease that exists 
for T7.
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5.2.4. Case-control analysis of disease association with the haplotypes.
The results of using multiple markers in stepwise logistic regression analyses shows that a 
group of markers spanning three genes BAT1, LTA and TNF correlate with the one 
disease signal (figure 5.1). To test the hypothesis that the three SNPs spanning BAT1, 
LTA and TNF share the one disease signal, we examined haplotypes containing the 
individually associated SNPs.
We utilized the GENEBPM algorithm (Morris 2005) to approximate the posterior 
probability of an association between the 15 tag-SNP haplotypes with disease phenotypes 
to further investigate the pattern of results obtained from the single-point and multi-locus 
analyses. The disease phenotype of each individual was modeled in a logistic regression 
framework, parameterized in terms of the odds of disease for each possible pair of 
haplotypes consistent with the observed SNP genotype and weighted by the 
corresponding phase assignment probabilities. A Bayesian partition model is utilized to 
cluster haplotypes according to their similarity, with each haplotype in the same cluster 
assigned the same odds of disease. This means haplotypes in the same cluster have the 
same risk of disease.
According to Morris et al (Morris 2005) we can approximate the posterior probability of a 
haplotype association with disease based on the number of clusters generated. The prior 
probability of more than 1 cluster of haplotypes is 0.5 (P=0.5). Thus, a posterior 
probability of greater than 0.5 (P>0.5) is suggestive of an association. A posterior 
probability of greater than 0.75 (P>0.75) is positive evidence o f an association; P>0.95 is 
strong evidence of an association; and overwhelming evidence of an association 
corresponds with P>0.99 (Morris 2005).
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Table 5.8 summarises the 21 haplotypes with a frequency of greater than 1% that were 
constructed based on the case/control genotyping data of 15 tag-SNPs. It also describes 
the haplotype clusters, the posterior mean relative risks of haplotypes, and the frequency 
of each haplotype in the population. Figure 5.3 presents a cladogram of the 21 common 
haplotypes (frequency greater than 1%) constructed from the output of the GENEBPM 
algorithm. The cladogram can be used to represent the similarity of haplotypes in terms 
of the tag SNPs they carry and their disease risk. Haplotypes that cluster closely are likely 
to share recent common ancestry and thus have similar risk of disease.
We identified at least three clusters of haplotypes, which are summarized in table 5.12, 
and labeled A-C in the dendrogram of the 21 common haplotypes (figure 5.3). The 
posterior probability was estimated to be 0.821 representing positive evidence of an 
association of the tag-SNPs haplotypes with disease.
Figure 5.3 highlights a specific low-risk clade of haplotypes (cluster A, also listed in table 
5.8) with their posterior mean relative risk lower than 0.95, relative to the most common 
haplotype with a relative risk of 1. The 2 other clusters B and C appear to be high-risk 
clades. However the relative risks are not distinct enough to clarify the high-risk o f the 
haplotypes in these clades. The relative risk of haplotypes in these two clades ranges 
from 0.97 to 1.22.
Haplotypes in the low-risk cluster A all carry the combination of alleles *12122*1111 at 
SNPs T l-T l 1, where * represents either allele. The minor allele (2) of SNP T7 occurs in 
one cluster (containing haplotypes 9 and 13; table 5.12 and figure 5.4) which defines a 
segment of cluster A. The minor allele (2) of SNP T l defines the other segment of cluster 
A containing haplotypes 15, 12, 5 and 18 (table 5.8 and figure 5.3). These two segments 
are in the low-risk cluster and are independent segments of this clade. This confirms the
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conclusion from the multi-locus logistic regression analysis that the effects of T l and T7
are independent in terms of their association with disease as they both represent
independent segments of the one low risk cluster of haplotypes. Furthermore, the minor
allele (2) at SNP T6 occurs only in this clade. This confirms that T6 is also the main SNP
controlling the association between the haplotypes and the disease. This agrees with the
multi-locus logistic regression analysis where T6 shares some of the association with Tl
and some of the association with T7, even though Tl and T7 are independent. Thus, in
the absence of SNPs Tl and T7, SNP T6 best isolates the low-risk clade, and thus
becomes significant in the multi-locus analysis.
Table 5.8: Haplotypes identified by the GENEBPM  algorithm with the estimated frequencies 
and posterior mean odds ratios relative to the m ost com m on haplotypes (relative risk).
cluster subcluster haplotype frequency relative risk SNPs T1-T15
A A
5 0.06 0.85 212122111111121
12 0.02 0.85 212122111111111
9 0.03 0.86 112122211112112
18 0.01 0.87 212122111111221
13 0.02 0.89 112122211112111
15 0.02 0.92 212122111112112
B
B1
7 0.04 0.97 111111111122112
1 0.12 1.00 111111111122111
B2
19 0.01 1.13 111111111111111
11 0.03 1.14 111111111121122
2 0.12 1.19 121111111121221
6 0.04 1.20 111111111121221
16 0.02 1.21 111111111111221
4 0.06 1.22 111111111111121
C
Cl
21 0.01 0.99 112221112111122
8 0.04 0.99 112121112211121
C2
3 0.09 0.97 112221112112112
14 0.02 1.04 122222112112112
20 0.01 1.06 122222112111111
17 0.02 1.09 122222112112111
10 0.03 1.12 112121122112111
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Haplotype
Figure 5.3: Cladogram of common haplotypes (frequency greater than 1%) constructed from the 
output of the GENEBPM algorithm. The most common haplotype is labeled ‘1’, the second 
most common is labeled ‘2 ’, and so on. Three clusters are indicated by A, B and C. The 
highlighted cluster (cluster A) represents the specific low-risk clade of haplotypes.
5.2.5. TNF release in typhoid patients with and without the protective haplotype 
* 12122*1111
A subset of the typhoid cases that were genotyped in this study were also previously 
investigated in a study of ex vivo cytokine response to LPS stimulation in whole blood 
from typhoid fever patients (House et al. 2002). The results of this study showed that 
there was a low level of TNF-a release during acute typhoid fever, and this was 
associated with a delayed recovery. Our results showing that *12122*1111 haplotypes 
(T l-T ll) are associated with a low-risk of typhoid fever was then used to ask the 
question whether TNF cytokine release in typhoid patients was affected by the presence or 
absence of the TNF region protective haplotype *12122*1111.
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In the ex vivo study, House et al (House et al. 2002) performed measurements of TNF-cc 
production in response to LPS stimulation of whole blood from patients with typhoid 
fever. Blood from typhoid patients on days 1, 4 and 7 of treatment were stimulated with 
1 pg/ml LPS for 24 hours, and the level of TNF-a production in the supernatant was 
measured. Results of this study were used to analyse the correlation between patients who 
contain and who do not contain the protective haplotype *12122*1111 and the level of 
TNF-a release. Figure 5.5 shows the levels of TNF-a release in typhoid patients that 
either have or do not have the * 12122* 1111 haplotype. The amount of TNF-a produced 
by the patients who have the *12122*1111 haplotype is significantly less than those who 
do not have the haplotype on day 4 of treatment (P=0.023). This trend is also observed 
on day 7 of treatment (P=0.057).
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5.2.6. Family-based analysis- Transmission Disequilibrium test (TDT).
To confirm the associations of SNPs with the disease identified by the case/control
association study, we investigated whether these associations could be replicated in a
familial genetic association study. Genotyping data of the 15 tag-SNPs in 95
case/mother/father family trios was used for familial association analysis including TDT
analyses.
The TDT was performed to see the informative transmissions from parents to offspring. 
TDT analysis was performed using the STATA package (see in chapter 2). Table 5.9 
shows that the number of cases that have valid genotypes for TDT analysis is over 80 
cases. However, the number of trios which have informative transmissions are small. In 
the case of SNPs TNF*3093668, 1C7*2708 and TNF*1800610, only sixteen to twenty- 
one trios have informative transmissions for TDT analysis. The TDT analysis identifies 
two SNPs (TNF* 1800610 and BAT2*2261033) to be associated with the disease. This 
result confirms the association of TNF* 1800610 with the disease as seen in the 
case/control analysis. However, it identifies another associated SNP (BAT2*2261033) 
which was not associated with the disease in the case/control analysis. The results from 
TDT are based on a small family sample set (N=95 family trios). Therefore there may not 
be enough power in the family sample set to generate reliable results to enable 
confirmation of the case/control analysis, which was based on a larger sample set with 
sufficient power to detect an association. As such, the associations identified by TDT 
may have appeared by chance. The limited power to detect an association using the 
family sample set by TDT is shown in table 5.10. Average power to detect a small 
association (OR=1.5) in an average sample size of informative transmission (58) ranges 
from 15% to 36% (P=0.05 and P=0.01).
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Table 5.9: TDT analysis o f 15 TNF region tag-SNPs
SNP name Cases Informativetransmission X2 l d f P
UAP56*1595 87 34 0.47 0.493
BAT1 *2071595 92 56 1.143 0.285
BAT1 *2239527 83 76 0.05 0.818
NFKBIL1 *2230365 94 52 1.92 0.165
hLT-alpha_NcoIJB 89 80 0 1
LTA*746868 94 67 1.209 0.272
TNF* 1800610 94 21 8.05 0.005
TNF*3093668 92 16 2.25 0.134
LST1*1052248 95 79 1.025 0.311
1C7*2708 89 20 0.2 0.655
1C7-412ATG 95 90 0.177 0.673
AIF1*2259571 95 88 0.045 0.83
BAT2*2736158 94 61 0.147 0.701
BAT2* 1046089 89 71 0.127 0.722
BAT2*2261033 93 71 6.21 0.013
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5.3. Discussion
Investigating the role of host genes in susceptibility to and protection from disease 
historically involved genotyping individual genetic markers in candidate genes and 
looking for disease associations. However this approach investigates only single gene loci 
and may identify only indirect markers of disease. In recent years development of a 
haplotypic approach to study genetic disease susceptibility has progressed rapidly (Daly et 
al. 2001). Data from the recently released HapMap project offers a powerful tool to 
potentially identify multiple genetic loci (and their interactions) that are responsible for 
protection from or susceptibility to, complex diseases (Altshuler 2005). In this study we 
have investigated a genetic association between typhoid fever and the MHC class III 
region using a haplotypic approach.
The TNFA gene and the MHC class III region have been shown to be associated with 
several diseases (Cabrera et al. 1995; Conway et al. 1997; Fernandez-Arquero et al. 1999; 
Knight et al. 1999; McGuire et al. 1994; McGuire et al. 1999; Moffatt and Cookson 1997; 
Nadel et al. 1996; Negoro et al. 1999) including typhoid fever (Dunstan et al. 2001). 
However, the results presented in Dunstan et al (Dunstan et al. 2001) did not specifically 
identify TNFA as the disease loci, as the associations were with HLA class II alleles as 
well as with alleles of TNFA. Although the conclusions of Dunstan et al (Dunstan et al. 
2001) were based on a small genetic study, it provided evidence to support that this 
genomic region is important in the defense against typhoid fever. Our study has added 
significantly to these original findings. We found that the allelic frequencies of 7 SNPs 
(T l, T2, T3, T5, T6, T7, and T8) were significantly different between typhoid cases and 
controls. The multi-locus combined logistic regression results support the hypothesis that 
there is only one signal associated with disease at this locus. Haplotype-based analysis of 
the tag SNPs provided positive evidence of association with typhoid (posterior probability 
0.821). The GENEBPM cladistic analysis highlighted a low-risk cluster of haplotypes
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that each carry the minor allele of Tl or T7, but not both, and otherwise carry the 
combination of alleles *12122*1111 at T l-T ll .  This further supports the one associated 
signal hypothesis.
Cladisitic analysis of SNPs is a novel approach to disease-gene mapping and provides 
considerably more power than single-locus methods (Durrant et al. 2004; Morris 2005). 
Cladisitic methods are based on the expectation that chromosomes with recent shared 
ancestry are similar in the vicinity of a disease gene. Based on LD, recombination rates 
and distance, strong correlations between alleles within neighbouring loci are expected, 
and this can be evidenced by haplotypes carrying similar markers. Taking into 
consideration the noise in the relationship between disease phenotype and genotype 
(environmental factors, polygenicity, epistasis, dominance, penetrance) one may expect a 
disproportionate amount of these disease haplotypes in patients with the disease and in 
individuals without disease. We used the GENEBPM algorithm to identify a cluster of 
low-risk haplotypes (*12122*1111) and identify groups of cases that harbour these 
haplotypes (Morris 2005). This algorithm gave a posterior probability of 0.821 (0.75 
corresponds to 3:1 odds against the hypothesis that the haplotypes and disease are not 
associated), which represents positive evidence of an association between tag SNP 
haplotypes and typhoid fever. Both the combined logistic regression results and the 
cladisitic analysis support the hypothesis that there is just one signal associated with 
disease at this locus, and this signal is marked by the * 12122* 1111 haplotype.
Haplotype-based analysis revealed that the frequency of *12122*1111 was higher in the 
control population compared to typhoid fever patients. This strong association is with 
hospitalized typhoid, as all cases genotyped in this study were inpatients. Although the 
group as a whole did not show specific disease complications, they represent individuals
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with more severe infections than typhoid sufferers within the community who are more 
likely to have less symptomatic disease.
Although we have identified a haplotype in the TNF region that affords protection from 
typhoid fever, we are yet to determine the causative disease loci. The seven associated 
SNPs span a region of 44.7kb and are found within the genes BAT1, LTA and TNF. 
BAT1, which is a member of the DEAD-box protein family encoding an ATP-dependent 
RNA helicase, has been shown to be a negative regulator of inflammation. BAT1 is 
involved in the modulation of TNF-a production (Allcock et al. 2001). LTA encoding 
lymphotoxin-a and TNF-a, members of the TNF superfamily, mediate a large variety of 
inflammatory and immunostimulatory responses. All three genes, or haplotypes spanning 
these genes, have been associated with a variety of infectious and inflammatory diseases 
(Cabrera et al. 1995; Knight et al. 1999; Migita et al. 2005; Moffatt and Cookson 1997; 
Zeggini et al. 2002), and functional variation of these proteins could potentially effect 
susceptibility to typhoid fever. In this study we have shown that patients who carry the 
protective haplotype *12122*1111 produce less ex vivo TNF than patients without the 
haplotype on day 4 of treatment, and this trend is also seen on days 1 and 7 of treatment. 
This preliminary functional study suggests that the protective haplotype suppresses the 
pyrogenic TNF response to S. typhi.
Our future work will involve investigating TNF expression in healthy individuals with or 
without the protective haplotype to clearly examine this relationship. In the process of 
looking for the causative mutation of a disease, our future work is to pinpoint the 
causative mutation responsible for the protective effect of the *12122*1111 haplotype 
either through a very high resolution association study of the region from TNF A to BAT 1 
or through re-sequencing of this region in Vietnamese individuals carrying this haplotype.
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6.1. Introduction
Recognition of Salmonella by macrophages leads to the secretion of antimicrobial 
molecules such as superoxide, hydrogen peroxide and nitric oxide (NO) to inhibit or kill 
intracellular bacteria. Several genes located in the human chromosome 17qll.2-q22 
region play a role in the secretion and up-regulation of antimicrobial molecules in defense 
against bacteria. This region contains genes encoding signal transducers and activators of 
transcription (STATs), the inducible nitric oxide synthase gene (NOS2A), and genes 
encoding members of the family of small inducible chemokines, the (3-chemokine cluster 
(SCYAs) (figure 6.1).
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Figure 6.1: The genetic and sequence positions of microsatellite markers and genes in the 
chromosome 17q 11.2 -  22 region (reproduced from Jamieson et al (Jamieson et al. 2004)).
6.1.1. NOS2A
The gene NOS2A encodes inducible nitric oxide synthase (iNOS), which is a member of 
the nitric oxide synthase family that includes endothelial specific nitric oxide synthase 
(eNOS) and neural specific nitric oxide synthase (nNOS). Following bacterial infection, 
iNOS expression is induced by pro-inflammatory and immunological stimuli,
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predominantly in macrophage cells (Everest et al. 1998; Fang 1997; Mastroeni et al. 
1998). The enzymatic activity of iNOS catalyses the production of microbicidal reactive 
nitrogen intermediates (RNI), including nitric oxide (NO) and its conversion products, 
from the amino acid L-arginine and molecular oxygen. NO is a critical agent of host 
defence and also is a central mediator of pathogenesis (reviewed in (Burgner et al. 1999). 
NO, a labile gas with antimicrobial, pro-inflammatory, and immunomodulatory effects, 
can be beneficial at appropriate levels but also detrimental in response to bacterial 
invasion. High levels of NO can have bactericidal as well as anti-apototic effects. NO 
has been also considered as a factor that can behave as a “double-edged sword”, similar to 
TNF-a and IL-8 in response to Salmonella (MacMicking et al. 1997a). There is evidence 
that NO can kill or inhibit the growth of many bacterial and parasitic species in vitro (De 
Groote and Fang 1995; Liew et al. 1990a) and, in particular, NO has been implicated in 
the control of intracellular pathogens including Salmonella (Fang 1997). NO has also been 
shown to exert immunomodulatory effects that include acting upon cell adherence and 
function, cellular proliferation and cytokine production as well as apparently playing a 
role in the regulation of gene expression (Bogdan 2001). In vivo experiments using 
inhibitors of iNOS, and knockouts of the NOS2A gene, have clearly shown its role in the 
control of murine infections as diverse as malaria (Seguin et al. 1994), leishmaniasis (Wei 
et al. 1995), tuberculosis (MacMicking et al. 1997b), and listeriosis (MacMicking et al. 
1995). Increased expression of iNOS following infection with Salmonella was 
demonstrated in vitro in human intestinal epithelial cell lines (Salzman et al. 1998; 
Witthoft et al. 1998) and a beneficial role of iNOS in controlling Salmonella 
multiplication at later stages of murine infection was indicated in vivo (Mastroeni et al. 
2000b). Some other studies however describe the harmful effects of NO such as 
neurotoxicity, reperfusion injury and severe hypotension during endotoxic shock 
(reviewed by (Michel and Feron 1997) and (Nathan 1997)).
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The N0S2A gene maps to chromosome 17qll.2-q22 (Marsden et al. 1994). In vitro 
studies suggest that human NOS2A expression is largely transcriptionally regulated (de 
Vera et al. 1996; Linn et al. 1997; Marks-Konczalik et al. 1998; Taylor et al. 1998) and so 
genetic variation within the 5’ regulatory region may influence gene expression. The 
proximal NOS2A promoter contains several SNPs (Burgner et al. 2003b; Kun et al. 1998) 
and a pentanucleotide microsatellite (the NOS2A_2.6kb CCTTT(n) microsatelite) (Xu et 
al. 1997). NOS2A SNPs, SNP haplotypes and microsatellite alleles are associated with 
human diseases (Burgner et al. 2003b; Burgner et al. 1998; Hobbs et al. 2002; Jamieson et 
al. 2004; Kun et al. 1998; Rutherford et al. 2001; Xu et al. 2000). There is evidence of 
association between the proximal NOS2A promoter region and malaria susceptibility, as a 
SNP in the promoter region of NOS2A at position G-954C protects heterozygous carriers 
against severe malaria as effectively as the sickle cell trait (Kun et al. 2001). A SNP at 
position C-1173T is significantly associated with protection from symptomatic malaria 
and severe malaria anaemia (Hobbs et al. 2002) and a SNP at position -1026 is associated 
with tuberculosis (Jamieson et al. 2004). A single haplotype that uniquely identifies SNP 
NOS2A-1659 has been shown to be associated with cerebral malaria (Burgner et al. 
2003b). Cramer et al (Cramer et al. 2004) suggested that iNOS promoter haplotypes rather 
than single SNPs are associated with malaria when he found the haplotype between 
microsatellite CCTTT(8) and SNP C-954G protected against hyperparasitaemia and 
haplotype CCTTT(13) and C-1173T increased fatality. Based on the collective findings 
above, NOS2A is an attractive candidate gene for typhoid fever susceptibility.
6.1.2. P-chemokine cluster
Chemokines are a family of pro-inflammatory activation-inducible cytokines. They are 
small secreted protein signals which are secreted by numerous cell types in response to a 
variety of exogenous stimuli, including bacterial and viral products, and endogenous 
stimuli, including pro-inflammatory cytokines. Chemokines can be sub-classified by
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structure according to the number and spacing of conserved cysteines into four major 
groups, given the preferred names CXC, CC, C and CX3C (Murphy et al. 2000). These 
families are clustered at specific loci within the genome. The p-chemokine cluster, or CC 
chemokine cluster is located on human chromosome 17. This cluster contains several 
chemokine genes (called either SCYA or CCL genes) which are believed to have arisen 
due to gene duplication and divergence. Some of which may have occurred relatively 
recently in evolutionary terms, as a number of chemokine genes in this cluster have no 
obvious murine homologue (Nomiyama et al. 2001).
Chemokines are released from a wide variety of cells in response to bacterial and viral 
infection, and agents that cause physical damage such as silica or the urate crystals that 
occur in gout. They function mainly as chemoattractants for leukocytes, recruiting 
monocytes, neutrophils and other effector cells from the blood to sites of infection or 
damage. They can be released by many different cell types and serve to guide cells 
involved in innate immunity and also lymphocytes in adaptive immunity. Several 
chemokines and their receptors have been shown to play a critical role in lymphoid 
development, mucosal immunity, and inflammation (reviewed by (Papadakis and Targan 
2000)). A variety of acute and chronic lung diseases have been shown to possess a 
chemokine component and contribute to the initiation and maintenance of lung pathology 
such as asthma (reviewed by (Kunkel et al. 1999) and (Lukacs et al. 1999)).
P-chemokines have been shown to play an important role in the development of 
inflammatory lesions in the central nervous system of patients with multiple sclerosis. 
Banisor et al (Banisor et al. 2005) identified that haplotypes spanning SCYA2, SCYA3 and 
SCYA11-SCYA8-SCYAJ3 were associated with multiple sclerosis, and a distinct regional 
regulation of SCYA2, SCYA7 and SCYA8 expression correlated with chronic 
inflammation in multiple sclerosis brains. They also provide data to support the 
involvement of SCYA2, SCYA7, SCYA8 and SCYA3 in the development of 
inflammatory demyelination. Polymorphisms in SCYA24 and SCYA26, located on
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chromosome 7ql 1.23, have been shown to be associated with ulcerative colitis, one of 
major forms of inflammatory bowel disease in humans, and asthma in the Korea 
population (Chae et al. 2004; Park et al. 2005). Polymorphisms within CCL18, CCL3 and 
CCL4 have been shown to be associated with tuberculosis (Jamieson et al. 2004) however 
no other associations between chemokine genes and intracellular bacterial infections have 
been reported.
6.1.3. Signal transducers and activators of transcription (STAT)
STAT proteins play an important role in cytokine signaling pathways. To date in 
mammals, seven STAT  genes (STAT1, 2, 3, 4, 5A, 5B and 6) exist and are believed to have 
arisen by successive genome duplication and functional divergence from an ancestral 
STAT gene. STAT3, 5A and 5B are clustered on human chromosome 17 with STAT5A and 
5B being very closely related, showing 93.6% sequence homology at the cDNA level 
(Ambrosio et al. 2002). Cytokines binding to their receptors initiates signaling leading to 
tyrosine-phosphorylation of STATs by Janus kinases (JAK). After phosphorylation, 
STAT proteins form homo or heterodimers rapidly translocating to the nucleus and 
inducing expression of several genes (Takeda et al. 1997; Williams 2000). Recent studies 
from mice deficient in several STAT family members have demonstrated that STAT 
proteins play an essential role in cytokine-mediated biological action. Among the 
mammalian STAT proteins, STAT3 plays the most diverse role (Akira 1999).
STAT3 plays a role during early embryogenesis as STAT3-deficient mice die early in 
embryogenesis (Takeda et al. 1997). Functions of STAT3 in anti-apotosis were 
demonstrated when STAT3-deficient T cells displayed a severely impaired proliferative 
response to IL-6 due to a defect in IL-6-mediated suppression of apotosis (Takeda et al. 
1998). Mice with STAT3-deficient macrophages and neutrophils were highly susceptible 
to endotoxin shock and demonstrated increased production of inflammatory cytokines 
such as TNFa, IL-1 and INFy. Production of inflammatory cytokines from STAT3-
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deficient macrophages is dramatically augmented in response to lipopolysaccharide 
(Takeda et al. 1999).
6.1.4. Human chromosome 17qll.2-q22
There is evidence that the region of conserved synteny on mouse chromosome 11/ human 
17qll.2-q22 carries susceptibility genes for intracellular pathogens. This region was 
shown to contain susceptibility genes to cutaneous leishmaniasis in mice (Mock et al. 
1993; Roberts et al. 1993) and to carry genes controlling susceptibility to tuberculosis and 
leprosy in humans (Jamieson et al. 2004). Recently, a microsatellite marker in this region, 
was associated with susceptibility to typhoid fever; the alleles of D17S250 were found to 
be significantly different in typhoid cases and controls (S.J. Dunstan, personal 
communication). The chromosome 17qll.2-q22 region is therefore a good candidate 
region for typhoid fever susceptibility due to 1/ it contains an abundance of relevant 
immune response genes, 2 / this region was associated with intracellular pathogens in 
mouse models, 3/ this region was associated with intracellular bacteria in human studies 
and 4/ preliminary data shows an association between a microsatellite within this region 
and typhoid fever in humans. In this chapter we investigate SNPs in the chromosome 
17ql 1.2-22 region to identify polymorphisms that are associated with typhoid fever in the 
Vietnamese population. Analysis of this genotyping data will allow us to determine which 
gene or genes within this region play a role in susceptibility to, or resistance from typhoid 
fever.
6.2. Results
6.2.1. Whole genome amplification -  preparation of DNA for genotyping
396 typhoid fever cases, 368 cord blood controls and 95 family trios (including typhoid 
fever case and both parents) were used as subjects in this chapter. Subjects have been 
previously described in chapter 2. In total, 1049 genomic DNA samples were prepared
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for w hole genom e am plification to increase the quantity o f  D N A  using the M D A  method 
prior to high throughput genotyping. After M D A am plification the am plified product was 
quantified using PicoGreen. lOng o f  genom ic D N A  o f  each sam ple was used for 
am plification resulting in 1200ng o f  am plified D N A  on average. H ow ever, in 1% o f  
sam ples a low  quantity o f  am plified D N A  was detected, ranging from 10-20ng. The 
quality o f  the am plified D N A  w as assessed  by agarose gel electrophoresis and PCR. 
Figure 6.2a show s that the am plified D N A  from 16 sam ples was over 20kb in size, as 
expected from this technique. The am plified D N A  w as then assessed  to see how  it 
performed as a PCR template. A ll M D A  D N A  sam ples performed adequately in the 
control PCR (figure 6.2b).
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Figure 6.2: Assessing the quality of MDA DNA. (a) Agarose gel containing the products of 
whole genome amplification. The expected size of DNA after MDA amplification was over 
15kb. A 1 kb molecular weight ladder was used (first and last lane), (b) MDA DNA samples 
were used as templates in a control PCR. The expected size of the PCR product was 300bp. 
PCR products were electrophoresed on an agarose gel. A lOObp molecular weight ladder was 
used (first lane).
6.2.2. Power estimation
Power calculations for cases and controls were im plem ented in Excel using calculations
written by Dr Heather Cordell, Cambridge Institue o f  M edical Reasearch, Cam bridge,
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UK. Based on the number of cases and controls, the theoretical power to detect an allelic 
association, assuming a multiplicative model at various odd ratios using markers of 
different allele frequencies, was calculated. The sample size we used in this study was 396 
cases and 368 controls. The power to detect an association for 396 cases and 368 controls 
at three significance levels, P = 0.05, P = 0.01 and P = 0.001 are shown in table 6.1.
In this study, with a sample size of 396 cases and 368 controls, 100% power can detect an 
association if the effect size is large [odds ratio (OR) = 3]. This power does not depend on 
the allele frequency in the population. However, if  the OR = 1 .5  the power is dependent 
on the frequencies of alleles in the population. The higher the allele frequency the more 
power there is to detect an association. With an allelic frequency of 5%, the power is 
highest at 48% giving a significance of R=0.05. This power is reduced to 9% and 26% at 
/M).001, and 0.01, respectively. When the allele frequency increases to 10%, the power 
increased from 24% (R=0.001) to 73% (P=0.05). Thus, power is reduced when either a 
lower effect size (OR<3) or a more stringent level of significance is imposed. Based on 
these conditions, only SNPs with a minor allele frequency of greater than or equal to 10% 
were included in this case control allelic association study. Therefore, we have at least 
73% power to detect an association.
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Table 6.1: Power calculation for 396 cases and 380 controls
M inor
allele
frequency
M ajor
allele
frequency
P value
% Power for 396 Cases/380controls
OR=1.5 OR=2 OR=3
0.5 0.5
0.05 98 100 100
0.01 91 100 100
0.001 74 100 100
0.4 0.6
0.05 98 100 100
0.01 91 100 100
0.001 74 100 100
0.3 0.7
0.05 96 100 100
0.01 88 100 100
0.001 68 100 100
0.2 0.8
0.05 92 100 100
0.01 78 100 100
0.001 53 99 100
0.15 0.85
0.05 86 100 100
0.01 68 100 100
0.001 40 98 100
0.1 0.9
0.05 73 100 100
0.01 51 98 100
0.001 24 89 100
0.05 0.95
0.05 48 92 100
0.01 26 79 100
0.001 9 53 100
6.2.3. SNP selection and genotyping
The chromosome 17qll.2-q22 region was selected for this study with the purpose of
looking for SNP(s) in this cluster of immune response genes which may be associated
with typhoid fever. 37 markers were selected from dbSNP
(http://www.ncbi.nlm.nih.gov/SNP/), which had previously been successfully genotyped
in a Brazilian population (Jamieson et al. 2004). These markers spanned 14 genes CRLF3,
NOS2A, SCYA1, SCYA2, SCYA3, SCYA4, SCYA11, SCYA13, SCYA15, SCYA16,
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SCYA18, SCYA23, STAT3, and THRA1. Initially, genotyping was carried out on a set 
of 368 DNA samples from typhoid fever patients to see whether these markers were 
polymorphic in the Vietnamese population. All SNPs were genotyped using the Invader 
assay. The SNP allele frequencies and failure rates are shown in table 6.2. Seventeen 
SNPs had a minor allele frequency of greater than or equal to 10% and a low failure rate 
(less than 20%). These 17 SNPs were selected (see table 6.2) for further genotyping in 
the complete case/control sample set. Seven markers with a failure rate greater than 20% 
and 13 markers with a minor allele frequency less than 10% (including 8 which were 
monomorphic) were excluded from further genotyping. In summary, only 46% of SNPs 
were validated for further genotyping. Of these 17 SNPs, 4 are in the NOS2A gene, 1 is 
in CREME9, 10 are across the beta chemokine gene cluster and 2 SNPs are in the STAT3 
gene.
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Table 6.2: SNPs genotyped in the chromosome 17q 11.2-q22 region in DNA samples from 368 
typhoid fever patients.
SNP Name rs num ber m inor alelle failure rate selected SNP
N O S 2 A /r s 9 4 4 7 2 4 9 4 4 7 2 4 0.17 1.3
N O S 2 A /r s 9 4 4 7 2 5 9 4 4 7 2 5 0.24 1.6 *
N O S 2 A /r s l 6 9 4 9 16949 0.21 1.3 *
N O S 2 A - 2 7 7 0.18 1.6 *
N O S 2 A - 1 6 5 9 0 .02 1
N O S 2 A - 2 4 7 0 7.8
C R E M E 9 /r s9 9 9 7 9 8 9 9 9 7 9 8 0.11 1.6 *
C R E M E 9 /r s9 9 9 7 9 6 9 9 9 7 9 6 0 100
S C Y A 2 /r s  1 0 2 4 6 1 0 1 0 2 4 6 1 0 0 .09 0.5
S C Y A 1 1 /rs 1 8 6 0 1 8 4 1 8 6 0 1 8 4 0.45 1 *
SC Y A 1  l / r s l 0 1 9 1 09 1 0 1 9 1 0 9 0 .0 9 1.3
S C Y A 1 3 / r s l 5 9 3 1 4 1 5 9 3 1 4 0.1 1.3 *
S C Y A l / r s l 5 9 2 7 0 1592 7 0 0 39.3
S C Y A  l / r s l5 9 2 7 1 159271 0 1
S C Y A l / r s l 5 9 2 7 2 1592 7 2 0 0.5
S C Y A l / r s l 5 9 2 7 3 159273 0 100
S C Y A 1 5 /r s 8 5 4 6 8 4 8 5 4 6 8 4 0.44 1.3 *
S C Y A  15 /r s 7 12048 7 1 2 0 4 8 0.42 1.8 *
S C Y A 1 5 /r s8 5 4 6 2 5 8 5 4 6 2 5 0.38 1.3 *
S C Y A 2 3 /r s  100 3 6 4 5 1003645 0.43 1.8 *
S C Y A 2 3 /r s  1 7 1 9 2 0 4 1 7 1 9 2 0 4 0.36 0.5 *
S C Y A 1 8 /r s 2 0 1 5 0 8 6 2 0 1 5 0 8 6 0.15 1.8 *
S C Y A  1 8 /rs2015 0 7 0 2 0 1 5 0 7 0 0 .09 1
S C Y A  18 /rs2015 0 5 2 2 0 1 5 0 5 2 0 85 .7
S C Y A  18 /rs712043 7 1 2 0 4 3 0.37 1
S C Y A 1 8 / r s l 4 3 0 4 14304 0.32 1.8 *b
S C Y A  18 /rs7 6 6 5 5 5 7 6 6 5 5 5 0 0.5
S C Y A 1 8 /r s 7 6 6 5 5 6 7 6 6 5 5 6 0.03 1.3
S C Y A 3 /r s l8 5 1 5 0 1 1851501 0 0
S C Y A 3 /r s l  7 1 9 1 3 3 1 719133 0 0.3
S C Y A 4 / r s l 6 3 4 5 16 1 6 3 4 5 1 6 0 .0 7 0.5
T H R A  l/rs3471 3471 0 100
T H R A l /r s 9 3 9 3 4 6 9 3 9 3 4 6 0 100
T H R A l /r s 8 6 7 2 7 3 8 6 7 2 7 3 0 1.3
T H R A  1/rs 1467 2 5  8 1467 2 5 8 0 100
S T A T 3 /rs7 4 4 1 6 6 7 4 4 1 6 6 0.48 0.3 *
S T A T 3/rs  1 0 2 6 9 1 6 1 0 2 6 9 1 6 0.48 1.3 *
(*) corresponds to SNPs selected for further genotyping.
(a) indicates which SNPs were excluded from the case/control dataset (see below).
(b) indicates which SNP was excluded from the family data set (see below).
The 17 selected SNPs were genotyped in 368 cord blood control DNA samples. Two 
SNPs completely failed in the cord blood control samples. These two SNPs were then 
excluded from the case/control dataset (see table 6.2). Table 6.3 shows the genotyping 
results for the 15 SNPs.
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6.2.4. H ardy-W einberg Equilibrium  (HWE) test
The genotypes of 15 SNPs from 368 cord blood control samples were tested for HWE in 
an attempt to identify possible genotyping error. This test was carried out using the 
STATA statistical software package. Based on the results of the HWE test, SNPs not 
displaying HWE (i.e. P O .05) were excluded from downstream association analysis. Two 
SNPs (SCYA23/rs 1003645 and SCYA23/rsl719204) were determined to be out of HWE 
(P=0 and P=0.02, respectively) (table 6.4). These two SNPs were excluded from the 
dataset prior to performing association analysis. Thirteen remaining SNPs displaying 
HWE were used for case/control association analysis.
Table 6.4: HW E calculation for 15 SNPs in the chromosome 17q 11.2-q22 region.
SNP name
control samples
HWE 
P  valueMinor allele Major allele
number frequency number frequency
NOS2A/rs944725 154 0.216 560 0.784 0.1494
NOS2A/rs 16949 105 0.145 617 0.855 0.4887
NOS2A-277 87 0.119 643 0.881 0.5549
CREME9/rs999798 70 0.096 660 0.904 0.321
SCYA 1.1/rs 1860184 331 0.457 393 0.543 0.1046
SCYA13/rsl59314 93 0.129 631 0.872 0.3413
SCYA15/rs854684 219 0.400 329 0.600 0.2307
SCYA15/rs712048 215 0.400 323 0.600 0.6042
SCYA15/rs854625 227 0.364 397 0.636 0.4211
SCYA23/rsl 003645 287 0.420 397 0.580 0.0234
SC Y A23/rs 1719204 228 0.491 236 0.509 0
SCYA 18/rs2015086 99 0.136 631 0.864 0.2257
SCYA18/rsl4304 244 0.411 350 0.589 0.9781
STAT3/rs744166 330 0.469 374 0.531 0.8883
STAT3/rs 1026916 340 0.475 376 0.525 0.7872
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6.2.5. Case/control-based association analysis
The association between SNPs in the chromosome 17ql 1.2-q22 region was tested using 
several types of analyses; single-point analysis, 2 loci logistic regression and forward 
stepwise logistic regression. Within single-point analysis (allelic and genotypic logistic 
regression) dominant and recessive models were tested to see which model best fits the 
data. All analyses were implemented within the GenAssoc package (http://www- 
gene.cimr.cam.ac.uk/clayton/software/stata) in STATA version 8.0. The Bonferroni 
correction for multiple testing was also applied for every single point test.
6.2.5.1. Single point logistic regression analysis
The allelic and genotypic logistic regression analysis using the case/control dataset for 
each marker was performed in a single-point manner. The comparison of the genotype- 
wise (2df test) and the allele-wise ( ld f  test) association allows the determination of any 
dominance effects, or deviation from the assumed multiplicative model at the candidate 
loci. The possible allelic and genotypic associations between the selected 15 SNPs and 
typhoid fever were investigated. Genotyping data was recoded into minor and major 
alleles based on the frequency of the SNP alleles in our Vietnamese population.
The allelic and genotypic frequencies compared between case and control groups by 
logistic regression are shown in table 6.5. Two SNPs, NOS2A-227 and N0S2A-rs 16949 
were significantly associated with the disease in the allele-wise analysis (TMl.Oll and 
P - 0.007 respectively; see table 6.5). An OR of 1.4 in both SNPs showed that these 
SNPs may influence susceptibility to disease. The two SNPs were also associated with 
disease genotypically (P=0.02 for both SNPs; see table 6.5).
P values obtained by logistic regression were corrected for multiple testing using the 
Bonferroni test. Following Bonferroni correction no SNPs showed a significant 
association (see Pc in table 6.5).
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Likelihood ratio tests were performed to investigate the allelic and genotypic logistic
regression results further. The likelihood ratio test was performed to see whether the
genotypic model (2df model) is a significantly better model than the allelic model ( ld f
model). If the 2df test is a better fit then we have significant evidence that the genotypic
model is a better explanation than a general multiplicative model (allelic model). All P
values in the likelihood ratio tests are greater than 0.05 (table 6.5). The results of this
test suggest that the allelic model is a better fit of the data than the 2df genotypic model.
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6.2.5.2.Dominant and recessive effect of minor allele on the disease
Dominant and recessive analyses were performed to see the degree of the effect that the 
minor allele of each SNP had on disease. The dominant genotypic comparison was 
performed by comparing the number of individuals in the population who have either 1 
or 2 copies of the minor allele, with individuals who have no copies of the minor allele. 
The recessive genotypic comparison was performed by comparing the number of 
individuals who have 2 copies of the minor allele with individuals who have 1 or two 
copies of the major allele. Results showed that individuals with one or two copies of the 
minor alleles of SNPs NOS2A-rs 16949 and NOS2A-277 have a disease risk of 1.4 [SNP 
NOS2A-rsl6949 (OR=1.4, 95%CI 1.05-2.00, P=0.02); SNP NOS2A-277 (OR=1.4, 
95%CI 1.01-2.00, R=0.03)] (table 6 .6). A higher disease risk was seen in individuals that 
have two copies of the minor alleles of these two SNPs [SNP NOS2A-rsl6949 (OR=2.5, 
95%CI 0.92-7.95, P=0.05); SNP NOS2A-277 (OR=3.3, 95%CI 1.03-14.02, P=0.03)] 
(table 6 .6).
Table 6 .6 : Single point genotype-wise association analysis of case/control dataset
SNP name
Dominant (22+12/11) Recessive (22/12+11)
O R 95%  C l X 2 1 d f P  value O R 95%  C l X 2 1 d f P  value
NOS2A/rs 16949 1.4 1.05-2.00 5.5 0.02 2.5 0.92-7.92 3.86 0.05
NOS2A-277 1.4 1.01-2.00 4.49 0.03 3.3 1.03-14.02 4.97 0.03
6.2.6. Two-locus logistic regression modeling
The single point analysis showed that the allele wise logistic regression was the model 
that best fit the data. Based on uncorrected allele wise logistic regression two SNPs 
NOS2A-rs 14969 and NOS2A-227 were significantly associated with the disease 
(.P<0.05). Next, two locus logistic regression was performed to see whether the effects of
220
these two associated SNPs were independent effects or not. Two tests can be performed 
within two locus logistic regression, Intralocus test is performed within the associated 
SNPs, and Interlocus test is performed between the most associated SNPs and other 
SNPs in the genomic region.
Two tests can be performed within Intralocus test of which the results complement each 
other, (1) adding another SNP to the logistic regression model containing the SNP of 
interest and (2) adding the SNP of interest to the logistic regression model containing 
another SNP. When performing Intralocus test, the null hypothesis was that the SNP of 
interest is associated with the disease, and the alternative hypothesis was that both SNPs 
are associated with the disease.
Interlocus test also can be performed in two tests, (1) adding another SNP to the logistic 
regression model containing the SNP of interest and (2) adding the SNP of interest to the 
logistic regression model containing another SNP. When performing Interlocus test (1), 
the null hypothesis is that the other SNP is not associated with the disease, and the 
alternative hypothesis is that both SNPs are associated with the disease. When 
performing Interlocus test (2), the null hypothesis is that the SNP of interest was 
associated with the disease, and the alternal hypothesis was that both SNPs are 
associated with the disease.
6.2.6.1.Two locus logistic regression with associated SNPs (NOS2A-227 and 
NOS2A/rsl6949) (intralocus test)
NOS2A-277 was added to a logistic regression model containing NOS2A/rs 16949 and 
conversely NOS2A/rsl6949 was added to a logistic regression model containing SNP 
NOS2A-227. These tests were performed to determine whether the association with
221
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disease was due to a combination of these two SNPs or whether the associations of
NOS2A-227 and NOS2A/rsl6949 with disease were independent of each other.
The results showed that there was no significant difference between the disease 
association of both individual SNPs alone and the disease association of the two SNPs 
combined (allele wise; 7M1.134 and P=0.229, see in table 6.7). This means that these 
two disease associated SNPs are not independent of each other, as they both do not add 
any significant effect when combined with the other in either of the two locus tests. This 
suggests they are both markers of the one disease loci.
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6.2.6.2.Two locus logistic regression between NOS2A/rsl6949 and other SNPs 
(interlocus test)
The results of the intra-locus test showed that two SNPs (NOS2A/rs 16949 and NOS2A- 
277) were not independently associated with disease. Therefore we selected the most 
significantly associated SNP in the single point logistic regression analysis, 
NOS2A/rs 16949 (see table 6.5) to perform an interlocus (or between loci) test. This test 
was performed similarly to the intralocus test, but in this case the test was carried out 
between NOS2A/rsl6949 and other SNPs in the region.
Each other locus was added to a logistic regression model containing NOS2A/rs 16949 
and NOS2A/rs 16949 were added to a logistic regression model containing each other 
locus. This was performed to determine whether the association with disease was due to a 
combination of two SNPs, or whether the associations of NOS2A/rs 16949 and each other 
locus with disease were independent of each other.
When NOS2A/rs944725 was added into the logistic regression model containing 
NOS2A/rs 16949, and this combined model was compared with the model containing only 
NOS2A/rsl6949, there was no significant difference between the two models (genotype 
wise P=0.801, allele wise P - 0.52, table 6 .8). This suggests that NOS2A/rs944725 does 
not contribute any added effect to the disease association of NOS2A/rs 16949. When the 
reverse analysis was performed, i.e. NOS2A/rsl6949 was added into the logistic 
regression model containing NOS2A/rs944725, and this combined model was compared 
with the model containing only NOS2A/rs944725, there was a significant difference 
between the two models (genotype wise P=0.033, allele wise / >=0.011, table 6 .8). This 
suggests that NOS2A/rs 16949 does contribute an added effect to the association of 
NOS2A/rs944725. The same pattern of results was observed with all other loci combined 
with NOS2A/rsl6949 (table 6 .8). These results suggest that NOS2A/rsl6949 is 
associated with disease independently from SNPs at other loci in the region.
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6.2.7. Linkage Disequilibrium (LD) between SNPs in the chromosome 17qll.2-q22  
region
As the associations of NOS2A-277 and NOS2A/rs 16949 with disease are not 
independent, we investigated the level of LD between the two SNPs and also between 
others SNPs in the region. To determine the level of LD between SNPs in the region, the 
data obtained from genotyping family trios (case and both parents) was used to estimate 
LD. The parental genotypes were actually used for LD estimation, with genotype data 
from affected children used to double check the parental genotypes.
Due to the size of this genomic region the level of LD was very low across most markers 
(data not shown). However the level of LD between NOS2A-227 and NOS2A/rs 16949 
was high (D,==0.72). The high LD between these two SNPs supports the hypothesis that 
the associations of these SNPs and disease are not independent of each other, and both 
SNPs are just markers of the one disease signal.
6.2.8. Family-based association analysis- Transmission Disequilibrium test (TDT)
With the aim of confirming the association observed between SNPs in the chromosome 
17q 11.2 -q22 region and typhoid fever, we performed a familial genetic association study. 
Ninety-five family trios, which contained an affected child and both parents were 
genotyped for 17 SNPs using the Invader method. One SNP (SCYA18/rsl4304) was 
excluded from analysis due to a genotyping failure rate of >50% (table 6.2). Genotyping 
data for 16 SNPs in 95 family trios was therefore available for analysis.
Allele-wise TDT analysis was carried out in STATA version 8.0. Genotyping data for 16
SNPs in 95 family trios was checked for pedigree transmission between parents and
offspring (table 6.9). Families exhibiting a genotyping error or families with incomplete
parental genotypes were excluded. Only datasets from complete family trios with
226
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informative transmissions (both parents are heterozygous for the SNP) are valid for TDT 
analysis. The number of typhoid fever cases with full parental genotypes, the genotyping 
error and the number of families with informative transmissions are listed in table 6 .8 .
Table 6.9: Family-based allelic association testing using the TDT for the chromosome 17q 11.2- 
q22 SNPs
SNP name Cases error
Informative
transmission x2 ld f
P
NOS2A/rs944724 95 3 44 2.27 0.132
NOS2A/rs944725 82 1 49 0.02 0.886
NOS2A/rs 16949 95 4 59 0.424 0.515
NOS2A-277 94 1 49 0.02 0.886
CREME9/rs999798 94 2 21 0.047 0.827
SC Y A ll/rs 1860184 91 2 79 1.025 0.311
SCYA13/rsl59314 94 0 33 0.272 0.601
SCYA15/rs854684 48 0 38 0.421 0.516
SCYA15/rs712048 92 5 82 1.756 0.185
SCYA15/rs854625 87 1 55 1.472 0.225
SCYA23/rs 1003645 93 1 87 0.287 0.592
SCYA23/rs 1719204 74 16 17 4.765 0.03
SCYA18/rs2015086 94 1 46 0 1
SCYA18/rs712043 95 0 80 3.2 0.073
STAT3/rs744166 94 1 83 0.012 0.912
STAT3/rs 1026916 95 0 81 0.308 0.578
For 12/16 SNPs, more than 95% (>90/95) of cases have both parental genotypes. For 3/16 
SNPs, 78-91% (74 -  87/95 cases) of cases have both parental genotypes. For the 
remaining SNP (SCYA15/rs854684) only 50% (48/95 cases) of cases have a genotype for 
both parents. Genotyping error occurred at a low rate (<5%) within the genotyped trios 
except for SNP SCYA23/rsl719204 which had a genotyping error rate of 21.6% (error in 
16/74 trios) (table 6.9). The numbers of informative transmissions within the valid trios 
were checked and 5 SNPs (SCYA1 l/rsl860184, SCYA15/rs712048, SCYA18/rs712043,
227
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STAT3/rs744166 and STAT3/rs 1026916) displayed a high number of informative 
transmissions (79 to 87). Eight SNPs (NOS2A/rs944724, NOS2A/rs944725, 
NOS2A/rs 16949, NOS2A-277, SCYA13/rsl59314, SCYA15/rs854684,
SCYA15/rs854625, SCYA18/rs2015086) displayed informative transmissions in 33 to 59 
families (table 6.9). The number of informative transmissions was very low for two SNPs 
(CREME9/rs999798, SCYA23/rsl719204) displaying 21 and 17 transmissions out of 94 
and 74 complete family trios, respectively. The TDT results (table 6.9) showed that one 
SNP SCYA23/rsl719204, was associated with typhoid fever at a significance of P=0.03. 
A second SNP, SCYA18/rs712043 showed borderline significance atP=0.073.
6.3. Discussion
Several regions of the human genome contain clusters of immune response genes such as 
the HLA region on chromosome 6 and the chromosome 5q23-q33 region which contains a 
cluster of several cytokine genes. Likewise, chromosome 17ql 1.2-q22 contains clusters of 
genes which play an important role in the immune system. Originally this genomic region 
was highlighted by the analysis of congenic mouse strains where progressive refinement 
of the congenic interval identified multiple genes contributing to regions of linkage with 
cutaneous leishmaniasis (Mock et al. 1993; Roberts et al. 1993). In humans, it is more 
difficult to demonstrate this as definitively as in mice, but there is evidence that the 
chromosome 17ql 1.2-q22 region is associated with leprosy and tuberculosis (Jamieson et 
al. 2004). Salmonella occupies a similar intracellular niche as Mycobacterium and as 
such there may be some overlap in the immune response mechanisms invoked by 
Mycobacterium spp. and Salmonella spp. in host cells. It is therefore possible that the 
same genetic factors may be responsible for this overlap. A previous study (S.J. Dunstan, 
personal communication) showed an association between a microsatellite marker in the 
chromosome 17qll.2-q22 region with typhoid fever. The combined evidence o f the 
chromosome 17qll.2-q22 region being associated with tuberculosis, leprosy and
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potentially typhoid fever encouraged us to pursue this region in further genetic studies of 
typhoid fever.
The SNPs in the chromosome 17qll.2-q22 region to be used in our case control genetic 
association study of typhoid were initially selected based on their power to detect a 
disease association in our sample set. The power of each SNP to detect an association 
was estimated for our sample size of 396 cases and 368 controls and 15 SNPs with a 
minor allele frequency of >10% in the Vietnamese population were selected. With an 
allelic frequency of >10% there is >73% power to detect a small disease effect. The 
median frequency of all 15 SNPs is 40% (IQR of 11-48%) and 50% (8/15) of these SNPs 
have frequencies higher than 40%. Therefore with our samples size and an allelic 
frequency of 40% we have 98% power to detect a small (OR=1.5, P=0.05) correlation in 
an association study. When detecting an association between a genetic variant and an 
infectious disease it is important to have enough power to detect a small effect. Infectious 
diseases are genetically complex diseases and as such it would be expected that multiple 
genes with small or moderate effects in combination would contribute to the overall 
genetic susceptibility of an individual to disease. Genotyping failure rate is also a factor 
which needs to be considered when selecting appropriate SNPs, and in this study a 20% 
failure rate was the accepted maximum. SNPs with higher genotyping failure rates were 
excluded to avoid the potential incorrect calling of alleles leading to inaccurate allele 
frequencies. The HWE test was also performed to further check the presence of 
genotyping errors. The HWE calculations of all 15 selected SNPs displayed a P  value 
>0.05, providing evidence that the genotyping data for all 15 SNPs was valid for further 
analyses. From the case/control genetic analysis 2 SNPs in the chromosome 17ql 1.2-q22 
region within the NOS2A gene, NOS2A-277 and NOS2A/rs 16949, were associated with 
typhoid fever, and individuals harbouring these SNPs had an increased risk of typhoid 
fever (ORs=T.45 and 1.46, respectively).
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Confirming disease associations identified by case/control association analysis using 
familial association testing adds an extra level of stringency to any genetic association 
study. A positive genetic association identified in a case/control association study can 
occur because (1) the marker allele is the disease causing allele (functional 
polymorphism), (2 ) the marker allele is in linkage disequilibrium with the disease causing 
allele or (3) the association is an artifact of population stratification and ethnic admixture. 
The advantages of performing familial association tests to reduce the effect o f population 
stratification in association studies have been demonstrated (reviewed by (Cardon and 
Bell 2001)). The transmission disequilibrium test (TDT) using case/mother/father trios 
focuses on heterozygous parental genotypes, thereby providing a joint test of linkage and 
association that eliminates the effects of population stratification.
We performed TDT analysis for 95 family trios which contained an affected offspring and 
both parents. The 2 associated NOS2A SNPs identified by the case/control genetic 
analysis were not confirmed by TDT. TDT identified 2 other SNPs (SCYA23/rsl719204, 
SCYA18/rs712043) that were associated with the disease. One reason why the familial 
analysis was unable to confirm the NOS2A SNP associations may be because of the small 
size of the family sample set. The number of valid families was small at <95 trios, with 
the number of informative transmissions being considerably less than this for all SNPs. 
Therefore this sample set was underpowered to detect a genetic association. For example, 
with a sample size of 52 validated trios (the median sample size for the 16 SNPs 
genotyped here) and an allele frequency of 22.5% (the median allele frequency of the 16 
SNPs) the maximum power to detect an association was only 20%. The requirement of a 
large sample size in family-based association studies has been demonstrated to enable 
enough power to detect an association (Morton and Collins 1998). The fact that the 
family sample set used here is so underpowered could account for the lack of 
confirmation of the NOS2A SNP associations identified in the sufficiently powered
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case/control dataset. The SNPs that showed an association with the disease in familial 
analysis may have just occurred by chance and a larger sample set of case/mother/father 
trios would be needed to establish whether these associations are real or not. To improve 
the power of the Vietnamese typhoid family sample sets the samples numbers would need 
to be expanded by 350 families to enable 85% power. The collection of further cases and 
parents is necessary to enable valid familial genetic association studies in the future.
Although the chromosome 17qll.2-q22 region has a large number of candidate immune 
response genes, only evidence to support a role of the NOS2A gene was identified in this 
study. The NOS2A gene has been previously demonstrated to contribute a main effect to 
allelic associations with leprosy and tuberculosis (Jamieson et al. 2004). In our study, 
NOS2A may also contribute a main effect to the allelic association identified with typhoid 
fever in the Vietnamese population as demonstrated by forward step wise logistic 
regression (intra and interlocus). The results of the NOS2A intra locus test indicated that 
the associations of NOS2A-227 and NOS2A/rs 16949 are not independent of each other, 
or they are not contributing separate effects to the association observed. These SNPs have 
a similar level of relative risk (OR 1.45 and 1.46), which increases from 1.4 to 3.3 fold 
when an individual is homozygous for the mutant alleles of these SNPs. In addition, 
there is a high level of LD between these two SNPs in the Vietnamese population. Thus, 
the logistic regression results, similar levels of relative risk and the high level o f LD 
between these two NOS2A SNPs suggest that these two SNPs are both effective markers 
for the one associated disease loci. No other SNPs genotyped within the chromosome 
17ql 1.2-q22 region were associated with typhoid fever. This could mean two things (1) 
that NOS2A may be the only gene important for typhoid fever in the chromosome 
17qll.2-q22 region or (2) the number of SNPs screened across the very large 
chromosomal region was too sparse and any other disease associations were missed. If
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there are any other important genes for typhoid fever within this region they may only be 
detected by genotyping a much larger number of SNPs across this region.
iNOS plays an important role in resistance to Salmonella infection as it has been shown to 
control the multiplication of Salmonella at later stages of infection in the murine model 
(Mastroeni et al. 2000b). Witthoft et al (Witthoft et al. 1998)demonstrated that the 
expression of iNOS in human colon epithelial cells is increased following infection with 
Salmonella in vitro and studies by Salzman et al (Salzman et al. 1998)showed that iNOS 
expression in vitro is more effective against Salmonella infection in the presence of INF-y. 
Conversely, the harmful effects of NO such as neurotoxicity, reperfusion injury and severe 
hypotension during endotoxic shock have also been shown (reviewed by (Michel and 
Feron 1997) and (Nathan 1997)). However, the role of iNOS in the ability of 
macrophages to inhibit or kill Salmonella has been somewhat less clear (Shiloh et al. 
1999).
Variation in NOS2A regulatory regions may alter iNOS expression and may affect host 
defence. Increasing production of NO has been found to correlate with a better clinical 
outcome in children with falciparum malaria (Anstey et al. 1996). It has been reported that 
mutations in the NOS2A regulatory region, NOS2A-954 and NOS2A-1175, are associated 
with protection against malaria and this is related to increasing levels of NO production 
(Hobbs et al. 2002; Kun et al. 2001). In vivo studies showed that NOS2A-1175 was 
associated with increased fasting urine and plasma NO metabolite concentrations (Hobbs 
et al. 2002). Ex vivo studies showed that cells isolated from people with mutation 
NOS2A-954 have a 7 fold higher baseline NOS activity compared with the levels detected 
in cells from subjects with the wild type gene (Kun et al. 2001). On the molecular level, 
Kun et al (Kun et al. 2001) also found a DNA protein which may be an activator of 
NOS2A gene expression. This protein binds to the polymorphic site (NOS2A-954) with a
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higher affinity than to the wild type sequence, leading to a higher baseline level of NOS 
activity. In summary there is evidence that mutations in the promoter region of NOS2A 
can result in higher production levels of NO.
At least 7 SNPs in the NOS2A promoter region including NOS2A-277 (the SNP 
associated in our typhoid study) and the 2 functional regulatory SNPs (NOS2A-954 and 
NOS2A-1175) have been shown to be in extremely strong linkage disequilibrium in the 
Gambian population (Burgner et al. 2003b). Burgner et al (Burgner et al. 2003b) showed 
that SNP NOS2A-277 is one of the SNPs in the haplotype uniquely defined by SNP 
NOS2A-1659. This haplotype, which also contains the 2 regulatory SNPs (NOS2A-954 
and NOS2A-1175) is associated with cerebral malaria in the Gambia (Burgner et al. 
2003b). In addition, in a Ghanaian population, the 2 regulatory SNPs (NOS2A-954 and 
NOS2A-1175) are in LD with alleles of the CCTTT(n) NOS2A promoter microsatellite, 
CCTTT(g) and CCTTT(i3); respectively. The haplotypes of these two SNPs with the 
microsatellite CCTTT(n) alleles are associated with malaria. The haplotype containing 
NOS2A-954 and CCTTT(g) protected against hyperparasitaemia whereas the haplotype 
containing NOS2A-1175 and CCTTT(i3) increased fatality (Cramer et al. 2004). NOS2A- 
277, one of the SNPs associated with typhoid fever in our study, has also been found to be 
in high LD with two SNPs, NOS2A-2447 and NOS2A-1026, which are associated with 
tuberculosis in a Brazilian population (Jamieson et al. 2004). The NOS2A-1026G allele 
increased the risk of tuberculosis 3.25 fold compared to the NOS2A-1026T allele. In 
Brazil it is unknown whether NOS2A-277 is in LD with the two functional regulatory 
SNPs (NOS2A-954 and NOS2A-1175) as they were not examined in this study.
In our study we have not defined the haplotypic structure o f this region in the Vietnamese 
population. However, NOS2A-277 has been shown to be in high LD with other SNPs in 
the NOS2A promoter region in at least two populations (Brazilian and Gambia) (Burgner
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et al. 2003a; Jamieson et al. 2004). It is possible that NOS2A-277 may also retain some 
LD with these two functional regulatory SNPs (NOS2A-954 and NOS2A-1175) in the 
Vietnamese population, and these SNPs may be responsible for the association of 
NOS2A-277 with typhoid fever. Besides the associated NOS2A promoter SNPs (NOS2A- 
227) and SNP NOS2A-2447, which was monomorphic in the Vietnamese population, no 
other NOS2A promoter SNPs were typed in the Vietnamese population. To fully 
understand the association between SNPs in the NOS2A promoter region and typhoid 
fever it is necessary to genotype more SNPs of sufficient frequency in the Vietnamese 
population and perform haplotype analysis. The 2 functional regulatory SNPs, NOS2A- 
954 and NOS2A-1175, have a low frequency in the Gambian population (6-7%) (Burgner 
et al. 2003a) but they have a high frequency in Han Chinese 37% and 22%, respectively 
(from HapMap project). However, SNP NOS2A-954 has very low frequencies in the 
South East Asian Thai and Papua New Guinean populations (2% and 4%, respectively) 
(Kun et al. 2001). NOS2A-1026, which is associated with tuberculosis and displays a 
high level of LD with NOS2A-227, has a frequency of 28% in Brazilians (Jamieson et al. 
2004) as well as in the Han Chinese (HapMap project). These SNPs could be genotyped 
in our population for further investigation of the role of NOS2A in typhoid fever.
Besides NOS2A promoter region SNPs, other candidate SNPs, particularly non- 
synonymous mutations in the coding region of the gene should also be investigated. Non- 
synonymous coding region SNPs have the potential to effect the structure and function of 
iNOS. Two non-synonymous mutations in NOS2A, rs3730017 and rs2297518, with high 
frequencies in the Han Chinese (14.3% and 23.6%, respectively) which also display high 
levels of LD with NOS2A-227 and NOS2A-954 would be appropriate candidate SNPs 
(HapMap project). By focusing future association studies of this genomic region on 
appropriately chosen candidate SNPs from NOS2A we hope to gain further evidence to 
demonstrate the importance of NOS2A in human typhoid fever.
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By typing more SNPs in NOS2A we will be able analyse the correlation between NOS2A 
with typhoid fever in the Vietnamese population using a haplotype-based approach. The 
haplotype structure of the SNPs within NOS2A will be constructed and then the 
association between haplotypes of NOS2A SNPs will be investigated. By using a 
haplotypic approach we may overcome the problems associated with doing multiple 
statistic tests on single SNPs. In our study, when we performed Bonferroni correction for 
multiple testing, all corrected P values for the SNPs were not significant (table 6.5). As I 
discussed in chapter 4, the haplotypic approach offers an advantage in genetic association 
analysis by overcoming the limitations of multiple single-point statistical tests. By 
increasing the amount of SNP genotyping data across NOS2A, and performing haplotype 
based analaysis, we may be in a better position to determine the causative disease loci.
This human genetics study has highlighted the relationship between NOS2A and typhoid 
fever and in light of this it would be beneficial to investigate the biological role of iNOS 
in typhoid fever. There are a number of approaches that involve combining genetic 
findings with functional studies once the causative mutation is identified. As all o f the 
typhoid patients in our genetic studies are part of larger clinical trials there is an 
abundance of clinical data where one could investigate the contribution of the NOS2A 
genotype on the clinical outcome of the patient. Another approach may be to investigate 
the expression of iNOS in cells from individuals harbouring the causative NOS2A 
mutation. This could be achieved by measuring NOS2A mRNA levels or measuring the 
production of NO from Salmonella stimulated cells. The precise nature of functional 
studies that could be performed in the future can be determined after further genotyping 
studies provide sufficient evidence to identify the NOS2A disease causing mutation.
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7. Concluding remarks
Concluding remarks
Several clinical and epidemiological studies have successfully identified a number of risk 
factors and routes of transmission associated with typhoid fever. However, the 
attributable risk of these factors to the actual development of disease in the individual may 
be limited because neither the variation in challenging dose or virulence of the bacterial 
clones, specific host characteristics, nor their interactions were taken into consideration. 
Host genetic factors presumably plays an important role in the defence against bacterial 
invasion as individuals with similar environmental exposure to a pathogen do not all get 
disease i.e. resistance to infection varies amongst individuals (reviewed by (Cooke and 
Hill 2001)).
One way to study the differences seen in innate disease resistance in a population is by 
genetic association studies which seeks to identify the association between host genotypes 
and the disease phenotype. Genetic association studies can lead to a greater 
understanding of the host’s immune response to pathogen infection potentially resulting in 
the design of novel therapeutics in the future. However, appropriate design of these 
studies is crucial if genetic association studies of infectious disease resistance are to yield 
convincing results (according to (Kwiatkowski 2005)).
When a host is invaded by an infectious pathogen, the first task is to recognize the invader 
and the second task is to kill or control it. This includes functions of both the innate 
immune and acquired immune systems. Studies in animals and humans suggest that the 
activation process or pathway of the host immune system involves complex networking of 
several molecules. It involves pathogen receptors, signaling molecules, cytokines and 
specialized cells which have an important role in human susceptibility to a variety of 
diseases. Defects in specific components of the innate immune system or acquired
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immune system have provided many clues to the complex immunological mechanisms 
underlying resistance or susceptibility to infection.
One important component o f the immune system is the pathogen receptor, the first point 
o f pathogen recognition leading to the activation o f host immunity. Recognition o f S. 
typhi within the host is an essential step that initiates the immune response to typhoid 
fever. TLR4 is an essential molecule for recognition o f S. typhi. Evidence that common 
variants o f TLR4 change its protein function in the immune system have been 
demonstrated (Arbour et al. 2000) but no evidence exists that mutations in the human 
TLR4 gene influences the efficacy o f  the host immune response to typhoid fever. It is 
possible that variation in the coding region o f genes may result in changes to protein 
function leading to the activation o f a suboptimal innate immune response against 
invading organisms. An example o f this is a mutation in the extracellular domain of 
TLR5, TLR5 , which has been shown to be unable to mediate flagellin signaling. 
This mutation is associated with susceptibility to pneumonia caused by Legionella  
pneumophila  (Hawn et al. 2003) possibly due to the inability o f these mutants to activate 
an optimal innate immune repsonse. In our study, a rare mutation in the coding region o f 
TLR4 (Ser73Arg) was associated with typhoid fever in the Vietnamese population. 
Although our study, like some other TLR4 genetic studies (Hawn et al. 2005; Smirnova et 
al. 2001) did not detect many common polymorphisms in TLR4, it is still possible that 
these rare mutations identified may contribute to susceptibility to typhoid fever. Although 
we found these mutations to be rare, it is interesting, although we cannot conclude 
categorically, that they are involved in diseases susceptibility as they only appeared in the 
typhoid case group. Potentially the rare mutations in the coding region o f  the gene, 
predominantly the extracellular domain, may alter the function o f TLR4, and may 
influence human susceptibility to infection. The five non-synonymous TLR4 mutations
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identified in our study may affect the immune response activated against bacterial 
invasion by altering the receptor recognition o f S. typhi.
Three other mutations identified in the upstream region o f TLR4 may also contribute to 
typhoid fever susceptibility if  they disrupt the transcriptional regulation o f the gene. 
Through binding o f specific transcription factors, gene promoters are directly involved in 
gene transcription initiation and regulation. Thus sequence variation in the gene promoter 
may alter transcription factor identification and binding, which in turn can influence gene 
expression potentially leading to a biological impact. Polymorphisms in the promoter 
regions o f immune genes have been prominent in genetic association studies o f human 
infectious disease (Koch et al. 2002; McGuire et al. 1994; Shin et al. 2000). Genetic 
variants in the promoter region o f a gene have been shown to be associated with disease 
phenotypes or changing gene expression. Heterozygotes for the IFNGR1-56 
polymorphism in the promoter region o f IFNGR1 were protected against cerebral malaria 
and against death resulting from cerebral malaria (Koch et al. 2002). The -1 7 4  G —>C 
SNP in the promoter region o f the IL-6 gene contributes to the reduction o f ex vivo 
endotoxin-stimulated IL-6 release (Rivera-Chavez et al. 2003). The promoter region o f 
NOS2A controls transcription o f iNOS. Deletion o f a repressor region in the proximal 
promoter o f NOS2A increases cytokine-stimulated transcriptional activation almost two 
fold compared with the full length promoter (Pance et al. 2002).
The genetic association study presented here was not sufficiently powered to clarify the 
role o f TLR4 variants in typhoid fever susceptibility. This was due to the very low 
frequency o f the mutations in our study population and the sample size used here was 
therefore inadequate. However, TLR4 is a major pathogen recognition receptor, 
particularly important in the recognition o f the LPS o f Salmonella when this pathogen 
infects the host (Huber et al. 2006; Muroi and Tanamoto 2002; Poltorak et al. 1998a;
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Ulevitch and Tobias 1995). An imbalance in signaling caused by a defective TLR4 may 
pose a problem for host cell defence against intracellular bacteria such as S. typhi. This 
may lead to an inappropriate level or change in the type o f cytokine secreted resulting in 
an ineffective innate or acquired immune response.
Cytokines are key immune regulators o f the host response to infection by controlling the 
inflammatory reaction which is an essential component o f the defense mechanism. 
Cytokines are intimately involved in both the innate and adaptive immune responses 
against bacterial infections. Mice with deletions in cytokine or cytokine receptor genes 
usually have defects in bacterial clearance (reviewed by (van Deventer 2000)). The 
major importance o f these immunomodulatary proteins in the pathogenesis and outcome 
o f infectious diseases has been clearly demonstrated. In humans, there is increasing 
evidence that the host's cytokine response is genetically determined and that the genetic 
variability o f cytokines underlies the complexity o f inter-individual differences in the 
immune response to microorganism invasion. Pro-inflammatory cytokine polymorphisms 
have been associated with the course o f severe infections such as cerebral malaria (Knight 
et al. 1999; McGuire et al. 1999), malaria (Walley et al. 2004), leishmaniasis (Cabrera et 
al. 1995), leprosy (Moraes et al. 2004), meningococcal disease (Nadel et al. 1996; Read 
et al. 2000) , hepatic schistosomiasis (Chevillard et al. 2003), septic shock (Barber et al. 
2004; Calandra et al. 1990), and severe acute respiratory syndrome (SARS) (Chong et al. 
2006). In addition, cytokines are essential for the host response against Salmonella  as 
they regulate immune cells and molecules, such as nitric oxide (NO) that contribute to the 
host immune response (Everest et al. 1998; Fang 1997; Mastroeni et al. 1998). A greater 
understanding o f the genetic factors that influence mortality and morbidity o f infectious 
diseases will permit identification o f genomic markers which may in the future be used 
for risk stratification o f patients targeted for novel immunomodulatory treatments.
240
Potentially enabling clinicians to select the most appropriate treatment options for their 
patients.
Molecular variation in the genes encoding cytokine molecules may lead to an ineffective 
immune response against the pathogen. There is evidence that a SNP in the TNFA 
promoter at position -308 is correlated with ex vivo T N F-a production capacity in 
response to LPS stimulation (Louis et al. 1998). This mutation is associated with 
susceptibility to severe malaria (Wattavidanage et al. 1999), leishmaniasis (Cabrera et al. 
1995), scarring trachoma (Conway et al. 1997) and lepromatous leprosy (Roy et al. 1997). 
The haplotypes o f SNPs across several immunity genes situated in the TNFA region, 
particularly SNPs across three genes BATJ , LTA and TNFA were shown to be associated 
with typhoid fever in this study. All three genes, or haplotypes spanning these genes, 
have been associated with a variety o f infectious and inflammatory diseases (Cabrera et 
al. 1995; Knight et al. 1999; Migita et al. 2005; Moffatt and Cookson 1997; Zeggini et al. 
2002), and functional variation o f these proteins could potentially affect the 
appropriateness o f an immune response.
Although the function o f BAT1 is not clear, there is evidence o f a correlation between 
BAT1 and the down regulation of acute phase cytokine production. Thus molecular 
defects in BATJ may affect the process o f cytokine production. (Allcock et al. 2001). 
Genetic variations in LTA and TNFA may result in deleterious changes to TNF-P (also 
known as LT-a) and TN F-a expression affecting the ability o f  host cells to effectively 
fight against the pathogen. Polymorphisms in these cytokines genes were strongly 
associated with typhoid fever. Typhoid patients possessing the protective haplotype 
*12122*1111, which was identified in this study, produced less ex vivo T N F -a than 
patients without this haplotype. This preliminary functional study suggests that the 
protective haplotype suppresses the pyrogenic T N F-a response to S', typhi. Perhaps lower
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expression o f TN F-a is beneficial to typhoid patients. In some diseases over expression 
o f TN F-a can lead to a worse clinical outcome.
Cytokines such as INF-y and TN F-a promote the activation o f macrophages which can 
lead to the killing o f intracellular pathogens. One molecule involved in the respiratory 
burst o f macrophages is iNOS. It is known that cytokines activate the transcriptional 
regulation o f the human NOS2A gene (de Vera et al. 1996) and a cytokine mix containing 
IL-12, IFN-y and TN F-a induces iNOS expression in response to Salmonella  infection. 
Activation o f iNOS leads to the production o f the antimicrobial molecule (NO) which has 
been shown to play an important role in the inhibition or killing o f intracellular 
Salmonella (Everest et al. 1998; Fang 1997; Mastroeni et al. 1998). Genetic defects in the 
NOS2A gene encoding iNOS, may lead to reduced NO production, detrimentally effecting 
the ability o f host cells to control intracellular bacteria. Conversely, variants o f NOS2A 
may also lead to increased NO production resulting in harmful effects such as 
neurotoxicity, reperfusion injury and severe hypotension as this has been reported to occur 
during endotoxic shock (reviewed by (Michel and Feron 1997) and (Nathan 1997)). The 
polymorphisms in the promoter region o f NOS2A, NOS2A-G-954C  and NO S2A-C-1173T 
cause an increase in ex vivo NO production, and these polymorphisms where associated 
with protection against malaria (Hobbs et al. 2002; Kun et al. 2001).
Two polymorphisms within and near NOS2A {NOS2AIrsl6949 and NOS2A-211) were 
strongly associated with typhoid fever in my study. These SNPs are potentially correlated 
with the functional SNPs, NOS2A-954 and NOS2A-X173, as in some populations these 
sets o f SNPs exhibit high LD. NOS2A-954 and NOS2A-W 15  have been shown to be 
associated with increased NO production in vitro and in vivo (Hobbs et al. 2002; Kun et 
al. 2001). This suggests that the two associated SNPs in this study may also correlate with
changes in expression o f iNOS by altering transcriptional regulation o f  the gene.
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Currently this remains unknown and further genetic association studies o f a larger number 
o f NOS2A polymorphisms needs to be undertaken in addition to iNOS functional studies 
in response to Salmonella infection.
Identifying gene variations that are associated with typhoid fever contributes to our 
understanding o f the host genetic factors involved in human typhoid fever. However, it 
has become apparent in recent years that genetic association studies have limitations in 
their ability to definitively unravel the causality between associated genetic variants and 
disease. Several common errors encountered in the implementation o f association studies 
o f complex diseases have been identified, such as small sample sizes, subgroup analysis 
and multiple testing, random error, poorly matched control groups, failure to attempt 
study replication, failure to detect linkage disequilibrium with adjacent loci, over­
interpretation o f results, positive association publication bias and unwarranted candidate 
gene declaration after identifying an association in an arbitrary genetic region (Cardon 
and Bell 2001). Recently, geneticists are moving towards a new generation o f host 
genetics studies, and one example o f this is the use o f haplotypic studies.
Today the new generation o f host genetic association studies is based on high throughput 
technologies, haplotypic analysis and LD analysis. The International HapMap Project is 
set out to create a resource that should accelerate the identification o f genetic factors that 
influence medical conditions. HapMap reports that with the new generation o f host 
genetics the generality o f hotspots o f recombination, long segments o f strong LD, and 
limited haplotype diversity have been identified which provide information for association 
study design. The most important finding from HapMap is that there is extensive 
redundancy among nearby SNPs, providing the potential to extract extensive information 
about genomic variation without complete re-sequencing and increasing efficiency 
through selection o f tag-SNPs and optimized association analyses. Beyond the
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biomedical context, the data o f HapMap have made it possible to identify deletion 
variants in the genome, explore the nature o f fine-scale recombination and identify 
regions that may have been subject to natural selection. An important application o f the 
HapMap data is to help make possible comprehensive, genome-wide association studies. 
Technology has been developed that now makes it practical to undertake such studies, and 
initial results are encouraging (Klein et al. 2005). The success o f HapMap will be 
measured in terms o f the genetic discoveries, the improved knowledge o f disease 
pathogenesis and ultimately the difference the knowledge gained makes to human health. 
Specifically, identifying which genes and pathways are causal in human disease has the 
potential to provide a new and solid foundation for biomedical research and hopefully 
therapeutic and other interventions. Where genetic mechanisms underlie treatment 
responses, both more efficient trials and individualized preventive and treatment strategies 
may become practical (Need et al. 2005). Success identifying alleles conferring 
susceptibility or resistance to common diseases will also provide a deeper understanding 
of the architecture o f disease; how many genes are involved, whether and how alleles 
interact with one another (Brem et al. 2005), and interact with environmental exposures to 
shape clinical phenotypes. Technological innovation and international collaboration in 
these areas will be required to advance the shared goal o f understanding, and ultimately 
preventing, common human diseases.
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Appendix 1: Melting profile. Melting profile for TLR4 fragments. Predicted melting
profile of TLR4 E1 (1A), TLR4_E2.1 (IB), TLR4_E2.2 (1C), TLR4_E3.1 (ID),
TLR4 E3.2 (IE), TLR4_E3.2 without GC clamp (IF), TLR4_E3.3 (1G), TLR4_E3.4 
(1H), TLR4 E3.5 (II), TLR4_E3.5 without GC clamp (1J), TLR4_E3.6 (IK), TLR4_E3.7 
(1L), TLR4_E3.7 without GC clamp (1M) fragment using the W AVEMAKER software, 
(a) helical fraction versus temperature (b) helical fraction versus base position (c) 
temperature versus base position.
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Appendix 2: Melting temperature curves. Melt curve generated for the T L R 4 E 1  (2A), 
T L R 4 E 2 .1  (2B), T L R 4 E 2 .2  (2C), T L R 4 E 3 .1  (2D), T L R 4 E 3 .2  without GC clamp (2E), 
T L R 4 E 3 .3  (2F), T L R 4 E 3 .4  (2G), T L R 4 E 3 .5  without GC clamp (2H), T L R 4 E 3 .6  (21), 
T L R 4 E 3 .7  (2J) fragment by using pooled PCR products at different temperature. From top to 
bottom the curves correspond to the temperatures.
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